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Abstract. 
Abstract 
The effect of different N-pentyl-2-pyridylmethanimine (NPMI) derivatives upon the rate 
of copper(I) mediated atom transfer radical cyclisation (ATRC) of mono-bromo- and 
trichloro-acetamides were investigated. 6-Functionalised NPMI derivatives retarded the 
rate of ATRC due to steric effects, while for the 5-substituted analogues, inductively 
increasing the electron density of the pyridine nitrogen increased the rate of ATRC. 
Multidentate amine derived copper(l) halide complexes were found to mediate the ATRC 
of I-halo-N-propargylacetamides. The cyclisation of trichloro- and dichloroacetamide 
precursors leads to a,~-unsaturated y-Iactams containing the gem-dihalide functional 
group, while monohaloacetamides gave rise to either cyclised atom transfer or reduction 
products depending upon the solvent and catalyst used. The tripyridyJamine (TPA) 
copper(I) halide complex facilitates the efficient ATRC of bromo-enamides to give p-
lactams exclusively with no formation of y-Iactams. Initial products result from 4-exo 
bromine atom transfer and subesqucnt elimination can be readily achieved to furnish the 
corresponding alkenes. A range of fused bicyclic lactams were prepared via copper(l) 
mediated 5-endo ATRC of halo-N-(cycloalk-l-enyl)acetamides and the use of this 
methodology for the synthesis of the Iycorane and erythrinane alkaloid skeletons was 
in vestigated. 
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Chapter 1 
Introduction 
1.1 General introduction. 
Free radicals are species containing one or more unpaired electrons. This definition 
includes certain stable inorganic molecules such as NO and N02, and many monatomic 
species, such as Na and CI. In contrast to ionic species, radicals react together without 
encountering any significant barrier to form stable neutral molecules. Hence, in the liquid 
phase radical-radical reactions are often limited only by the rate at which the reaction 
partners can diffuse through solution. I However, persistent radicals have appreciable 
lifetimes due to steric factors and can allow the rates of such reactions to be slowed. 
This reactive nature, coupled with significant undesirable solvent side reactions limits the 
synthetic utility of radical-radical reactions. However, reactions of radicals and non-
radicals can be conducted in a more controlled manner and this has much more scope for 
synthetic development. 
Radicals are synthetic intermediates of considerable importance, and when compared to 
their ionic counterparts have a number of unique features. Radical reactions typically 
proceed with significant functional group tolerance and with high levels of regio- and 
stereoselectivity. Radical reactions are often tolerant of steric crowding, particularly at 
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the radical centre and the application of heat can often be avoided by utilising photolysis 
for radical generation. In addition, radicals are free from solvent, counterion and 
aggregation effects. 
1.2 Carbon radicals. 
As the employment of free radicals in organic synthesis continues to grow in popularity 
much effort has focussed on the use of carbon centred radicals. The work in this thesis 
covers the generation and reaction of carbon centred radicals and as such an introduction 
to their chemistry only is given here. 
1.2.1 Stability and structure. 
Dissociation energies (D values) of R-H bonds provide a measure of the relative inherent 
stability of free radicals. Table 1 lists these energies for selected carbon centred radicals 
(R),2 the higher the D value, the less stable the radical. 
R D R D kJ / mol) 
Phe Pre 417 
CF3· ChC· 401 
CH2=CII· 444 Me2CH· 401 
Cyc1opropyle 444 Cyc10hexyl 400 
Me· 438 PhCH2• 368 
Ete 419 CHFCHCH2· 361 
Me3CClh· 418 
Table 1. Selected bond dissociation energies. 
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Note that the order of stability of free radicals is tertiary > secondary > primary > 
methane. This series is analogous to that in carbocations and is explainable by 
hyperconjugation. The stability of free radicals also increases with reasonance 
possibilities.3 Thus, allylic and benzylic radicals, for which conical forms can be drawn 
are substantially more stable than simple alkyl radicals. 
Carbon centred radicals may either adopt a planar (s/ bonding) or pyramidal (sp3 
bonding) structure as outlined in figure 1. ESR spectra, and other evidence, indicate that 
simple alkyl radicals have planar structures.4 This is in accordance with the observed loss 
of optical activity when a radical is generated at a chiral carbon.5 Although simple alkyl 
radicals prefer a planar geometry the energy difference between planar and pyramidal 
radicals is relatively small. However, radicals with electron withdrawing substituents 
(e.g. CF3 e) prefer a pyramidal structure,6 hence, increasing electronegativity favours 
deviation from planarity. 
-kl ~II 
Planar Pyramidal 
Figure t. Structure of alkyl radicals. 
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1.3 Radical reactions. 
The increase in synthetic application and development of radical reactions may partly be 
attributed to the large number of kinetic and mechanistic studies that have been 
conducted? The large variety of useful transformations that can now be accomplished 
using free radical reactions has been extensively covered in a number of reviews.8 Most 
of these reactions can be classified into two broad groups: atom (or group) transfer and 
addition to multiple bonds. 
1.4 Atom transfer reactions. 
In atom transfer reactions,9 a radical directly attacks and displaces an atom or group from 
an organic molecule to produce a new radical located at the former site of the abstracted 
functionality (scheme 1). These direct substitutions are analogous to the SN2 or SE2 
displacements of heterolytic chemistry and are termed SH2 substitution reactions (also 
called abstractions). 
A-X + B - A- + B-X 
Scheme 1. Atom transfer reaction. 
In this very broad class of reaction the most commonly abstracted groups are univalent 
atoms such as hydrogen or halogens, although abstraction of other groups (e.g. SR) are 
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also useful. The position of equilibrium is detennined by the relative strengths of the 
fonning and breaking bonds. Hence, the rate of reaction is controlled largely by its 
exothennicity. 
1.5 Addition reactions. 
The addition of radicals to multiple bonds is an important class of reaction and is one of 
the mildest techniques available to extend a carbon chain. Although additions to alkenes 
and alkynes has received most attention,8,lo additions to carbon-nitrogen and carbon-
oxygen bonds have begun to emerge as useful reactions. Both inter- and intramolecular 
radical additions are common. However, intramolecular addition is pertinent to the work 
described within this thesis and will be covered in more detail. 
1.5.1 Intermolecular addition. 
Carbon-carbon bond fonnation is arguably the most important synthetic step in the 
construction of organic molecules and is increasingly being achieved by the addition of 
carbon centred radicals to carbon-carbon multiple bonds (scheme 2.). 
R- + c=y 
Scheme 2. Radical addition reaction. 
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This addition is often a highly energetically favourable process since a C-C a-bond is 
fonned at the expense of a C-C 1t-bond. The effects of substituents located on both the 
radical and the unsaturated partner on the rate and regioselectivity of the reaction are well 
established. I I 
1.5.1.1 Electronic character of carbon radicals. 
Carbon centred radicals can be classified as nucleophilic, electrophilic or ambiphilic 
depending upon the substituents attached to the radical. This electronic nature will 
detennine the radicals reactivity. The origin of these substituent effects in radical 
additions to alkenes can be understood in tenns of frontier molecular orbitals. The 
important interactions occur between the radicals singly occupied molecular orbital 
(SOMO) and the alkenes highest occupied orbital (HOMO) and lowest unoccupied 
orbital (LUMO) as represented in figure 2.7 
. : .... 
: "" .. 
/ /.:.)-1 -L-U-M-O-1+,./ . . 
: , , 
. . . 
. . . 
// \\, ZC~ JMO < ... + .. ~:+ 
'\ •••• HOMO 
(A) (8) 
Figure 2. Frontier orbital diagram for radical addition to an alkene. 
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Nucleophilic radicals including vinyl, aryl, acyl and alkyl radicals react preferentially 
with electron deficient alkenes. Intennolecular additions to unactivated alkenes are 
generally too slow to be synthetically useful. However, reaction rates can be increased by 
electronic modification of the alkene partner. Thus, intennolecular additions can be 
greatly accelerated by introducing an electron withdrawing substituent at the p-position 
of the alkene.9 This serves to lower the LUMO thereby decreasing the SOMO-LUMO 
gap resulting in stabilisation of the transition state (figure 2, diagram A). 
Electrophilic radicals generally contain two electron withdrawing groups and react 
preferentially with electron rich alkenes. The introduction of electron withdrawing 
substituents at the radical centre will have the effect of lowering the SOMO, which 
pennits stronger SOMO-HOMO interactions resulting in an increase in reaction rate 
(figure 2, diagram B). Electron donating substituents on the alkene have a similar effect 
but to a much lesser extent. 12 
Distinction between electrophilic and ambiphilic radicals is unclear. Generally ambiphilic 
radicals possess SOMO energies between those of electrophilic and nucleophilic radicals. 
1.5.2 Intramolecular addition (cyclisation). 
The preparation of cyclic systems is fundamental to the synthesis of complex natural 
products. However, it was not until the early 1980's that Stork,13 Bachi 14 and Beckwith 15 
among others started to explore the synthetic utility of intramolecular free radical 
additions. Radical cyclisation reactions have gained increasing attention and now 
represent an extremely powerful tool for the construction of cyclic arrays. 
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This section outlines the scope of such methodologies. Work described within this thesis 
mainly concerns exo cyclisations and as such emphasis will be placed upon this area. 
In every radical cyclisation to an alkene there are two competing pathways: An endo 
cyclisation involves a radical addition to the terminal end of the multiple bond resulting 
in a larger ring, while an exo cyclisation occurs when the radical attacks the internal end 
forming a smaller ring (scheme 3). 
a B • Endo 
Scheme 3. Exolendo pathway of intramolecular radical additions. 
1.5.2.1 Exo cycIisations. 
Intramolecular radical additions are generally regioselective and in accordance to 
Baldwins rules 16 favor 3 to 7-exo cyclisations over their endo counterparts. In addition, 
activating suitable radical acceptors with an electron withdrawing group at the terminus 
of the carbon-carbon multiple bond will improve both regioselectivity and yield. 
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1.5.2.1.1 3- and 4-Membered ring formation. 
Radical cyclisations to fonn three- and four-membered rings do not compete well with 
the reverse ring opening process and are therefore highly unfavourable. The release of 
ring strain strongly biases the equilibrium toward the direction of the acyclic radicals. 
However, radical cyclisations that fonn three-membered rings have been observed if the 
ring closed radical is resonance stabilised, for example, Luh and Weng have 
demonstrated sequential 5-exo and 3-exo cyclisations leading to the fonnation of fused 
cyclopropanes (1)17 (scheme 4). 
BUaSnH 
cat. AIBN 
.. 
• 
-
Scheme 4. Formation of fused cycIopropanes (1). 
o 
(1 ) 
A few literature examples have demonstrated that suitably designed radical acceptors can 
accelerate 4-exo cyclisations and stabilise the resulting ring closed radicals. ls ~-Lactams 
have been synthesised by several different methods using radical cyclisation protocols. 19 
All these methods have some mechanistic factor that promotes the otherwise 
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unfavourable 4-membered ring formation. This area will be discussed in more detail in 
chapter 4. 
1.5.2.1.2 Hexenyl radical cyclisations. 
The formation of five-membered rings by 5-exo cyclisation of hexenyl radicals are the 
most useful class of radical cyc1isation reaction. These cyclisations are typically 
irreversible and have been studied kinetically and mechanistically in some detail.2o 
1.5.2.1.2a Regioselectivity. 
5-Hexenyl radical cyclisation results in the formation of both the 5-exo derived 
methylcyclopentyl radical (2) and the 6-endo derived cyclohexyl radical (3) in a ratio of 
49: 1 (scheme 5).11 
• 
6 • + o 
(2) 98% (3) 2% 
Scheme 5. regioselectivity of 5-hexenyl radical cyclisation. 
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On thennochemical grounds the more stable cyclohexyl radical (3) would be expected to 
give cyclohexane as the major product. However, cyclisation proceeds predominantly via 
5-exo ring closure demonstrating the reaction to be under kinetic control.21 
The transition state model devised by Beckwith22 predicts that the main product of 
cyclisation occurs via the lowest energy strain-free 5-exo chair transition state (figure 3). 
It is suggested that this arrangement accommodates maximum overlap between the semi 
occupied 2p orbital and the vacant 1[* orbital.23 This stereoelectronic influence is regarded 
as the single most important factor favoring 5-exo over 6-endo cyclisations.24 
A::::J 2-) ;[;::J 
-- . 
5-exo chair 5-exo boat 6-endo chair 
o kcal mor1 +1 kcal mor1 +3 kcal mor1 
Figure 3. Transition state models for S-hexenyl radical cyclisation. 
l.S.2.1.2b Stereoselectivity. 
The stereochemical outcome of the eyclisation of substituted 5-hexenyl radicals has been 
well studied. The Beckwith-Houk chair-like transition state model serves as the basis for 
d" d' 1" h 1" f h . 22b 25 L k b pre IctIng an ratlona Ismg t e stereose ectlvlty 0 sue reactIons.' ater wor y 
Spellmeyer and Houk25 advanced this understanding and recognised the importance of 
the 5-exo boat transition state. The model states that major eyclisation products are 
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formed via a chair-like transition state with substituents preferentially occupying pseudo-
equatorial positions as depicted in scheme 6. 
5-exo 
Scheme 6. Beckwith model for stereoselectivity of 5-hexenyl radical cyclisations. 
Thus, the model predicts cis products from 1- or 3-substituted hexenyl radicals and 
predominantly trans products from 2- or 4-substituted radicals. The energy difference 
between two conformers of a cyclic transition state corresponds to the conformational 
preference of the substituents. Therefore, stereoselectivity is most pronounced when 
substituents are sterically bulky. 
1.5.2.1.3 Formation of larger rings. 
The formation of six-membered rings by exo cyc1isation of 6-heptenyl radicals is 
significantly slower than that of their 5-hexenyl counterparts. The exo mode of ring 
closure is still favoured, however competition between 6-exo and 7-endo cyclisation is of 
greater importance since the increased chain length now permits the formation of greater 
amounts of the endo derived product. In addition, heptenyl radical cyclisations are 
complicated further by a competing 1,5-hydrogen atom transfer reaction. As with ring 
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closure of other sizes, electron-withdrawing substituents at the tenninus of the multiple 
bond have been employed to accelerate 6-exo cyclisation (scheme 7).26 
Br 
BU3SnH 
cat. AIBN 
Scheme 7. Example of 6-exo ring closure. 
Stereoselectivities of 6-exo cyclisations of substituted heptenyl radicals are still 
predictable using the transition state model, but with some Iimitations.27 The model 
predicts formation of cis products from 2- and 4-substituted radicals, and trans from 1-, 
3- and 5-substituted radicals. Hanessian26 systematically studied 6-exo closures of 
substituted heptenyl radicals and other examples of stereoselective 6-exo cyclisations 
appear in the literature.28 
The Porter and Hutchinson groups29 have demonstrated that fonnation of larger rings via 
exo-cyclisations can be achieved. However, in general tenns, as the size of the ring 
increases the rate of closure decreases as does the preference for exo mode of cyclisation. 
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1.5.2.2 Endo cyclisations. 
In comparison to their exo counterparts, endo cyclisations are usually minor processes in 
the formation of standard and medium sized rings. However, appropriately designed 
radical acceptors have the ability to change the regioselectivity to favor endo cyc1isation. 
For example, endo cyclisations for larger ring closures are favourable when an electron 
withdrawing group is present at the inner position of the multiple bond. This concept is 
exemplified by the synthesis of 7-epi-~-bulnesene (4) by Negishi and coworkers (scheme 
BU3SnH 
cat. AIBN 
Ph Me, 110°C 
68% 
(4) 
Scheme 8. Synthesis of 7-epi-~-bulnesene via endo cyclisation. 
In addition, suitably designed halo-enamide substrates have been reported, within the 
Clark group, to undergo 5-endo cyclisation.31 Thus, reaction of mono-halo substrates (5) 
(n=l, R=Bn) furnished two alkene products (6) and (7) in 82% yield (1:1 ratio) (scheme 
9). The reaction was found to be tolerant of a variety of ring sizes and ring substitutions. 
This area will be covered in more detail in chapter 4. 
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DCM, RT, 20 min. 
:±:=(),.,~ :to),.,., 
1
0 7 R R 
30 mol%CuBr 
30 mol% Me6-tren 
• 
(5) (6) (7) 
Scheme 9. 5-Endo cyclisation of monohalo enamides (5). 
In contrast to smaller ring formation, most radical macrocyclisations that appear in the 
literature are designed to utilise endo ring closures. Porter and co-workers pioneered the 
synthesis of macrocyclic ketones and lactones by radical cyclisation reactions.32 Boger 
and Pattenden among others extended this chemistry to include acyl and allyl radical 
cyclisations and applied this methodology to the synthesis of a series of biologically 
interesting compounds.33 
The construction of complex heterocyclic systems is increasingly achieved via radical 
cyclisation protocols. Endo cyclisations are often employed for this purpose, particularly 
in the preparation of fused ring systems. The formation of such systems using the less 
common 5-endo mode of cyclisation will be discussed in detail in chapter 5. 
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1.6 Methods of performing radical reactions. 
A diverse range of transformations can be achieved using free radical reactions. 
However, the number of practical methods available to conduct free radical reactions is 
quite limited. The work reported in this thesis utilises copper mediated atom transfer 
reactions for the generation of radicals, and hence this section will be discussed at length. 
For synthetic application the selection of method is extremely important as it will 
determine the fate of intermediate radicals. Identical radicals generated by different 
methods may have different lifetimes and therefore provide different products?7 
1. 7 Chain reactions. 
The maintenance of a low concentration of radicals over the course of a reaction is 
desirable since unlike anions and cations, radicals react with themselves at rates 
approaching the diffusion controlled limit. Chain reactions are well suited to meet this 
requirement. Chain reactions consist of initiation, propagation and termination steps. 
Initiation steps generate radicals and are often achieved by homolytic bond cleavage of 
an initiator (AIBN, BPO) or by a photochemical or redox reaction. All desired· 
transformations in a chain occur in the propagation steps, while termination steps remove 
radicals via dimerisation and disproportionation reactions. 
To be useful synthetically, a given chain reaction must generate radicals selectively and 
these radicals must have sufficient lifetime to react. This lifetime must be carefully 
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controlled by the nature of the chain transfer step since radicals that are pennitted too 
long a lifetime may engage in chain tennination steps. 
1.S Metal Hydrides. 
1.S.1 The tin hydride method. 
The use of organotin hydrides has become the most commonly used method for the 
synthetic application of free radicals to carbon-carbon bond fonnation.34 The 
characteristics of this approach are outlined below in a generalised example of a 
tributyltin hydride (Bu3SnH) mediated reaction (scheme 10). Typically the chain carrier 
Bu3Sn
e
, is generated in an initiation step from tributyltin hydride using 
azobisisobutyronitrile (AIBN) as a chemical initiator. The tributyltin hydride radical then 
abstracts an atom or group X from the precursor to generate the organic radical Ae• This 
then undergoes a transfonnation (inter- or intramoleculary) to fonn a new radical Be. 
Hydrogen atom transfer then provides the final product B-H and regenerates the chain 
carrying tributyl tin radical. 
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A-X + BU3Sn - .. A - + BU3SnX 
A- .. B-
B- + BU3SnH .. B-H + BU3Sn -
Competing reaction 
A- + BU3SnH .. A-H + BU3Sn -
Scheme 10. Tributyltin hydride mediated radical reactions. 
A common problem in organostannane mediated reactions is the premature reduction of 
A· by the reagent itself. The maintenance of a low concentration of the hydride reagent 
over the course of the reaction is therefore desirable. Hence, syringe pump techniques are 
often used for the addition of the hydride and serve to maintain a steady, low 
concentration of this reagent. Related techniques include the use of polymer bound tin 
hydrides35 and the generation of trialkyltin hydrides in-situ by the reaction of a catalytic 
amount of tin halide with standard hydride reducing agents (NaBH4 or NaCNBH3).36 
A variety of radical precursors can be used in the tin hydride method. A reactivity scale 
has been determined by Beckwith and Pigou.37 They established in order of decreasing 
reactivity that I > Br > PhSe > secondary and tertiary xanthate esters> tertiary nitro> Cl 
> PhS> MeS. For the least reactive alkyl chlorides and alkyl phenyl sulfides the rate of 
abstraction may not be sufficient to propagate a chain. In general, iodides are the 
precursor of choice since trialkyltin radicals abstract iodine from alkyl iodides at rates 
approaching the diffusion controlled limit. 
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Despite this versatility, there are major disadvantages associated with the use of 
trialkyltin hydride mediated radical reactions. These include their high toxicity, high 
expense, their reductive nature and the difficulty in removing tin compounds from 
product mixtures. 
I.S.2 Mercuric Hydrides. 
The use of mercuric hydrides to conduct radical chain reactions has been developed by 
Giese.38 The mercuric hydride reagent is generated in-situ by the reduction of alkyl 
mercuric salts (typically halides or acetates) with hydride donors such as NaBH4. 
Thermal or photochemical initiation is unnecessary in this method as the chain is started 
by spontaneous decomposition of the mercuric hydride. This approach has several 
advantages over the tin method as reactions proceed under mild conditions, are rapid and 
the separation of mercury during work-up is non-problematic.27 However, reduction is 
facile due to superior hydrogen transfer from mercuric hydrides. Thus, this methodology 
is typically only employed in syntheses involving reactive, electron-poor alkenes as 
summarised in scheme 11.39 
A-HgX + NaBH4 II A-HgH 
• 
A. + /"R II A~ R 
• A~R + A-HgH II A~R + A. + Hg(O) 
Scheme 11. Chain reaction for mercuric hydride. 
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1.8.3 Tris(trimethylsilyl)silane method. 
Tris(trimethylsilyl)silane (TTMSS) has been reported to be an efficient free radical 
mediator due to a relatively weak Si-H bond which enables it to participate in radical 
chain reactions as a hydrogen donor.4o TTMSS is an effective radical mediator with alkyl 
bromides and iodides, isocyanides, selenides and carbonyl derivatives.41 
The non-toxic TTMSS is environmentally superior to trialkyl tin hydrides and the ease of 
purification of products makes it an attractive reagent. The use of TTMSS has a further 
advantage over trialkyl tin hydrides as TTMSS is a poorer hydrogen donor, therefore 
lower rates of hydrogen transfer are achieved leading to the formation of less reduction 
product. The mode of action of TTMSS is analogous to that of tin hydride as shown in 
scheme 12. 
(Me3SibSi--H + In· 
A-X ---I .... A. 
A· 
Scheme 12. Chain reaction using Tris(trimethylsilyl)silane. 
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1.9 The fragmentation method. 
The fragmentation method involves the generation of the chain-transfer agent by a 
fragmentation reaction (scheme 13) rather than by an atom abstraction as in the tin 
hydride method. 
Re +~y .. e R~Y .. R...... ~ ..........", ~ + ye 
Scheme 13. Generation of the chain transfer agent. 
The rapid fragmentation of an appropriate C-Y bond produces the radical Y·, which may 
be the chain-transfer agent itself or generate the chain-transfer reagent in a subsequent 
reaction with a neutral molecule. Instead of obtaining reduced products, substitution 
products are formed as an alkene is regenerated in the fragmentation step. The process 
utilises the fact that relatively weak bonds such as C-Br, C-SnR and C-SR can fragment if 
located p to a radical. Allyl and vinyl stannanes have become the most popular reagents 
for this method. The chain mechanism for allylation with allyltributylstannane is shown 
in scheme 14. Abstraction of X (normally a halogen) by the tributyltin radical provides a 
carbon radical from the organic substrate. Addition of the generated radical Ae to 
allyltributylstannane, followed by p-scission then affords the allylated product and 
regenerates the tributyl tin radical in order to propagate the chain. 
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A-X + 
A- + ~snBU3 A~snBU3 
A~snBU3 A~ + BU3Sn-
Scheme 14. Chain reaction for allyltributylstannane mediated allylation. 
The advantage of this approach is that tin hydride is not required in the reaction. Hence, 
the lifetimes of intermediate radicals are not limited by the rate of hydrogen atom 
abstraction and since intermediate radicals are not intercepted low concentrations are not 
required. This ability to provide long lifetimes for intermediate radicals is the key 
element in the success of the fragmentation method and often allow one or more reactions 
to be conducted between radical generation and allylation.42 
1.10 The thiohydroxamate ester method. 
This method was developed by Barton and co-workers43 and utilises the chemistry of 
thiohydroxamate acid esters. The thiohydroxamate ester approach differs from other 
methods in that group transfer is achieved by an addition/elimination mechanism rather 
than by a homolytic substitution. Mechanistic studies by Barton have provided good 
evidence for the propagation sequence as outlined in scheme 15.44 
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+ R. )l /N • o QI R 0 
(9) SR 
o QI )l /N • 
R 0 
R. + 
(9) SR 
R. + X-V ------.~ R--X + V. 
)l /N • o QI 
R 0 
(10) SV 
Scheme 15. Propagation sequence for thiohydroxamate ester method. 
Initial addition of the alkyl radical Re to the thiohydroxamate (8) produces (9). 
Fragmentation of (9) then occurs and may be concerted or stepwise, involving an 
intermediate carboxy radical. The alkyl radical Re is the chain carrying species. The 
formation of carbon dioxide and the aromatization to the mercaptopyridine provide the 
enthalpic driving force for the reaction. For the successful formation of products R-X the 
alkyl radical must abstract an atom or group (X) from X-Y at a rate more rapid than the 
direct addition to the starting hydroxamate. The resulting radical Y· then adds to the 
precursor to produce (lO), which itself fragments to transfer the chain. 
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The power of the Barton method lies in the ability of the intennediate radical R· to be 
intercepted by a variety of other neutral molecules, X-Y. A wide range of functional 
groups X can thus be incorporated using this general approach. 
1.11 The atom transfer method. 
Developed by Kharasch, the addition of a reagent X-Y across a carbon-carbon multiple 
bond is one of the fundamental reactions of organic free radicals.45 A general mechanism 
for this addition (or cyclisation) reaction is outlined in scheme 16. 
In. + X-V • In-X + Y • 
• 
Y • + ~R • y~ R 
X 
• Y~ Y~R + X-V • + y • 
R 
Scheme 16. Atom transfer reaction scheme. 
The key chain transfer step involves donation of an atom or group X from the starting 
material X-Y, with the resulting radical Y· being the chain transfer agent. Therefore, in 
effect, both chain transfer and generation of the initial radical are combined into a single 
step. In methods that employ an external reagent (such as tin hydride), these functions are 
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accomplished in two separate steps. The transfer of X must be relatively rapid so that 
standard radical termination or polymerisation reactions cannot compete. 
1.11.1 Hydrogen atom transfer. 
Both hydrogen and halogen atom transfer reactions are possible. Early studies by Julia on 
hydrogen atom transfer cyc1isations have contributed much to the present understanding 
of the kinetic and thermodynamic factors controlling free radical cyc1isations.46 Julia 
found that treatment of activated hexenyl derivatives (11) with peroxide initiators gave 
mixtures of cyc10pentane and cyc10hexane products (12) and (13) (scheme 17). 
peroxide 
.. 
(11 ) (12) 
Scheme 17. Ilydrogen atom transfer cyclisation. 
However, large amounts of initiator are generally required and is some cases, a non-chain 
mechanism may predominate since even the most activated C-H bonds are barely reactive 
enough to maintain a viable chain reaction. In addition, the hydrogen atom transfer 
approach results in a rcductively terminated reaction, which is of limited synthetic 
benefit.47 
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1.11.2 Halogen atom transfer. 
In comparison, halogen atom transfer reactions have much scope for synthetic 
development. This method often permits initial and intermediate radicals long lifetimes 
with respect to chain transfer, allowing relatively slow reactions to occur. This situation 
cannot occur in the tin hydride method, since all radicals have similar lifetimes with 
respect to chain transfer. This is ilIustrated in an example reported by Chang.48 Thus, 
attempted cyc1isation of iodo ester (14) with BU3SnH provided the reduction product (15) 
only. However, ditin-mediated halogen atom transfer cyc1isation of (14) at high 
concentration (O.3M) gave lactone (16) in 55% yield (scheme 18). 
0 
OACH 
BU3SnH 6' 0 o~1 (15) Not formed 
6 
(14) 
BU3SnSnBu3 
H 
(16) 
Scheme 18. Ditin mediated halogen atom transfer cyclisation of iodo ester (14). 
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In the tin hydride method, the slow cyclisation of the initial radical cannot compete with 
hydrogen atom abstraction, even at low BU3SnH concentrations. However, under atom 
transfer conditions the same radical is permitted a much longer lifetime. Hence rapid 
iodine atom transfer from (14) produces lactone (16). Further work by Curran and Chang 
has demonstrated that the ditin-mediated atom transfer cyclisation of stabilised radicals 
provides the ability to generate ring sizes other than 5-membered (scheme 19).49 
Heat 
.. 
Heat 
~ 
Scheme 19. Ditin-mediated atom transfer radical cyclisation. 
Thus, the relatively slow cyclisations possible atom transfer conditions allow both 6-exo 
and 7-endo ditin-mediated reactions to be conducted. The halogen atom transfer 
cyclisation method therefore provides a valuable area for synthetic application. In 
addition, a versatile halogen is retained in the product under these conditions, allowing 
unique and powerful synthetic sequences to be designed using this approach. 
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1.12 Transition metal mediated halogen atom transfer reactions. 
Over the last decade transition metal promoted atom transfer radical reactions have 
emerged as a viable alternative to stannane based radical chemistry. This is largely due to 
the pioneering work of Kharasch45c and others.50 Transition metal mediated atom transfer 
processes are non-reductive and reactions are usually terminated with inclusion of 
functionality in the product. In addition, reaction work-up is not complicated by the 
removal of the toxic tin by-products that are associated with traditional stannane based 
procedures. The advantages of transition metal promoted reactions have led to much 
research activity in this field. As a result transition metal mediated radical reactions have 
emerged as important synthetic methods for carbon-carbon bond formation. The most 
popular types of reagent are those based upon ruthenium, iron and and copper although 
numerous other metals have also been utilised.51 
1.12.1 Ruthenium complexes. 
The synthetic utility of radical reactions via the interaction of dichlorotris(triphenyl 
phosphine) ruthenium(II) with an organic halide has found widespread use in organic 
synthesis. The Ru(lI) catalysed addition of polychloroacetic acid to alkenes is a high 
yielding reaction. In the hands of Matsumot052 and others this reactions was found to be 
particularly useful for additions involving polymerisable olefins such as styrene and 
methyl methacrylate. The intramolecular version of this reaction has been utilised by 
Weinreb53 for the preparation of y-halocarboxyl and y-Iactones. Thus, dihalo ester (17) 
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can be efficiently transfonned via exo closure of a 5-hexenyl-type radical to afford both 
(18) and (19) (scheme 20). 
~' CI ~O'R CO2 A RuCI2(PPh3h • + 
~ (17) H CI H 
For R = H 89% (1 :1.2) (18) (19) 
Scheme 20. Ruthenium mediated cyclisation of dihaloesters. 
Itoh extended the utility of the RuCh(PPh3)3 catalyst by application to synthesis of y-
lactams54 from both secondary and tertiary ami des as shown in scheme 21. 
CI 
• 
A" 
CI~lf 
oAN A" 
I 
A' 
A' = H, alkyl 
Scheme 21. Ru(lI) mediated cyclisation of trichlroacetamides. 
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In addition, the precursor (21) (for the total synthesis of pretazettine (22» has been 
prepared in 57% yield by RuCh(PPh3)3 mediated atom transfer cyclisation of 
chloroacetamide (20) (scheme 22).55 
(XAr CI ~ SPh 
OMe"'" N~ 
I 
Me 
(20) 
20 mol% CI SPh 
RUCI2(PPh~3 cJS~r 
C6H6 2.5 hrs 0 
150 DC OMe'\"· i ~ 
H Me 
(22) 
o 
Ar 0-( dj- Bu -- ~ ~ 
Mao'\"· i ~ 
H Me 
(21) 
Scheme 22. Synthesis of pretazettine via Ru(II) mediated cyclisation. 
1.12.2 Iron complexes. 
Halogen atom transfer additions of a-haloesters to alkenes have been widely investigated 
and more recently the use of environmentally friendly reagents for this purpose has 
attracted much interest. Ghelfi and co-workers reported that halogen atom transfer radical 
additions of methyl 2,2-dichlorocarboxylates to alkenes are efficiently promoted by iron 
filings (scheme 23).56 
+ ~RU Feo, DMF/DCE .. 
R' AU 
H3COOXY, 
Scheme 23. Feo promoted radical addition to alkenes. 
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In a continuation of this work Feo-FeCb has been shown to mediate cyclisation of N-
allyl-N-benzyl-dichloroacetamides to 2-pyrrolidinones in good yields (scheme 24).57 
CI 
100 °e, DMF, 20 hrs 
N 
I 
Bn 
Scheme 24. Feo.FeCb promoted preparation of 2-pyrrolidinones. 
More recently the use of iron in the fonn of Fe(JI) tris-pyridine-2-ylmethyl-amine has 
been utilised in the synthesis of various lactones under milder reaction conditions.58 
1.12.3 Copper Complexes. 
The most successful transition metal catalysts for atom transfer radical additions are those 
derived from copper(J)-based halogen compounds.51 The Cuel catalysed intennolecular 
addition of polyhalocarbons to alkenes has been known for some time (scheme 25).59 The 
intramolecular version of this reaction can provide rapid and convenient access to a 
variety of cyclic systems. 
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CuC), Et02C-CCI3 
.. 
EtOH, reflux, 32% 
Scheme 25. copper catalysed intermolecular addition reaction. 
In comparison to alternative reductive methods, the use of copper mediated radical 
cyclisations has a number of advantages including: the efficient catalytic nature of the 
process, the low cost of copper halides and the ease of separation of copper complexes 
from reaction products. 
1.12.3.1 Reactions using CuC)' 
Itoh has demonstrated that copper-based oxidative atom transfer cyclisations of activated 
trichloroacetates60 involve a redox reaction between copper(l) and copper(II) salts. As 
shown in scheme 26, CuCl formally abstracts a chlorine atom from trichloroacetate (23) 
which generates the initial radical (24) and CuCh. Following 5-exo ring closure the 
newly formed primary radical (25) reacts with the CuCh to regenerate the CuCI catalyst 
and furnish the cyclised product (26). 
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CuCI 
CI 
CI 
CI 
o 
(26) 
30 mol%CuCI 
MeCN,140oC 
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aif 
o 0 
(24) 
(25) 
Scheme 26. copper(I) mediated atom transfer radical cyclisation. 
Atom transfer radical cyclisations mediated by CuCI have also been utilised by Itoh for 
the preparation of y_lactams.54•61 Thus, reaction of trichloroacetamides 27a-b with a 
catalytic amount of CuCI in MeCN at 140°C afford the 5-exo atom transfer products 28a-
b (scheme 27). 
27a R = H 
27b R = allyl 
30 mol %CuCI 
MeCN,140oC 
1-20 hrs. 
• 
CI 
28a R = H, 57% 
28b R = allyl, 87% 
Scheme 27. Copper(I) mediated radical cycJisation of trichloroacetamides. 
60 
Chapter 1 : Introduction. 
Using this methodology the cyclisation of both secondary 27a and tertiary 27b amides 
were possible. Note that cyclisation of the tertiary amide was the more efficient and that 
no products arising from 6-endo closure were detected. 
Bicyclic lactams which possess pyrrolidine alkaloid skeletons are readily prepared using 
this approach. Accordingly, mesembrane (30) has been synthesised61 in 47% yield by 
CuCI catalysed cyclisation of N-allyl-trichloroacetamide (29) (scheme 28). 
OMe OMe 
OMe OMe 
MeO Cu(I)CI 1) BU3SnH 
• .. 
2) LiAIH4 
CI 
A o~ N 
I (29) Me (30) 
Scheme 28. Preparation of mesembrane via CuCI mediated radical cyclisation. 
1.12.3.2 The use of copper halide: 2,2'.bipyridine complexes. 
Itoh screened a range of copper salts as potential catalysts62 and found that a number of 
compounds were effective in mediating the cyclisation of trichloroacetate (31) (scheme 
29). However, the addition of an equimolar amount of 2,2' -bipyridine (bipy) to CuC) 
resulted in a marked increase in the rate of reaction. 
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5mol%CuCI 
5 mol% 2,2'-bipy 
MeCN,1400C 
1.5 hrs, 83% 
• 
CI 
CI 
CI 
Scheme 29. CuCl: bipy promoted cyclisation of trichloroacetate (31). 
Further work in this field has demonstrated that in general the addition of either amine or 
pyridine-based ligands causes rapid rate enhancements for a variety of cyclisation and 
intennolecular addition reactions.62 Thus, reaction of substrates 32a-c (table 2) shows 
that CuCI:bipy catalysed the cyclisation more rapidly than CuCI alone.63 
32a R = Bn 
32b R = Ts 
32c R = Boc 
• 
CI 
CI --.,. __ ~ 
33a R = Bn 
33b R=Ts 
33c R = Boc 
Substrate Catalyst (mol %) Temp (OC) Time (hrs) 
32a CuCI (30) 80 18 
32a CuCI : bipy (30) RT 1 
32b CuCI (30) RT 24 
32b CuCI : bipy (5) RT 0.2 
32c Cuel (30) 80 4 
32c CuCI : bipy (30) RT 2 
Reactions with CuCl were run in MeCN, reactions with CuCl(bipy) were run in DeM. 
CI 
Yields (%) 
68 
98 
97 
9] 
80 
78 
Table 2 Effect of catalyst and protecting group on cyclisation of trichloroacetamides 
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Ligands such as 2,2' -bipyridine accelerate the atom transfer process by solubilising the 
CuCI and by altering the redox potential of the catalyst system. Thus, the use of more 
activated catalysts often permit cyclisations to be conducted at room temperature 
(table 2). The nature of the N-protecting group was also found to influence the rate of 
cyclisation. In general, bulky or electron withdrawing N-protecting groups (32b-c) 
facilitate cyclisation by altering the conformational population of the substrate in favour 
of the anti conformer (scheme 30).64 
elf elf 
o N 
I 
R 
anti 
cyclisation 
eI~eI A 
oAN/' 
~ 
syn 
no cyclisation 
Scheme 30. conformations of the amide bond. 
Stereoselectivities of the CuCI:bipy-catalysed 5-exo cyclisation of trichloroacetamides 
34a-b were also found to be dependant on the protecting group. Cyclisation of N-benzyl-
(34a) and N-methyl-N-allyl-trichloroacetamide furnished the corresponding trans isomer 
as the major product. In contrast, cycliastion of the N-tosyl (34b), N-mesyl, N-Cbz and N-
Boc analogues predominantly afforded the cis isomer (scheme 31).63 
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CuCI:bipy 
.. 
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KC' ~ CI CI ..•• ~' o N 
R 
+ ):jCI ,,-CI § CI .•• ,~ 
'·""111/ 
o N 
R 
98% (95:5) 
78% (15:85) 
Scheme 31. Effect of protecting group on stereochemical outcome of reaction. 
The highly active CuCI:bipy catalyst system permits cyclisation of mono-halo substrates, 
albeit at elevated temperatures (_80°C).65 In addition, Speck amp has demonstrated that 
medium sized lactones can be effeciently prepared by CuCI:bipy mediated cyclisation of 
di- and trichloroacetates (scheme 32).66 
CI 
~ ~O CRCI2 CuCI:bipy .. 
n = 1-4 yield 57-75% 
Scheme 32. CuCI:bipy mediated macrocyclisations. 
The efficiency of these medium ring cycIisations coupled with the inability of BU3SnH 
based procedures to facilitate such reactions has prompted suggestion that reactions may 
proceed via a copper templating process.66 Despite the versatility of CuCI:bipy mediated 
cyclisations, large amounts of catalyst are often required (typically 30 mol%), and 
64 
Chapter I : Introduction. 
fonnation of larger rings (l0-12 membered) is not possible without rigid structual 
control.66 
1.12.3.3 The second generation of copper based catalysts. 
The ability to modify both the solubility and redox potential of atom transfer catalysts by 
introducing a ligand has prompted much activity in the use of alternative ligand systems 
for cyclisation reactions. The discovery that different ligands can govern the reactivity, 
yield and selectivity of atom transfer cyclisations has resulted in the preparation of a 
range of highly activated catalysts and has greatly expanded the scope of this 
methodology. 
1.12.3.3a N,N,N',N'· Tetramethylethylenediamine (TMEDA). 
Ghelfi has reported the use of CuCI:TMEDA as an efficient promoter for atom transfer 
radical cycJisation reactions.67 Compared to the classic CuCl:bipy reagent combination, 
improved yields at lower catalyst concentrations were obtained. In addition, cycJisations 
were often conducted at lower temperatures using this highly active system. 
Thus, cyclisation of (35) with 10 mol% CuCl(TMEDAh at 60°C furnished (36) as a 
single diastereomcr in 88% yield (scheme 33).67 Note that attempts to cycJise (35) using 
CuCI:bipy failed, emphasising the importance of the correct choice of ligand. 
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C'Xf 
o N 
I 
Sn 
(35) 
CuCI:TMEDA 
~ 
MeCN,60oC 
20 hrs, 88% 
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CI 
PhH2C I c3:5~ 
o N 
I 
Sn 
(36) 
Scheme 33. CuCI(TMEDAh mediated cyclisation of dichloroacetamide (35). 
The synthetic utility of CuCI:TMEDA mediated cyclisations has been demonstrated 
further by application to the total synthesis of pilolactam68 and in the preparation of 
biologically interesting 3-benzylimino-2-pyrrolidinones (scheme 34).69 
CI 
Senzylamine, Nal 
~ 
THF, sooc, 24 hrs 
Bn 
I ):) 
o N 
I 
Rl 
Scheme 34. CuCI:TMEDA promoted synthesis of 3-benzylimino-2-pyrrolidinones. 
66 
Chapter 1: Introduction. 
1.12.3.3b N,N,N',N',N",N"-hexamethyltriethylenetetramine (Me6-tren). 
Ghelfi reported that two equivalents of bidentate TMEDA : copper halide were required 
for optimum activity.67 As a direct consequence of this observation a number of 
multidentate amine ligands have been investigated as potential catalysts for ATRC 
reactions. The most successful polydentate amine ligand of those screened was found to 
be the tetradentate Me6-tren ligand.7o Thus, the use of a 1: 1 ratio of copper halide:Me6-
tren in a variety of solvents has enabled a range of monohalo substrates to be cyclised at 
room temperature (scheme 35). 
30mol% 
CuBr: Mes-tren 
DCM, RT 
2 hrs, >90% 
Br 
H I RH~"'#' A) 
o N 
I Ts Mea-tren 
Scheme 35. CuHr:Me6-tren promoted cyclisation of monobromoacetamides. 
The use of this catalyst system has also enabled the formation of bicyclic lactams via the 
less common 5-endo mode of cyclisation (section 1.5.2.2). Using this extremely active 
catalyst system it is not necessary to use dried glassware or solvents. In addition, a facile 
work-up procedure often provides cyclised products without the need for purification. 
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1.12.3.3c Tris-(2-pyridyl-methyl)-amine (TPA). 
Verlhac and co-workers recently reported that multidentate pyridine ligands were 
successful in mediating a range of macrocyc1isation reactions.58 The employment of this 
ligand system has enabled macrocyclisations that were previously impossible using the 
copper halide:bipy derived catalyst. For example, reaction of (37) with 10 mol% 
CuCI:TPA afforded (38) in 70% yield (scheme 36). In addition, this versatile approach 
has been utilised for the preparation of a range of crown ethers71 and 8-lactams.7oa 
I~ 
CuCI:TPA 
~ 
CI 
I N ~ ~ ~ 
TPA I # (37) 
Scheme 36. CuCI:TPA mediated macrocyclisation reaction. 
68 
Chapter I: Introduction. 
1.12.3.4 Solid supported copper(I) atom transfer catalysts. 
In order to develop re-usable atom transfer catalysts the immobilisation of pyridine-imine 
ligands onto solid supports has been investigated within the Clark groUp.72 Thus, reaction 
of pyridine-2-carboxaldehyde with aminopropylated silica followed by stirring with a 
solution of copper halide furnished the catalyst (39) (scheme 37). 
Toluene, reflux, 24 hrs 
+ 
H2N~ (39) 
Scheme 37. Synthesis of solid supported ligand. 
The catalyst was active in both 5-exo and 5-endo atom transfer radical cyclisation of a 
range of haloacetamide substrates. However, the supported catalyst was less active than 
its equivalent homogenous counterpart (which will be discussed in detail in chapter 2). 
Upon re-use, a decrease in activity of the supported catalyst system was observed. This 
was found to be due not to leeching of the copper from the polymer bound catalysts, but 
due to the formation of an inactive copper dihalide complex. 
69 
Chapter 1: Introduction. 
1.12.3.5 Perfluorous substituted atom transfer cyclisation catalysts. 
The use of perfluorous catalysis in a variety of organic reactions has been developed. In 
general, two phases are used in the reactions (a perfluorous solvent and an organic 
solvent). Hence, in this approach the perfluorous catalyst is confined to the perfluorous 
phase while the organic reactants and products are confined to the organic phase. 
However, at elevated temperatures the two phases are miscible allowing the desired 
reaction to be catalysed. Upon completion, the reaction is cooled (normally to ambient 
temperature) and the phases again become imiscible allowing easy separation of products 
from catalysts. The perfluorinated analogue (40) of the Me6-tren ligand (section 
1.12.3.3b) was shown to be soluble in perfluorocyclohexane.73 
The ligand was used as a I: 1 mixture with CuCl and screened in the macrocyclisation of 
trichloroester (41) (scheme 38). Cyclisation was slower using (40) in the perfluorous 
solvent than the corresponding Me6-tren system under conventional atom transfer 
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conditions. However, reaction of (41) with 5 mol% CuCl(40) afforded (42) after 10 hours 
in 97% yield. 
(41) 
5 mol% CuCI:40 
1 :2: 1 perfluoroheptane 
:trifluorotoluene:DCE 
CI 
Scheme 38. MacrocycIisation using perfluorous catalysis. 
CI 
(42) 
Recycling of the catalyst is possible by simple decantation of the perfluorous layer. In 
addition, the inertness of most perfluorous solvents further increases the attractiveness of 
this relatively environmentally friendly methodology. 
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Chapter 2 
Ligand Electronic Effects On Rates Of Copper Mediated Atom 
Transfer Radical Cyclisation And Polymerisation 
2.1 Introduction. 
The use of transition metal complexes to mediate atom transfer radical cyclisation 
(ATRC) and atom transfer radical polymerisation (ATRP)1 has attracted much interest in 
recent years. Radical cyclisations of N-allylhaloacetamides with a range of transition 
metal based catalysts including (RuCh(PPh3)J,2 FeCh(P(OEt)3)J,3 CuCI(Bipy),4 
CuCI(TMEDAhs and CuCI(N,N,N',N',N"-pentamethyltriethylenetetramine)6 have been 
reported. Ilowever, even with these catalysts elevated temperatures and highly activated 
carbon-halogen bonds (e.g. <X,a,<x-trihaloacetyls) are often required. By far the most 
successful systems are those derived from copper(I) halogen compounds and the most 
widely used catalysts, particularly for ATRP are based upon bipyridine ligands. 
Improving catalytic efficiency should result in increased yields at lower temperatures and 
permit the cyclisation of less activated monohaloacetamide precursors. To enhance the 
rate of catalysis it would be necessary to alter the redox potential of the system thus 
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influencing the equilibrium A and B (scheme 39). This may be achieved by variation of 
the copper ligand. 
CIX'f CI A Clif 
o N o N 
R R 
Cu(l) Cu(lI) 
J 
CI 
Xi CI CI CIU· B o N o N 
R R 
Scheme 39. Mechanism of copper(I) mediated atom transfer radical cyclisation. 
By preparing analogues to the bipyridine system Matyjaszewski7 has demonstrated that it 
is possible to alter both the solubility and electronic effects of complexes and 
consequently affect the position of equilibrium, thus allowing for limited control over the 
rate of product formation. However, while a range of different catalyst systems have been 
investigated no study on the modification of existing ligands has been undertaken in 
order to elucidate structure activity relationships. This is probably due to the inherent 
synthetic difficulties associated with the chemical modification of ligands such as 
bipyridine8 (43) and TMEDA (44). Consequently a related class of ligand (45) was 
selected for investigation as a potentially tunable synthetic alternative to bipyridine. 
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I 
"N~N" I 
(43) (44) (45) 
Like bipyridine (43), N-alkyl-2-pyridylmethanimine (NPMI) (45) ligands have a 
conjugated 1t system which is able to accept electron density from the metal thus serving 
to stabilise the Cu(I) oxidation state. In fact NPMI ligands have been reported to be 
superior to bipyridine in both stabilising and solubilising copper(I) halides.9 
These ligands are readily prepared by reaction of commercially available amines with 
pyridine carboxaldchydes in the presence of MgS04 (scheme 40). Therefore a wide range 
of structurally related ligands can be prepared and assessed as atom transfer catalysts 
enabling structure activity relationships to be obtained . 
.. 
Scheme 40. Preparation of N-alkyl-2-pyridylmethanimines. 
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2.2 Work previously conducted within the Clark group. 
2.2.1 Efficiency of the CuCI(N-alkyl-2-pyridylmethanimine) catalyst. 
Initial work to detennine the efficiency of the copper complex of this ligand focussed on 
the known cyclisation of trichloroallylacetate (31). Hence cyclisation of (31) under atom 
transfer conditions with 30 mol% CuCl and 30 mol% of either N-pentyl-2-
pyridylmethanimine (NPMI), TMEDA (44) or bipyrdine (43) as ligand was attempted 
(table 3).10 
30 mol%CuCI(ligand) 
Reflux in toluene 
(31 ) 
Ligand 
TMEDA 
Bipyridine 
N-Pentyl-2-pyridylmethanimine 
a Reactions stopped after 4 hrs. 
:1+rCI ~~) a a .. 
(47) 
Ratio of (31):(47t 
4:1 
5:1 
t : t 
Table 3. Comparison of ligand efficiency. 
The N-pentyl-2-pyridylmethanimine ligand gave a moderate rate enhancement over the 
other two ligands demonstrating the synthetic potential of this system. Further work 
within the group has shown that CuCI(NPMI) is also effective in facilitating the atom 
transfer of both activated and non-activated a-haloacetamides. 11 Comparisons with 
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previously reported systems have shown that the NPMI catalyst offers improved yields 
and greater diastereoselectivities than when using RuCh(PPh3)3. Reaction rates were 
comparable with those obtained using the CuCI(TMEDA)2 system reported by Ghelfi 
with high levels of conversion and little or no reduction in selectivity observed. In 
addition, copper NPMI complexes have been reported to be extremely effective in the 
atom transfer radical polymerisation of methyl methacrylate12 further demonstrating the 
utility of this system. 
2.2.2 Optimisation of the CuCI(N-alkyl-2-pyridylmethanimine) catalyst. 
Work within the group has indicated that the steric nature of the imine substituent (Rl) is 
crucial in controlling the rate and stereoselectivity of cyclisation. Primary substituents 
gave optimum activity whilst more bulky imine substituents retarded the rate of 
cyc1isation (table 4).10 
Ligand 
45a 
45b 
45c 
45d 
() (4Sa-d) 'N~I 
N, 1 A 
30 mol% CuCI 
30 mol% 4Sa-d 
0.12 M DCM 
AT, 48 hrs 
Rl group 
n-Bu 
i-Bu 
s-Bu 
t-Bu 
.. 
C!,. ~-CI M"jJ + 
o N 
Ts 
Relative rate 
45 
28 
3 
1 
e~CI M~) 
o N 
Ts 
Diast. Ratio 
18:82 
28:72 
32:68 
51:49 
Table 4. Effect of imine substituent on cyclisation. 
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The optimum ratio of bidentate ligand to eu was found to be 2: I suggesting the active 
catalyst to be a four-coordinated complex (48). The X-ray structures of such complexes 
have been published9 and indicate a regular tetrahedral arrangement of ligands around the 
copper. 
+ 
CI 
(48) 
The difference in rate of cyclisation when using I: I and 2: I ligand:copper was not 
significant enough to warrant the use of larger amounts of ligand. Hence, all studies are 
based upon a ):) ratio of Iigand:copper. 
2.3 Initial aims. 
Our ultimate aim was to investigate how catalyst structure related to activity. Based on 
the success of the coppcr(NPMI) system and encouraged by the effect of the imine alkyl 
group on catalytic activity, we proposed to investigate how electronic effects in this 
ligand influence reacti vity. Therefore, varying the electronic nature of substituents at the 
pyridine nucleus (R I) (49) and investigating the effects of p-substituted aromatic imine 
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substituents (R2) (50) should enable us to detennine structure activity relationships for 
this class of ligand and result in optimising both the A TRC and ATRP processes. 
(49) 
() 
"Nli N-o-R' 
(50) 
Scheme 41. Proposed NPMI derivatives for structure activity investigation. 
2.4 Ligand synthesis. 
2.4.1 Synthesis of 6-functionalised N-pentyl-2-pyridylmethanimine ligands. 
In order to investigate ligand electronic effects on catalytic activity we initially prepared 
a range of NPMI ligands that were substituted at the 6-position of the pyridine nucleus 
(51a-c). 
x 
51a X=H 
51b X=Me 
51c X=OMe 
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The preparation of N-pentyl-2-pyridylmethanimine (51a) and 6-methyl-N-pentyl-2-
pyridylmethanimine (SIb) was readily achieved by a facile condensation reaction 
between the appropriate commercially available pyridinecarboxaldehyde and amyl 
amine. Thus, to either 2-pyridinecarboxaldehyde or 6-methyl-2-pyridinecarboxaldehyde 
in diethyl ether containing excess magnesium sulphate was added amyl amine. The 
mixtures were then stirred overnight at room temperature. Both reactions proceeded 
cleanly in almost quantitative yield to afford the desired compounds (51a) (94%) and 
(51 b) (82%). Subsequent purification of the products was unnecessary. 
The corresponding 6-methoxy ligand (SIc) was prepared from 6-bromo-2-methylpyridine 
(52) as described in scheme 42. 
n MeO N Br 
1. Bull n 
2. DMF ~ I ~ 
57% ~ 
MeO N CHO 
CSHllNH2~ ~~ 
MgS04 // 
MeO N I 
N-CSHll 
(52) (53) (51c) 
Scheme 42. Synthesis of 6-methoxy-N-pentyl-2-pyridylmethanimine. 
Reaction of 6-bromo-2-mcthylpyridine (52) with BuLi followed by DMF was conducted 
in accordance to standard literature procedure to afford 6-methoxy-2-
pyridinecarboxaldehyde (53).13 Subsequent condensation with amyl amine as described 
previously then furnished 6-methoxy-N-pentyl-2-pyridylmethanimine (SIc) in 89% yield. 
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2.4.2 Synthesis of 5-functionalised N-pentyl-2-pyridylmethanimine ligands. 
We next turned our attention to the synthesis of the related class of 5-substituted NPMI 
ligands (54a-d). 
54a X=H 
54b X=Me 
54c X=N02 
54d X=OMe 
The synthesis of 5-methyl-N-pentyl-2-pyridylmethanimine (54b) was conducted in a 
manner analogous to that used for the preparation of the 6-methoxy ligand (SIc) (section 
2.4. I scheme 42) and resulted in an overall yield of 43% from the starting 2-bromo-5-
methoxypyridine. However. a similar approach was found to be unsuitable for the 
preparation of the corresponding 5-nitro substituted ligand (54c). The reaction of 2-
bromo-5-nitropyridine (55) with BuLi and DMF to give 5-nitro-2-
pyridinecarboxaldehyde (58) failed. Compounds isolated from the reaction mixture 
would seem to indicate that the presence of the strongly electron withdrawing N02 group 
facilitated a nucleophilic aromatic substitution reaction resulting in the introduction of 
butyl groups to the pyridine ring. Therefore an alternative route was utilised in which 5-
nitro-2-pyridinecarboxaldehyde (58) was prepared in a two step procedure as reported by 
Ishiil4 (scheme 43). 
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(56) (57) 
Scheme 43. Synthesis of 5-nitro-N-pentyl-2-pyridylmethanimine (54c). 
This involved using a modification of the procedure of Dummel and Mosher. ls Thus, 
Nail was added to a solution of diethyl malonate and after the evolution of hydrogen had 
subsided 2-chloro-5-nitropyridine (56) was introduced. The solvent was removed and the 
resultant residue was then retluxed in 6M sulfuric acid for 7 hours to afford 2-methyl-5-
nitropyridine (57) in 69% yield. Subsequent oxidation was conducted by retluxing with 
selenium dioxide in 1,4-dioxane at I IOoC for 6.5 hours. Purification by column 
chromatography furnished 5-nitro-2-pyridinecarboxaldehyde (58) in excellent yield 
(85%). Reaction with amyl amine as described previously then provided the desired 5-
nitro-N-pentyl-2-pyridylmethanimine ligand (54c). 
The preparation of the 5-methoxy-N-pentyl-2-pyridylmethanimine ligand (54d) 
proceeded via the route outlined in scheme 44. The two step synthesis of the key 
pyridinic aldehyde (61) involved initial O-alkylation of 5-hydroxy-2-methylpyridine (59) 
followed by oxidation of the methyl group to the carbonyl. The O-alkylation was carried 
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out using 2 equivalents methyl iodide in DMSO with potassium hydroxide (4 
equivalents) as a base. The mixture was stirred at room temperature for 2 hours and 5-
methoxy-2-methylpyridine (60) was then isolated in 50% yield using column 
chromatography. 
HO~ MeO~ Me~ Me~ I Mel. KOH I 121 DMSO I NH2CsHll I 
~ • ~ o· ~ • ~ 
N N 9 Yo N CHO N I 
(59) (60) (61) (54d) N-C5H11 
Scheme 44. Synthesis of 5-methoxy-N-pentyl-2-pyridylmethanimine (54d). 
To oxidise 5-methoxy-2-methylpyridine (60) to 5-methoxy-2-pyridinecarboxaldehyde 
(61) we employed the method reported by Markovac and others l6 in which oxidation is 
brought about by attack of iodine and dimethylsufoxide. The resultant pyridinic aldehyde 
(61) is reported to be unstable at room temperature and highly susceptible to 
decomposition,l7 which may account for the poor yield obtained. A simple condensation 
reaction then provided the target ligand (54d). 
2.4.3 Synthesis of p-substituted phenyl-pyridin-2-ylmethylene-amine ligands. 
A range of p-substituted phenyl-pyridin-2-ylmethyleneamine ligands (64a-d) were 
readily prepared in one step from the corresponding phenyl amine (63a-d) and 2-
pyridinecarboxaldehyde (62). 
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Hence, aniline, p-toluidine, p-anisidine and 4-aminobenzotrifluoride were each stirred 
with 2-pyridinecarboxaldehyde (62) in dry dichloromethane containing excess 
magnesium sulfate overnight at room temperature. The magnesium sulfate was removed 
by filtration and the solvent removed under reduced pressure to provide the desired 
ligands without the need for further purification (table 5). 
Q. DR MgS04 C('N "" I .. N~ CHO 
A 
(62) 63a R=H 64a R=H 
63b R=Me 64b R=Me 
63c R=OMe 64c R=OMe 
63d R=CF3 64d R=CF3 
Ligand R Yield 
64a H 94% 
64b Me 88% 
64c OMe 93% 
64d CF3 89% 
Table S. Synthesis of ligands 64a-d. 
2.5 Precursor synthesis. 
With a range of modified ligands now in hand we turned our attention to the synthesis of 
the radical cyclisation precursors. The majority of published atom transfer procedures 
uti lise activated trihaloacetamide precursors. Therefore, N-allyl-N-toluenesulfonyl-2,2,2-
trichloroacetamide (66) was selected for preparation. However, the generation of highly 
functionalised cyclic systems has limitations in the preparation of natural products. The 
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inclusion of too many halogen atoms usually necessitates a dehalogenation reaction later 
in the synthesis. Therefore, a truly versatile atom transfer procedure should provide the 
ability to generate radicals from non-activated monohalo precursors and without the 
requirement of elevated temperatures. Consequently N-allyl-N-(2-bromo-2-
methylpropionyl)toluene-p-sulfonamide (67) was selected as our standard substrate with 
which to initially assess the modified ligands. The preparation of the selected cyclisation 
precursors (66-67) was conducted according to standard literature procedures. Thus, a 
solution of BuLi was added dropwise over a period of 5 minutes to a stirred solution of 
N-allyl-N-toluenesulfonamide (65) (previously prepared by literature procedure) in dry 
THF at -78°C under an atmosphere of nitrogen. The mixture was stirred for 30 minutes at 
this temperature, the appropriate acid halide was then introduced and the mixture stirred 
for a further 3 hours (scheme 45). Following work-up purification by column 
chromatography afforded the desired compounds in moderate to good yield. 
HN~ 
I 
Ts 
(65) 
1. Bull, THF 
• 
2. Acid chloridelbromide 
(66) R,=CI R2=CI X=CI 60% 
(67) R,=Me R2=Me X=Br 80% 
Scheme 45. Synthesis of N-allyl-N-toluenesulfonyl-N-tri and mono-haloacetamides. 
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2.6 Atom transfer radical cyclisation reactions. 
In order to obtain comparable rate data for cyclisation reactions using our modified 
ligands a standard experimental procedure was adopted. Thus, cyclisations were 
conducted at ambient temperature under an atmosphere of nitrogen and all reactions were 
run at 0.12 M concentration in order to be consistent with previous work. The copper 
complex of the appropriate ligand was formed in solution before being added to the 
substrate. In all cases the atom transfer catalyst formed immediately and appeared as a 
dark brown solution. 
2.6.1 Copper mediated ATRC using 6-functionalised NPMI ligands. 
Initial reactions were carried out using N-allyl-N-(2-bromo-2-methylpropionyl)toluene-p-
sulfonamide (67) in dichloromethane (0.12 M) at room temperature with 30 mol% CuBr 
and 30 mol% of ligand (5Ia-c) (scheme 46). 
ct~ ..... CSHll I N .&' N 51a X=H 51b X=Me X 51cX=OMe 
• 
±Jar 
o N 
I 
Ts 
(67) (68) 
Scheme 46. ATRC of 67 mediated by CuBr(51a-c). 
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However, attempted cyclisation of (67) using ligands (SIb-c) failed with only starting 
material being recovered after 24 hours. By comparison, the control ligand (Sla) 
mediated the cyclisation of (67) under identical conditions to afford 4-bromomethyl-3,3-
dimethyl-l-(toluene-4-sulfonyl)-pyrrolidin-2-one (68) in 96% yield in 24 hours. This 
poor activity prompted us to repeat the screening of ligands (Sla-c) using the more 
activated trichloroacetamide substrate (66). Thus, reactions were conducted as described 
above but using CuCl instead of CuBr (scheme 47). 
C'iC'f 
o N 
I 
y :::::,.. ..... C5Hll I N .&' N 51a X=H 
51b X=Me 
X 51c X=OMe 
30 mol% CuCI(ligand), CH2CI2 
Ts 
(66) (69) 
Scheme 47. ATRC of 66 mediated by CuCI(Sla-c). 
After 100 minutes the reactions were worked up by passing the reaction mixture through 
a small silica plug using dichloromethane as eluent. Conversions were then measured 
from the I II NMR of the crude reaction mixture. Analysis indicated that while the 
reaction mediated by the 6-methoxy ligand (SIc) had gone to completion, reaction using 
(SIb) proceeded to give only a 2:1 mixture of (69);(66). By comparison cyclisation of 
(66) with the control ligand (Sla) was complete in less than 5 minutes under the same 
conditions. These results indicate that substitution at the 6-position of the pyridine 
nucleus significantly retards the cyclisation reaction. The reason for this is likely to be 
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steric in origin and parallels the loss of reactivity observed when the imine nitrogen was 
substituted with bulky alkyl groupS.l0 
2.6.2 Copper mediated ATRC using 5-functionalised NPMI ligands. 
Due to the relative inactivity of the 6-functionalised analogues (section 2.6.1) we next 
investigated the affect of NPMI ligands substituted at the 5-position. With the use of 
ligands (S4a-d) steric interactions would be less significant allowing contributions from 
inductive electronic effects onto the pyridine nitrogen to be determined. However, groups 
in the 5-position are also mesomeric ally linked to the imine nitrogen and hence analysis 
of the effect of substituents is likely to be complicated by a combination of both these 
phenomena. Reactions were carried out using (67) in dichloromethane (0.12 M) at room 
temperature with 30 mol% CuBr and 30 mol% of ligand (54a-d) (scheme 48). 
=r'f 
o N 
I Ts 
(67) (68) 
Scheme 48. Investigation of affect of ligands (54a-d). 
After 2 hours the reactions were worked up as described before and the conversion 
determined from the crude IH NMR (table 6). 
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Mass Balance (%) 
95 
96 
96 
95 
Ratio 67:68 
41:59 
34:66 
100:0 
73:27 
Table 6. Cyclisation of 67: effect of ligand on conversion. 
The strongly electron withdrawing N02 group (ligand 54c) had a marked effect on the 
conversion of (67) with no cyclisation product (68) detected after 2 hours. The use of the 
less inductively withdrawing methoxy ligand (54d) also retarded the rate of cyclisation 
but to a lesser extent. Conversions for the control ligand (54a) and the 5-methyl 
substituted ligand (54 b) were of similar magnitude with the inductively donating (54b) 
the most efficient. In order to obtain more accurate rate data reactions mediated by 
ligands (54b-d) were then run individually against the control ligand (54a). A plot of 
In([sub]J[sub]() against time for each ligand produced the results shown in figures 4-6. 
The results obtained for the 5-nitro substituted ligand (54c) confirmed the striking 
reduction in rate previously observed (table 6). The reaction was stopped after 45 hours 
having proceeded only to give a 77:23 ratio of (67):(68). Assuming a pseudo first order 
rate plot where [cat]=constant and thus k = k(rds) x k[cat], this translates to a reaction 
rate of k[A TRC] = 2.3 x 10-6 S·I compared to that of k[ATRC] = 1.2 x 10-4 S·I for the 
control ligand (54a) (figure 4). The rates obtained for ligands (54b,d) were also 
consistent with initial observations. The use of the 5-methoxy ligand (54d) resulted in a 
decreased reaction rate of k[ATRC] = 9.97 x 10.5 S·I (figure 5) while the electron 
donating (54b) was found to be the most efficient with a reaction rate of k[ATRC] = 1.92 
x 10-4 S·I (figure 6). 
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ATAe of (67): Effect of ligand (54c) on reaction rate. 
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Figure 4. Rate of ATRC of (67) using ligand (54c). 
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ATAe of (67): Effect of ligand (54d) on reaction rate. 
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Figure 5. Rate of ATRC of (67) using ligand (54d). 
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ATRC of (67): Effect of ligand (S4b) on reaction rate. 
6.---------------------------------. 
5 
4 
2 
5-Met yl Ugand (S4b) 
k[ATR 1 = 1.92E-4 8-1 
Contr I Ugand (548) 
k[A 1 = 1.23E-4 8-1 
o~--~-----+----~----~----+_--~ 
o 5000 10000 15000 20000 25000 30000 
Time (sec) 
Figure 6. Rate of ATRC of (67) using ligand (54b). 
These results demonstrate that in the ATRC of (67) the rate ofreaction follows the order 
Me(54b»H(54a»OMe(54d»N02(54c). This implies that inductively increasing the 
electron density of the pyridine nitrogen increases the rate of ATRC reactions. 
2.6.3 Copper mediated ATRC using p-substituted phenyl-pyridin-2-
ylmethyleneamine ligands (64a-d). 
Next we investigated the affect of p-substituted phenyl-pyridin-2-ylmethyleneamine 
ligands (64a-d). In this class of ligand the presence of a bulky phenyl group adjacent to 
the imine nitrogen might significantly retard cyclisation. However, aromatic substituents 
in the para position are in resonance with the imine nitrogen. Therefore, the relative rates 
96 
Chapter 2 : Ligand electronic effects on rates of ATRC and ATRP. 
of reaction using ligands (64a-d) are of interest and will allow us to better assess the 
optimum electronic contributions of both nitrogen atoms to A TRC. Hence, reactions were 
conducted as before using (67) in dichloromethane (0.12 M) at room temperature with 30 
mol% CuBr and 30 mol% of ligand (64a-d) (scheme 49). 
:r~f 
I 
Ts 
(67) 
~X 
crNN 
64a X=H 
64b X=Me 
64c X=OMe 
64d X=CF3 
.. 
KB' 
o N 
I 
Ts 
(68) 
Scheme 49. Investigation of effect of ligands (64a-d). 
After 3 hours the reactions were worked up as previously described and the conversions 
determined from the crude 'H NMR (table 7). 
Ligand 
64a 
64b 
64c 
64d 
Mass Balance ( % ) 
97 
94 
96 
96 
Ratio 67:68 
26:74 
0:100 
87:13 
85:15 
Table 7. CycJisation of 67: effect of ligand (64a-d) on conversion. 
The methoxy and CF3 substituents (ligands 64c-d) both impeded the cyclisation to a 
similar extent. Reaction using the control ligand (64a) proceeded to give a 26:74 ratio of 
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(67):(68) while the p-methylligand (64b) was again the most efficient (el section 2.6.2) 
having proceeded to completion after 3 hours. The rates of reaction for ligands (64a-b) 
were then determined (figure 7). As expected the results indicate that this class of ligand 
significantly retards cycIisation in comparison to the N-pentyl analogues (54a-d) (note 
that for 54a k[ATRC] = 2.23 x 10-4 s-\ This is probably due to steric reasons. 
0.45 
0.4 
0.35 
0.3 
~ 0.25 
s:: 
0 
~ 0.2 :s 
0.15 
0.1 
0.05 
0 
0 
ATRC of (67): Effect of ligand (64a-b) on reaction rate. 
5000 10000 15000 
Time (sec) 
20000 
p- ethyl Ligand (64b) 
klA [I . 2.0E-05 s-1 
Control Ligand (64a) 
k[A~C] = 1.03E-05 5-1 
25000 
Figure 7. Rate of ATRC of (67) using ligand (64a-b). 
The apparent lack of any pattern based on electronic considerations for the activity of the 
p-substituted phenyl-pyridin-2-ylmethyleneamine ligands (64a-d) suggests that these 
results are complicated further, perhaps by solubility arguments. 
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2.7 Atom transfer radical polymerisation reactions. 
Atom transfer radical polymerisation (ATRP) has emerged as an efficient method for the 
polymerisation of vinyl monomers. 18-21 ATRP processes promoted by a range of low 
valent metal complexes including Cu(I)Br-bipyridine,19 Ru(II)Ch(PPh3)/O and 
Ni(II)[C6H3(CH2NMe2)2-2,6]Br21 are known. More recent reports have demonstrated that 
N-pentyl-2-pyridylmethanimine (54a) copper(I) complexes are extremely effective for 
the ATRP of methyl methacrylate (MMA).12 As a consequence we decided to examine 
the effectiveness of our modified NPMI ligands (S4a-c) in the polymerisation of MMA. 
Polymerisation reactions were conducted by A. M. Heming of the Haddleton research 
group using ethyl 2-bromo-2-methylpropionate (70) as an initiator under standard living 
radical conditions (100:1:1:2 of [MMA]:[initiator]:[CuBr]:[S4a-c] at 50% v/v in toluene 
at 90°C) (scheme 50). 
-0CE1 
Br 
(70) 
+ 
JyC 
OMe 
(71) 
2 
.. 
Scheme 50. ATRP of MMA: Effect of ligands (54a-c). 
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Each reaction run exhibited a linear first-order rate plot indicating that the concentration 
of the propagating species remained constant throughout the reaction (figure 8). 
3 
Rates of polymerisatlon of MMA with ligands 54a-c """"""~ 
2.5 
2 
0.5 
o 
o 50 100 150 
Time (min) 
200 250 
Uga 54b 
Uga 54a 
300 
Figure 8. Rates of polymerisation of MMA with ligands (54a-c). 
The rates of polymerisation of MMA parallel those found for the atom transfer 
cyclisation of (67) (section 2.6.2) with the electron withdrawing N02 ligand (54c) 
showing poor activity, while the methyl substituted complex (54b) was more efficient 
than the control (54a). 
The average molecular weights of polymers increased linearly with conversion in each 
case. Control was evidently greater when using ligands (54a-b) where Mn's fit well with 
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those predicted. This was not the case for the reaction mediated by ligand (54c) which 
resembles a normal free radical polymerisation (figure 9). 
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Figure 9. Dependence of Mn on conversion for ATRP of MMA with ligands 54a-c. 
Polydispersities (PDls) remained relatively low when using ligands (54a-b) indicating 
that initiation was fast compared to propagation and that all polymer chains increased at 
similar rates. However, the control in polydispersity with ligand (54c) was significantly 
poorer. 
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2.8 Conclusions. 
We have demonstrated that substitution at the 6- and 5-position of the pyridine nucleus in 
N-pentyl-2-pyridylmethanimine ligands can effect the rate of both ATRC and ATRP 
reactions significantly. We have also shown that substitution at the imine nitrogen with p-
substituted aromatic groups has a marked effect on the rate of ATRC. This may be due to 
electronic, sterle or solubility reasons or a combination of all three. 
Substitution at the 6-position (mesomeric ally linked to the pyridine nitrogen) caused the 
ATRC of the monobromo acetamide (67) to fail presumably due to steric effects. 
However, reaction with the activated trichloroacetamide substrate (66) indicated that the 
mesomeric ally electron donating methoxy ligand (SIc) was more efficient than the 6-
methyl ligand (SIb). Groups at the 5-position can inductively alter the electron density of 
the pyridine nitrogen and mesomerically that of the imine nitrogen. Therefore, for each 
substituent a combination of both these effects will detennine the overall rate of reaction. 
If the inductive effect on the pyridine nitrogen is the dominant feature then the order of 
activity would be expected to be Me(S4b»H(S4a»OMe(S4d»N02(S4c) thus following 
Om. However, if the electronic mesomeric effect of substituents onto the imine nitrogen is 
dominant the order would be expected to follow OMe(S4d»Me(S4b»H(S4a»N02(S4c) 
thus paralleling op. Our results demonstrate that in the ATRC of (67) the rate of reaction 
follows the order (S4b»(S4a»(S4d»(S4c) which suggests that inductive effects onto the 
pyridine nitrogen are the dominant feature for this class of ligand in cyclisation reactions. 
The rates of A TRC and A TRP reactions may therefore parallel the basicity of the 
pyridine nucleus. This would be consistent with the observation that more basic sp3 
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amine ligands (TMEDA, N,N,N',N',N" -pentamethyldiethylenetriamine and tris(N,N-
dimethylaminoethylene)-amine) are more active catalysts for both ATRC22 of (67) and 
ATRP of MMA.23 Reaction with the most inductively electron withdrawing group (ligand 
54c) caused a striking decrease in the rate of both ATRC and ATRP. This may be due to 
the electronic effects discussed above however, the possibility of the N02 group 
competitively complexing the metal and changing the nature of the catalyst cannot be 
ruled out at this time. The apparent lack of any electronic pattern for the activity of the p-
substituted phenyl-pyridin-2-ylmethylene-amine ligands (64a-d) suggests that the picture 
is more complicated, perhaps due to solubility reasons. Overall, the use of the modified 
NPMI ligands does not appear to result in a significant increase in rate compared to the 
control1igand (54a) (Le. 100 times). Therefore, the effort required in their preparation is 
unlikely to warrant the use of these new ligands. 
2.9 Future work. 
The preparation and study of NPMI ligands substituted at the 4-position of the pyridine 
nucleus would allow us to test the conclusions presented here and provide a complete 
assessment of substituent electronic effects on rates of ATRC and ATRP. However, the 
synthesis of 4-substituted pyridine carboxaldehydes is not trivial and would entail 
considerable synthetic effort. 
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Chapter 3 
5-Exo Atom Transfer Cyclisation Onto Alkynes Mediated By 
Copper(1) Complexes 
3.1 Introduction. 
The use of radical cyclisation protocols for the preparation of cyclic systems continues to 
gain in importance.25 However, while BU3SnH-mediated cyclisations onto alkenes are 
generally facile, cyclisations onto terminal alkyne functional groups using 
organostannane methods can be complicated by competing hydrostannation.26 In 
addition, these procedures are terminated under reductive conditions. However, 
functionality can be retained in products if cyclisations are carried out under atom 
transfer conditions. The use of (Bu3Sn)2 to promote atom transfer cyclisations onto 
alkynes has been reported by Curran,z7-28 Thus, cyclisation of simple hex-5-ynyl iodides 
(72) with (Bu3Sn)z (l 0%) in refluxing benzene for 10 hours resulted in formation of vinyl 
iodides (73) in good yields (41-71 %) (scheme 51).27 This approach has also been 
successfully utilised by Curran in tandem radical cyclisations to give triquinanes.28 
However, due to the high toxicity of tin reagents a range of alternative atom transfer 
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catalysts have been developed including copper halide complexes of bipyridine,4 N-
alkylpyridylimines1o,29 and multidentate amines.6,30 
R 
" 
72a R=H 
72b R=Me 
72c R=SiMe3 
10%AIBN 
10% BU3SnSnBu3 
refluxing benzene 
10 hrs 
73a (70%) 
73b (71%) 
73c (41%) 
Scheme 51. Atom transfer cyclisation of hex-5-ynyl iodides. 
While these copper(l) based systems are known to mediate the atom transfer radical 
cyclisation of a range of haloacetamides onto alkene functional groups, there are very few 
reports on the application of this methodology to cyclisation onto alkynes.31 Ghelfi has 
recently reported that attempted cyclisation of N-Benzyl-2,2,dichloro-N-prop-2-ynyl-
acetamide (74) using CuCI(TMEDA) failed (scheme 52),32 although no explanation of 
why the reaction failed was given. 
CI:iJ 
o N 
10% CuCI(TMEDA}z 
.. No reaction 
MeCN. 20 hrs 
I 
Sn (74) 
Scheme 52. Attempted cyclisation of I-dichloro-N-propargylacetamide (74) 
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In the last chapter we demonstrated that copper halide N-alkyl-pyridylmethanimine 
complexes were effective in facilitating the atom transfer cyclisation of both activated 
and non-activated a-haloacetamides onto alkenes. Consequently we propose to 
investigate the use of this system for cyclisation onto alkyne functional groups. 
3.2 Precursor synthesis. 
In 5-exo ATRC of haloacetamides onto alkenes the nature of the N-substituent often 
affects the efficiency of the cyclisations. Nagashima et al.33 reported that efficiencies 
were greatest when tosyl or Boc substituents were used as the N-protecting group. 
Therefore, in addition to the N-benzyl precursor (74) used by Ghelfi, we prepared a range 
of N-tosyl and N-Boc cyclisation precursors in order to investigate their ATRC reactions 
onto alkynes. 
3.2.1 Synthesis of N-tosyl-mono, di and trihalo-N-propargylacetamides. 
The general procedure for the preparation of the initially chosen N-tosyl cyclisation 
precursors (76-79) was carried out according to standard literature procedures. Thus, a 
solution of BuLi (1.6M in hexanes) was added dropwise over a period of 5 minutes to a 
stirred solution of N-propargyl-toluene-4-sulfonamide (75) (previously prepared by 
standard literature procedure) in dry THF at _78°C under nitrogen. The mixture was 
stirred for 30 minutes at this temperature, the appropriate acid halide was then introduced 
and the mixture stirred for a further 3 hours (scheme 53). 
106 
Chapter 3 : 5-Exo atom transfer cyclisation onto alkynes. 
HN~ 
I 
Ts 
(75) 
1. BuLi, THF 
.. 
2. Acid bromide/chloride 
Scheme 53. Synthesis of N-tosyl cyclisation precursors. 
(76-79) 
The reaction was quenched by the careful addition of water. Then, following work-up, 
the crude compounds were purified by column chromatography to furnish the desired 
cyclisation precursors in moderate to good yield (table 8). 
Precursor RI R2 X Yield (%) 
76 Me Me Br 55 
77 Me H Br 65 
78 Me Cl Cl 58 
79 Cl Cl Cl 64 
Table 8. Yields of N-tosyl cyclisation precursors. 
The acid halide used for precursor (78) was not available commercially and was prepared 
from the corresponding acid by reaction with refluxing oxalyl chloride in accordance 
with standard literature procedure. 
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3.2.2 Synthesis of N-Boc-mono and dihalo-N-propargylacetamides. 
The synthesis of the related N-Boc cyclisation precursors (81-82) was conducted in a 
manner similar to that used for the preparation of the N-tosyl derivatives described in 
section 3.2.1. Thus, BuLi (1.6M in hexanes) was added to a stirred solution of prop-2-
ynyl-carbamic acid tert-butyl ester (80) in THF at -78°C. Addition of the appropriate acid 
halide and subsequent purification by flash column chromatography afforded precursors 
(81-82) in moderate yield (scheme 54). 
HN~ 
I 
Boc 
(80) 
Precursor 
81 
82 
Me 
Me 
1. BuLi, THF 
2. Acid bromide/chloride 
Me 
CI 
x 
Br 
CI 
Scheme 54. Synthesis of N-Boc cyclisation precursors. 
(81-82) 
Yield (%) 
76 
24 
3.2.3 Synthesis of N-benzyl-2,2,dichloro-N-prop-2-ynyl-acetamide (74). 
We also decided to re-examine the failed cyclisation reported by Ghelfi32 of the N-benzyl 
precursor (74). Preparation of this precursor was conducted according to standard 
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literature procedures. Thus, to a solution of benzyl-prop-2-ynyl-amine (83) (previously 
prepared by literature procedure) and triethylamine in dichloromethane was added 
dichloroacetyl chloride dropwise. The mixture was stirred for 4 hours at room 
temperature and then was added, with stirring, to a saturated aqueous solution of 
potassium carbonate. The mixture was extracted with ether and the combined extracts 
were then dried over anhydrous magnesium sulfate and concentrated under reduced 
pressure. Purification by flash column chromatography furnished N-benzyl-2,2,dichloro-
N-prop-2-ynyl-acetamide (74) in 62% yield (scheme 55). 
J CI CI J triethylamine :IN ... HN OK" I U Bn CI CI (83) (74) ~
Scheme 55. Preparation of N-benzyl-2,2,dichloro-N-prop-2-ynyl-acetamide. 
The N.M.R spectra of the N-benzyl protected precursor (74) exhibited splitting of 
individual signals. The precursor was isolated as an inseparable 1: 1 mixture of rotomers, 
which is consistent with previously published resuIts.32 
109 
Chapter 3 : 5-Exo atom transfer cyclisation onto alkynes. 
3.3 Cyclisation reactions. 
3.3.1 CycIisation of dichloro-N-propargylacetamides. 
Attempted cyclisation of the N-benzyl substituted precursor (74) with 30 mol% 
CuCI(NPMI) failed with only starting material being recovered. We therefore repeated 
the reaction using an increased amount of catalyst. Thus, to a 0.12M solution of N-
benzyl-2,2,dichloro-N-prop-2-ynyl-acetamide (74) in dry dichloromethane under nitrogen 
was added Cuel (1 equivalent) and N-pentyl-2-pyridylmethanimine (NPMI) (1 
equivalent). The resulting mixture was stirred at room temperature overnight. The crude 
mixture was then passed through a short silica plug eluting with dichloromethane. 
Interestingly, the reaction furnished not the desired atom transfer product (84), but gave 
the dimer (85) exclusively in 98% yield (scheme 56). 
CI 
CI CI J c±j CI CI ........ Bn oy~ N CuCI(NPMI) ~<o :iN • RT, 12 hrs o N N I OCM I Bn/ CI CI Bn Bn 
(74) (84) (85) 
Scheme 56. Dimerisation of N-benzyl-2,2,dichloro-N-prop-2-ynyl-acetamide. 
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Tenninal alkynes are known to undergo facile oxidative dimerisation and intennolecular 
coupling reactions when subjected to copper halide pyridine/amine complexes.34 
Therefore fonnation of the dimer (85) may also account for the failed cyclisation of (74) 
originally reported by Ghelfi.32 
Next we turned our attention to the cyclisation of the related N-tosyl and N-Boc protected 
dichloro-N-propargylacetamides (78, 82). We were pleased to find that these precursors 
underwent cyclisation in the presence of 30 mol% CuCI(NPMI) at room temperature in 
dichloromethane to furnish the corresponding atom transfer products (86a-b) (scheme 
57). 
CI CI J' Mel 
a N 
I 
A 
78 A =Ts 
82 A = Boc 
30 mol% CuCI(NPMI) 
AT, OCM, 24 hrs 
Cl 
CI 
86a A = Ts, 48% 
86b A = Boc, 50% 
Scheme 57. ATRC of N-Boc and N-tosyl dichloro-N-propargylacetamides. 
No dimerisation products were detected. However, the reactions did not go to completion 
and gave a 1: 1 mixture of cyclised product starting material after 24 hrs at room 
temperature (100% mass balance). Extended reaction times did not significantly improve 
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upon this yield. However, stirring (78) with 1 equivalent of CuCl(NPMI) afforded an 8: 1 
ratio of (86a):(78) (89% yield). 
The gem dihalide (86a) was readily converted to the corresponding aldehyde derivative 
(87a) by reaction with aqueous silver nitrate in refluxing THF (scheme 58). This reaction 
provides a useful functional group for further synthetic manipulation and demonstrates 
the significance of retaining functionality in products under atom transfer conditions. 
CI 
CI AgN03, THF, H2O 
):)CHO 
reflux, 15 hrs 
0 .- ° N I 
Ts 
(86a) (87a) 77% 
Scheme 58. Conversion of gem dihalide (86a) to aldehyde (87a). 
3.3.2 Cyclisation of 4-methyl-N-prop-2-ynyl-N-(2,2,2-trichloroacetyl)-
benzene sulfonamide. 
Having initially focussed on the reactions of dichloroacetamides (74, 78, 82) we next 
attempted cyclisation of the trichloroacetamide derivative (79). Cyclisation under 
standard conditions with 30 mol% CuCl(NPMI) gave a mixture of products in a mass 
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balance of 96% after 24 hrs. Following purification by column chromatography the 
mixture was found to consist of cyclised products (88) (75%) and (89) (11 %), the cleaved 
N-tosyl amide (75) (3%) and a small amount of unreacted starting material (79) (11 %) 
(scheme 59). 
CI CI 
C'i'J CuCI(NPMI) c):j-- c;d J _ CI RT, DCM .. o N 24 hrs o N o N HN I I I I Ts Ts Ts Ts 
(79) (88) 75% (89) 11% (75) 3% 
Scheme 59. Cyclisation of trichloroacetamide (79). 
The formation of the two major products (88) and (89) can be rationalised by initial atom 
transfer cyclisation of (79) to give vinyl chloride (90) followed by abstraction of a second 
halogen atom to furnish the allyl radical (91) (scheme 60). Radical species (91) may then 
undergo a second atom transfer reaction resulting in the observed product (88). 
Alternatively, reduction of (91) (either from the solvent or via the ligand) would give rise 
to the minor cyclic product (89). A secondary halogen atom abstraction would also 
account for the <l,p-unsaturated y-lactam products (86a-b) obtained from the cyclisation 
of dichloroacetamides (78, 82) (section 3.3.1). Although, in the case of the 
dichloroacetamide precursors, reactions were cleaner providing only one cyclised product 
and no products arising from reduction of the intermediate allyl radical were detected. 
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C,X'J c~CI C1:JCI ATRC CUCI • • 
o 7 o N o N I I Ts Ts Ts 
(79) (90) 
t £lei ~CI • ~CI 
o • • 
7 o N o N I I Ts Ts Ts 
(89) (91 ) (88) 
Scheme 60. Proposed mechanism of formation of cyclised products (88) and (89). 
3.3.3 Cyclisation of monobromo-N-propargylacetamides. 
Following the successful atom transfer cyclisation of di- and trihaloacetamides with 
CuCI(NPMI), we next investigated the cyclisation of the less activated 
monobromoacetamide precursors (76-77, 81). Cyclisation of (76) with 30 mol% 
CuBr(NPMI) in dichloromethane at room temperature for 24 hours furnished two 
products, the atom transfer product (92a) (2:5 mixture of (E)- and (2)- isomers) as well as 
the reduced product (93a) (scheme 61). Thus, it may be inferred that the intermediate 
vinyl radical can undergo either bromine atom transfer to produce (92a) or hydrogen 
atom transfer to give (93a). 
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M:irJ Me Me 30 mol% CuBr(ligand) MtJsr Mjj 
AT, DCM, 24 hrs o N o N o I I I A A A 
(76) A=Ts (92a) R=Ts (93a) A=Ts (81) A=Boc (92b) A=Boc (93b) A=Boc 
Scheme 61. Cyclisation of monobromoacetamides (76, 81). 
As a consequence we were able to significantly alter the ratio of products (92) and (93) 
by conducting the reaction with different solvents or ligand (table 9). 
Substrate Ligand Solvent 92:93 92 (E:Z) 
76 NPMI DCM 25: 1 (96) 2:5 
76 NPMI Benzene 74:1 (94) 1:4 
76 Tren-Me6 THF 1 :20 (95) 1:4 
81 NPMI OCM 10: 1 (96) 1 :2 
Percentage yield of combined products shown in brackets. 
Table 9. Ratio of atom transfer products: Effect of solvent and ligand. 
Thus, repeating the reaction in benzene gave the bromine atom transfer product (92) 
almost exclusively. This is presumably due to the poorer hydrogen atom donating ability 
of benzene compared to dichloromethane. Conversely, the use of a better hydrogen atom 
donor (THF) in conjunction with the tren-Me6 ligand leads to (93) as the major product. 
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Independent of reaction conditions (table 9), the bromine atom transfer product (92) was 
obtained as a separable mixture of (E)- and (Z)- isomers. The major isomer was 
confirmed as (Z)-4-bromomethylene-3,3-dimethyl-l-(toluene-4-sulfonyl)-pyrrolidin-2-
one by n.O.e difference data, the percentage enhancements are shown in figure 10. 
1.2%~H 
/ Br 
~--<' 
H 
I~ Ts 
1.4% 
(E)-isomer (Z)-isomer 
Figure 10. n.O.e evidence for the major isomer of cyclised product (92). 
Next we investigated the reaction of the deactivated 2-bromo precursor (77). However, 
reaction with 30 mol% CuBr(NPMI) overnight at room temperature did not lead to any 
observed cyclisation product and only starting material was recovered. Repeating the 
reaction with the more activated CuBr(tren-Me6) catalyst system resulted in only 50% 
conversion after 48 hours at room temperature. The reaction gave a 1: 1 mixture of the 
two products (93) and (94), which were subsequently isolated in 35% yield (scheme 62). 
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H Br J ):jBr ):) M.:r 30 mol% CuBr(tren-Me6) .. 
o N RT, DCM, 48 hrs o N o N I I I Ts Ts Ts 
(77) (93) (94) 
Scheme 62. Cyclisation of deactivated monobromo precursor (77). 
Finally, having investigated the cyclisation of a range of haloacetamides onto terminal 
alkyne functional groups, we were interested in attempting cyclisation onto a 
disubstituted alkyne precursor. Thus, N-(2-bromo-2-methyl-propionyl)-N-but-2-ynyl-4-
methyl-benzenesulfonamide (95) was prepared in 62% yield from N-but-2-ynyl-4-
methyl-benzenesulfonamide according to the procedure outlined in section 3.2.1. 
Interestingly, cyclisation of the disubstituted alkyne (95) with 30 mol% CuBr(NPMI) in 
dichloromethane at room temperature proceeded to give the bromine atom transfer 
product (96) only. (1: 1 mixture of (E)- and (Z)- isomers in 94% yield) (scheme 63). 
e Me Me 
:ir II Br M3H 30 mol% CuBr(NPMI) Me • RT, OeM, 48 hrs 0 
o ~ ~ o N I 
Ts Ts Ts 
(95) (96) Not formed 
Scheme 63. Cyclisation of disubstituted alkyne precursor (95). 
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No products arising from hydrogen atom transfer were detected suggesting that the 
intermediate vinyl radical is less reactive towards hydrogen abstraction than those 
derived from the corresponding reactions of terminal alkynes (76) and (81) (scheme 61). 
3.4 Conclusions. 
We have demonstrated that a range of trichloro-, dichloro- and monobromo-acetamides 
may undergo CuX(NPMI) or CuX(tren-Me6) mediated 5-exo atom transfer radical 
cyclisations onto alkynes at room temperature. Cyclisation of trichloro-, dichloro- and 2-
bromo-acetamides (77-79, 82) resulted in formation of a.,~-unsaturated y-Iactams in 
moderate to good yield. However, reaction of mono-bromoacetamides (76) and (81) 
proceeded to give exocyclic alkene derivatives which could be terminated reductively or 
by bromine atom transfer depending upon the nature of the ligand and solvent used. The 
nature of the N-substituent also affected the reaction. Thus, while N-tosyl and N-Boc 
protected precursors underwent atom transfer cyclisation, reaction of the N-benzyl 
substrate (74) resulted in exclusive formation of the dimer. No products arising from 6-
endo cyclisation were observed for either the terminal or disubstituted alkynes. In 
general, the relatively slow rate of conversion (in comparison to their alkene 
counterparts) is not surprising and is often characteristic of cyclisation reactions onto 
alkynes.35 
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Chapter 4 
Efficient B-Lactam Synthesis Via 4-Exo A tom Transfer 
Radical Cyclisation 
4.1 Introduction. 
The use of cyclisation protocols to prepare J3-lactam compounds continues to gain in 
importance.36 Cyclisation using tin-based radical methods is possible37 but suffers from a 
number of disadvantages including the toxicity of the reagent, and poor yields due to 
competitive trapping of non-cyclised radicals. Consequently, we wished to examine the 
use of copper-mediated atom transfer radical cyclisation (ATRC) for the preparation of J3-
lactams. While copper systems are known to mediate 5-exo ATRC of a range of 
haloacetamides there are very few reports on the application of this methodology to 4-exo 
versus 5-endo cyclisation onto enamides (scheme 64).38 This is probably because 5-endo 
cyclisation is a disfavoured process39 and 4-exo cyclisation is generally a reversible 
process in which the release of ring strain strongly biases the equilibrium toward the 
direction of the acyclic radicals.4o 
119 
4-exo 
(98) 
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5-endo 
(97) 
R'r __ (' 
O~N) 
I 
P 
(99) 
Scheme 64. 4-Exo versus 5-endo ring closure of halo-enamides. 
In these examples the cyclisation of halo-enamides generally results in formation of the 
5-endo derived prodUCt.41 This is intriguing because the initial carbamoyl methyl radical 
(97) will preferentially form y-Iactam (99) (via 5-endo ring closure) rather than undergo 
the more favourable 4-exo cyclisation leading to p-Iactam (98). The Clark group42 has 
demonstrated this preference for the 5-endo mode of cyclisation. Thus, reaction of 
tertiary bromo-enamide (100) (scheme 65) with 30 mol% CuBr(Tren-Me6) was observed 
to furnish the unsaturated pyrrolidine derivatives (102-103) in excellent yield. No p-
lactams were isolated from these reactions and products were proposed to arise not from 
atom transfer but from pathways involving an intermediate N-acyl iminium ion (101). 
B~~(D CuBr(Tren) t.=o ~ t.D +±G II OCM, AT o N 
I 20 mins. I I I Sn Sn Sn Sn 
(100) (101 ) (102) 43% (103) 39% 
Scheme 65. Oxidative 5-elldo cyclisation of enamide (100). 
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However, the regioselectivity of 4-exo versus 5-endo radical cycIisations might be 
influenced by the nature of the substituents, both at the radical centre and at the terminal 
end of the alkene. Hence, suitably designed precursors might be used to encourage 4-exo 
radical cycIisation leading to ~-lactam formation. 
4.1.1 Substituent effects on the 4-exo versus S-endo pathway. 
Substituents on the enamide double bond play a crucial role in determining the 
regiochemistry of cycIisations that proceed via a 4-exo or 5-endo pathway. The 4-exo 
mode of ring closure is generally only observed when bulky radical stabilising groups are 
introduced on the ~-position of the double bond. Thus, it has been reported that BU3SnH 
mediated cyclisation of en amide (104) results in formation of ~-lactam (l08) when R = 
PhS or Ph (scheme 66).43 
5-endo oJ:)· oJ:) 
• 
R=H I I 
P P 
· AyA (105) (106) O~N I 
R 
;=CA I J=CA P (104) 4-exo 
• 
R = SPh 
or Ph a P o P 
(107) (108) 
Scheme 66. Effect of groups at the ~-position of the enamide double bond. 
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These groups serve to stabilise the p-lactam radical (107) by electronic effects and also 
sterically hinder attack at the P-position of carbamoyl radical (104). 
Substituents at the radical centre also affect the regiochemistry of 4-exo versus 5-endo 
cyclisations. Ikeda44 has reported that BU3SnH mediated radical cyclisation of 2-chloro-
N-(3.4-dihydro-2-naphthyl)-N-methylacetamides (109a-d) in boiling toluene gave P-
lactams (lIla-c) and/or 'Y-lactams (ll2c-d) depending on the nature of the substituent at 
the carbamoyl methyl radical centre (llOa-d) (scheme 67), 
CIJyO 
roN'Me 
109a R=H 
109b R=CI 
109cR=Me 
109d R=Ph 
111 a-c 
toluene reflux 
and I or 
110a-d 
112c-d 
Scheme 67. The effect of substituents at the radical centre upon regiochemistry. 
These results44 indicate that p-Iactam formation is favoured when R=H or Cl (scheme 
67), while radical stabilising substituents such as methyl, phenyl, phenylthio, dimethyl 
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and dichloro lead predominantly or exclusively to y-Iactam formation. 
4.1.2 4-Exo versus 5-endo cyclisation mechanism. 
The observations outlined in the last section may be rationalised on the basis of a 
reversible cyclisation mechanism in which the p-lactam is the kinetic product and the y-
lactam is the thermodynamic product. Support for this proposed mechanism has been 
derived from the examination of the effects of reaction temperature.45 Thus, 2-
bromopropanamide (113) when treated with BU3SnH in boiling benzene (at 80°C) gave 
p-Iactam (118) as the major product, whereas in boiling toluene (at 110°C) the y-lactam 
(116) was obtained as the major product (scheme 68) . 
.,J:r . y 
roN'R - roN'R 
(113) 
(116) 
(114) 
I 
-
(117) 
Ratio of (118):(116) in benzene 73:27 
in toluene 31 :69 
I (115) 
(118) 
Scheme 68. Effect of temperature on mode of cyclisation. 
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Hence, at higher temperatures (boiling toluene) the ring opening of radical (115) occurs 
rapidly and the resulting radical (114) will cyclise in a 5-endo manner to give the 
thermodynamically stable (117). However, at lower temperatures (boiling benzene) the 
kinetically favoured 4-exo cyclisation predominates. 
Consequently, in order to promote p-lactam formation, we were interested in 
investigating the copper-mediated ATRC of enamides that were substituted at the 
terminal end of the alkene only (scheme 69). 
Scheme 69. General structure of terminally substituted enamide precursors. 
By using precursors of this type we hoped to impede the rate of any competing 5-endo 
cyclisation and stabilise the resulting p-Iactam radical. In addition, the use of a highly 
active atom transfer catalyst at relatively low temperature should facilitate rapid trapping 
to give the kinetic 4-exo product. 
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4.2 Precursor synthesis. 
We prepared a range of enamide substrates in order to assess their suitability towards 4-
exo radical cyclisation. The general procedure for the preparation of the initially chosen 
precursors (119-130) was carried out using standard literature procedures. Thus, the 
appropriate aldehyde (1.0 eq.) was added to a solution of the required primary amine and 
excess anhydrous magnesium sulfate in dichloromethane under an atmosphere of 
nitrogen. The mixture was stirred for four hours at room temperature then the magnesium 
sulfate was removed by filtration and the solvent removed under reduced pressure 
(scheme 70). To a solution of the resulting imine in dry dichloromethane was added the 
appropriate acid bromide followed by diethylaniline. The mixture was stirred for two 
hours at room temperature then washed with a 10% solution of HCl followed by a 
saturated solution of sodium chloride. The organic phase was then dried and concentrated 
under reduced pressure to yield the crude products. 
R R3~ yR' H2N/ /R N 
0 
MgS04 R'yl Acid bromide + .. .. RylH AT diethylaniline o N I A2 A 
A2 (119-130) 
Scheme 70. Synthesis of bromo-enamides (119-130). 
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The crude bromo-enamides required purification by column chromatography and the 
overall yields were generally good (28%-74%) (table 10). Using this method we prepared 
a range of different substrates in which the nature of the N-protecting group was varied 
from benzyl, para-methoxy benzyl and o-bromo benzyl as well as sterically (10, 2° and 
3° groups). We also investigated the effect of alkene substituents by enclosing them in 5-, 
6- and 7-membered rings as well as using non-cyclic substituents. Finally we prepared 
substrates in which cyclisation would take place via a 3° and a 2° radical. 
Precursor R RI RZ RJ Yield 
119 CH2Ph (CH2)s (CH2)s Me 58% 
120 CH2Ph (CH2)s (CH2)s H 40% 
121 CH2Ph CH3 CH3 Me 74% 
122 CH2Ph (CH2)4 (CH2)4 Me 53% 
123 CH2Ph (CH2)6 (CH2)6 Me 63% 
124 CH2Ph CH3 CH2CH3 Me 52% 
125 CH2Ph H CHCH3CH3 Me 60% 
126 PMB (CH2)S (CH2)S Me 55% 
127 t-Bu (CH2)S (CH2)s Me 28% 
128 i-Bu (CH2)S (CH2)s Me 47% 
129 o-bromo Bn (CH2)s (CH2)S Me 66% 
130 CHCH3Ph (CHz)s (CHz)s Me 58% 
Table 10. Yields of bromo-enamide cyclisation precursors (119-130). 
Not all the aldehydes required for the preparation of substrates were commercially 
available and those that were not were synthesised from their corresponding alcohols 
using pyridinium chlorochromate (PCC).46 
126 
Chapter 4 : Efficient B Jactam synthesis via 4-exo ATRC. 
4.3 Cyclisation reactions. 
Initial studies (chapter 2) and other work recently reported within the group47 has 
demonstrated that the nature of the ligand in copper(I) mediated atom transfer 
cyclisations has a dramatic effect upon the rate of reaction. Tertradentate ligands (131· 
132) were found to be the most active in simple 5-exo radical cyclisations allowing 
reactions to be carried out under milder conditions than existing copper-bipyridine48, 
copper-TMEDA 49 or RuCh(PPh3h50 technologies. 
~ 
Me2N/'...../N~NMe2 
(131 ) (132) 
Therefore, tripyridylamine (TPA) ligand (132) was selected for use in the cyclisation of 
bromo-enamides (119·130). The extremely active nature of this catalyst should permit 
reactions to be conducted at room temperature or below with rapid trapping, therefore 
hopefully favoring formation of the kinetic 4-exo product. 
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4.3.1 Effect of the N-substituent upon cyclisation. 
In the 5-exa atom transfer radical cyclisation of haloacetamides onto alkenes the N-
substituent often affects the efficiency of the reaction.48 Thus, we initially attempted the 
cyc1isation of substrates (119, 126-129) in order to ascertain if the N-alkyl substituent had 
any effect upon the cyclisation. Hence, reactions of substrates (119, 126-129) were 
carried out using 30 mol% CuBr and 30 mol% (132) (TPA) in dichloromethane (0.12 M) 
at room temperature. After 1 hour, following work-up by passing through a silica plug, 
the corresponding tert-bromo 4-exa atom transfer products (133-136) were obtained in 
excellent yield (table 11). 
(119,126-129) 
Substrate R 
119 Bn 
126 PMB 
127 t-Bu 
128 i-Bu 
129 a-Br-Bn 
Reaction of 128-129 required 2 hrs. 
30 mol%CuBr 
30mol% TPA 
oeM, RT, 1 hr 
.. 
Product 
133 
134 
135 
136 
o 
(133-136) 
Yield 
96% 
98% 
0 
98% 
98% 
Table It. Effect of enamide N-alkyl substituents upon cyclisation. 
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No products arising from 5-endo cyclisation or reduction of the initial radical were 
detected. However, the cyclisations of substrates (128-129) required 2 hours to go to 
completion indicating that the sterle bulk of the N-alkyl group plays a role in determining 
the rate of cyclisation. In fact, the most hindered substrate (127) (R = t-Bu) did not 
. undergo cyclisation at all, even after extended reaction times (12 hours) under reflux in 
dichloroethane (80°C). 
We found that the synthetic utility of the process can be expanded by manipulation of the 
tertiary bromide moiety. Thus, stirring bromides (133) (R=Bn), (134) (R=PMB) and 
(136) (R=o-BrBn) with one equivalent of 1,8-diazabicyclo[5.4.0]-undecene (DBU) in 
dichloromethane at room temperature for 12 hours furnished the corresponding alkene 
products (137-139) in excellent yields (table 12). 
o 
(133, 134, 136) 
tert-Bromide 
133 
134 
]36 
OBU, oeM, 12 hrs . 
.. 
o 
(137-139) 
Elimination product (137-139) 
94% 
92% 
98% 
Table 12. Yields of J3-lactam elimination products. 
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4.3.2 Effect of the enamide substituent. 
Having investigated the effect of the N-alkyl group we next turned our attention to the 
cyclisation of substrates in which we had varied the enamide substituents. We were 
pleased to discover that cyclisation of both (121) and (124) were extremely facile and 
gave rise to the corresponding bromo functionalised ~-lactam products (141-142) within 
20 minutes and again in excellent yield (scheme 71). 
"rXf 30 mol% CuSr 30 mol% TPA Sr OCM, RT, 20 min 
• o N 
97% N" I 
Sn 0 Sn 
(121 ) (141) 
"rX} 30 mol% CuSr 30mol% TPA OCM, RT, 20 min 
• o N 96% N" I 
Sn 0 Sn 
(124) (142) 2: 1 mixture of 
diastereomers 
Scheme 71. CuBr(TPA) mediated cyclisation of enamides (121) and (124). 
Note that the cyclisation of (124) furnished the tertiary bromide (142) as an inseparable 
2: 1 mixture of diastereomers. No attempt was made to determine which isomer was the 
major one. 
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Interestingly, cycIisation of the mono-substituted enamide (125) was not possible even 
after extended reactions times and at reflux (scheme 72). Only starting material was 
recovered from the reaction and no reduction of the substrate was detected. 
"'ir o N 
I 
Bn 
(125) 
30 mol% CuBr 
30 mol% TPA 
OCM, RT, 1 hr. 
.. No reaction 
Scheme 72. Attempted cyclisation of mono-substituted enamide (125). 
The failure of this cyclisation demonstrates the importance of having two enamide 
substituents in stabilising the resulting 4-exo radical. Finally, we investigated the 
cyclisation of substrates (122-123) which contain a cyclopentyl and cycIoheptyl ring 
appended to the alkene respectively (scheme 73). 
"'i5k" 
o I 
Bn 
(122-123) 
30 mol% CuBr 
30 mol% TPA 
oeM, AT, 1 hr . 
97-99% 
.. 
o N" Bn 
(143) n=1 99% 
(144) n=3 97% 
Scheme 73. Cyclisation of cyclopentyl and cycloheptyl enamide derivatives. 
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These too underwent cyclisation to give ~-lactam products (143-144) exclusively. 
4.3.3 Further variation of substrate. 
The cyclisation of secondary halides using atom transfer is often problematic and 
generally requires elevated temperatures, even with activated ligands (131-132). Thus, 
reaction of secondary bromide (120) with 30 mol% CuBr(TPA) in refluxing 
dichloromethane failed with only starting material being recovered. However, heating at 
a higher temperature in refluxing toluene (llOOC) for 24 hours gave a 2.8: 1 mixture of 
diastereomers (145) in 82% yield (scheme 74). 
(120) 
30 mol%CuBr 
30 mol% TPA 
toluene, reflux, 24 hrs 
.. 
(145) 
Scheme 74. Cyclisation of secondary bromide (120). 
Elimination of the tertiary bromide occurred under these reaction conditions resulting in 
formation of the alkene (145) directly without the need for DBU mediated elimination 
(section 4.3.1). Again, no attempt was made to determine which isomer was the major 
product. 
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Finally, cyclisation of the chiral substrate (130) was examined. The reaction proceeded as 
expected to give a 0.8: 1 ratio of diastereomers of the bromide (146) in 96% yield (scheme 
75). 
(130) 
30 mol%CuBr 
30mol% TPA 
DCM, AT, 1 hr 
.. 
Scheme 75. Reaction of chiral substrate (130). 
(146) 
4.4 Comparison of efficiency with reported ruthenium(II) atom transfer 
cyclisation catalyst. 
The atom transfer cycJisation of bromo-en ami des (119) and (121) with RuCh(PPh3)3 has 
recently been reported.38 Therefore, a comparison of the results obtained using our 
CuBr(TPA) system to those published by Ghelfi is given here. Ghelfi reported that 
reaction of bromide (121) with RuCh(PPh3)3 (0.5 eq.) in refluxing toluene (110°C) for 
6.5 hours resulted in a mixture of the unsaturated p-lactam (147) and reduction product 
(148). Cyclisation of the related precursor (119) gave the corresponding alkene (137) 
after 19.5 hours under the same conditions (scheme 76). 
133 
8(1) 
o N 
I 
Bn 
(121) 
(119) 
RuC12(PPhab 
(0.5 equiv.) 
.. 
toluene, reflux 
6.5 hrs. 
RuCI2(PPh3b 
(0.5 equiv.) 
.. 
toluene, reflux 
19.5 hrs. 
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Hi) 
+ 
o N 
I 
Bn 
(148) 9% (147) 84% 
(137) 74% 
Scheme 76. Ruthenium(II) promoted cyclisation of bromo-enamides. 
Substrate AT Catalyst Reaction Reaction Time Yield of~-
Temp. Lactam 
119 CuBr(TPA) (0.3 eq.) RT 1 hr. (133) 96% 
119 RuCh(PPh3h (0.5 eq.) 110°C 19.5 hrs. (137) 74% 
121 CuBr(TPA) (0.3 eq.) RT 20 min. (141) 97% 
121 RuC\z(PPh3)3 (0.5 eq.) 110°C 6.5 hrs. (147) 84% 
Table 13. Comparison between CuBr(TPA) and RuCh(PPh3h catalysts. 
The results in table 13 clearly show that the CuBr(TPA) system offers significant 
advantages over the use RuCh(PPh3h enabling cyclisation under milder reaction 
conditions and in shorter times. In addition, elimination of hydrogen bromide results in 
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direct formation of the unsaturated p-lactams (137, 147) further limiting the use of the 
ruthenium system. 
4.5 4-Exo versus 5-exo radical cyclisation. 
Finally, we were interested in investigating the reaction of substrates in which ring 
closure might occur in a 4-exo or 5-exo manner. Thus, the preparation of precursors (149-
151) was conducted according to the procedures outlined in section 4.2. 
(149) (150) (151 ) 
For precursors (149-150) 4-exo cyclisation onto the enamide double bond might be 
expected to produce the kinetically favoured p-lactam, alternatively, 5-exo cyclisation 
onto the N-allyl group might give the thermodynamically more stable y-lactam product. 
Therefore, by varying the reaction conditions we hoped to be able to control the 
regioselectivity of the cyclisation. 
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Reaction of (149) with 30 mol% CuBr(TPA) in dichloromethane at room temperature for 
1 hour gave an inseparable mixture of y-lactam (152) and p-lactam (153) in a ratio of 
1.8: 1 (scheme 77) (Le. the y-Iactam was the major product). 
sri 9 }jsr o N 
30 mol% CuBr(TPA) \) N o N • ~ DCM, RT, 1 hr 96% ~ 
(149) (152) (1.8: 1.0) (153) 
Scheme 77. CuBr(TPA) mediated cyclisation of (149). 
By repeating the reaction at a lower temperature and by using a higher catalyst 
concentration we hoped to increase formation of the kinetic 4-exo product (153). 
However. reaction of (149) with 1 equivalent of CuBr(TPA) in dichloromethane at O°C 
did not significantly alter the product distribution. Cyclisation of (149) with 3 mol% of 
CuBr(TPA) in toluene at 110°C was also attempted (in order to further promote 
formation of the thermodynamically more stable y-Iactam (152» but failed due to 
solubility problems. We next turned our attention to the cyclisation of the related 
precursor (150). Reaction with 30 mol% CuBr(TPA) in dichloromethane at room 
temperature for 20 minutes afforded a mixture of y-Iactam (154) and p-Iactam (155) in a 
ratio of 1 : 4.25 (scheme 78). 
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BriY 
30 mol% CuBr(TPA) 
}-)Br 
o N .. o N N ~ DCM, AT, 20 mins 97% y ~ 
(150) (154) (1.0: 4.25) (155) 
Scheme 78. CuBr(TPA) mediated cyclisation of (150). 
Interestingly, the regioselectivity of the reaction has now switched and the ~-lactam (155) 
is now the major product. This is possibly due to the less hindered enamide (150) 
favouring formation of the 4-exo derived product. Repeating the reaction with 3 mol% 
CuBr(TPA) in dichloroethane at 80°C (in order to encourage formation of the 
thermodynamically stable y-lactam) had little effect upon the product ratio. Overall, the 
inability to alter the product distributions suggests that interconversion between the two 
possible amide conformations is not rapid enough to allow control over regioselectivity. 
Finally, reaction of (151) with 30 mol% CuBr(TPA) in dichloromethane at room 
temperature for 20 minutes furnished ~-lactam (156) exclusively (scheme 79). In this 
case a much slower 6-exo cyclisation obviously can not compete with 4-exo ring closure. 
It was hoped that 6-exo cyclisation might then follow the initial 4-exo reaction to afford 
the corresponding bicyclic system. However, cyclisation of (151) with 1 equivalent of 
CuBr(TPA) in refluxing dichloroethane in a sealed tube for 48 hours resulted in 
formation of the monocyclised product (156) only. 
137 
",i) 
o ~ i mol% C""'(TP~ (CM, AT, 20 mlos 95% 
(151) 
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Br 
(156) Not formed 
Scheme 79. CuBr(TPA) mediated cyclisation of (151). 
4.6 Conclusions. 
In conclusion, we have demonstrated that atom transfer cyclisation of terminally 
substituted enamides using a catalytic amount of CuBr(TPA) furnishes bromo-
functionalised ~-lactams in excellent yield (82-99%). Reactions proceeded via a 4-exo 
radical cyc1isation and no products arising from 5-endo ring closure or reduction of the 
original radical precursors were detected. The efficient formation of the ~-Iactam 
products permits cyclisations to be conducted under extremely mild reaction conditions 
and offers distinct advantages over the use of RuClz(PPh3h. It is generally accepted that 
the 4-exo cyc1isation products are the kinetically derived products while those arising 
from 5-endo cyclisation are thermodynamically favoured. In this chapter we have shown 
that cyc1ising onto terminally substituted enamides (which will sterically impead 5-endo 
cyclisation), in conjunction with the use of a very active atom transfer catalyst (that 
allows rapid trapping of the intermediate radicals at ambient temperature) favours the 
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fonnation of the kinetic ~-lactam products. Interestingly, even at 110°C in toluene, 
cyclisation of secondary bromide (120) furnished the 4-exo product exclusively thus 
highlighting the efficient nature of the atom transfer catalyst used in trapping out the 
intennediate cyc1ised radical. 
4.7 Future work. 
Work is currently underway within the group to apply this methodology towards the 
synthesis of ~-lactam derived natural products that are of biological interest. In order for 
this work to be successful investigation into a reliable method for the deprotection of N-
benzylamide type cyclisation products is a priority. 
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Chapter 5 
Lycorane and Erythrinane Skeleton Synthesis Via 5-Endo 
Radical CycJisation 
5.1 Introduction. 
In recent years considerable attention has been directed towards the use of free-radical 
eyclisation reactions for the synthesis of nitrogen-containing heterocycIes.26b Thus, a 
wide range of N-allyl-haloacetamides are known to undergo 5-exo radical cyclisation via 
a carbamoyl radical to give five-membered lactam products.2.5 The potential utility of this 
methodology in the field of natural product synthesis was initially illustrated by 
application to the synthesis of pyrrolizidine and Sceletium alkaloids.51 Radical cyclisation 
protocols have subsequently been applied to a much wider range of bi- and poly-cyclic 
nitrogen heterocycles25 and can now be envisaged for synthetic use in most ring systems. 
In the previous chapter we examined the mode of cyclisation of halo-enamide substrates. 
In principle, the ring closure of substrate (157) may either occur in a 4-exo or 5-endo 
manner (scheme 80). Ilowever, halo-enamides (157) preferentially undergo the 
disfavoured 5-endo mode of ring closure, although, we have demonstrated that suitably 
designed precursors can be used to encourage 4-exo cyclisation. 
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4-exo ::IN) 5-endo oJ:) 
I I p p 
(157) 
Scheme 80. 4-Exo versus 5-endo cyclisation of halo-enamides. 
Consequently, we propose to prepare a range of fused five-membered lactams via 
copper(f) mediated 5-t>nclo atom transfer radical cycJisation of halo-N-(cycloalk-l-
cnyl)acctamides, and investigate the feasibility of this method for the synthesis of the 
Iycorane and crythrinane skeletons. 
5.1.1 The Iycorlne family. 
The Iycorine-typc AmaryllidllCl'(lc' alkaloids (e.g. (159» are characterised by the presence 
of the galanlhane ring systcm (158). Many of these alkaloids display potentially useful 
biological properties including antiviral, antineoplastic and antimitotic activity.52 Others 
arc known to inhihit plant £rowth and disrupt peptide bond formation in protein 
synthesis. 'Y-Lycorane (159) itself docs not appear to possess any useful pharmacological 
properties. fllm'cver, it has become a popular synthetic target as its pentacyclic structure 
provides a means of demonstrating the utility of new synthetic strategies. 
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(158) (159) 
5.1.2 Radical approaches towards the Lyeorane ring system. 
Cossy et al~3 have reported a ten step procedure for the synthesis of y-lycorane from the 
pipcronylic alcohol (160) and cyclohex-2-enol (161) involving radical cycJisations for the 
formation of the Band C rings (158) (scheme 81). 
~ '9 v:lN ~ '9 v:l~' 
(164) (163) (162) 
il 
~ o I # OH {= ~ I # NH2 
·OH9 
(160) il 
(161 ) Q 
OH 
Scheme 81. Synthesis of Iyeorane skeleton (164) as reported by Cossy et al. 
142 
Chapter 5 : Lyeorane and Erythrinane skeleton synthesis. 
Thus, precursor (162) (prepared via a seven step synthesis) underwent cyclisation with 
CuCVCuCIz in THF/H20/AcOH to afford the C ring (163). Following elimination with 
DBU, intermediate (163) then underwent a tributyl tin mediated radical cyclisation to 
give the B ring and hence the desired product (164). 
A four step synthesis of racemic y-lycorane has also been reported by Zard.54 Formation 
of the key C ring was accomplished using a nickel/acetic acid promoted 5-endo radical 
cyclisation to give (166). Again, a tin mediated 6-endo radical cyclisation was then used 
to furnish the Bring (167). Reduction of (167) using sodium cyanoborohydride then 
LiA1I14, to remove the carbonyl, gave y-lycorane (164) (scheme 82). 
0 Reflux. toluene QC1iCI Ni. AcOH ~o 
• 
N 0 • 
+ CI3CCOCI aX AcONa <xX <xX: o I ~ NH2 o ~ Br o # Br 
(165) 
J BU3SnH 
(166) 
1. NaBH3CN, AcOH 
~ 2. LiAIH4• THF <0 • 0 
0 
(164) (167) 
Scheme 82. Synthesis of Iycorane skeleton (164) reported by Zard. 
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The syntheses of 'Y-Iycorane (164) described above both utilise an organotin mediated 
cyclisation for the fonnation of the B ring. However, Rigby et al55 have reported use of a 
selective intramolecular Heck process for the fonnation of both the Iycorane and 
erythrinane skeletons. Thus, endo-cyclisation of (168) (n= 1) fonns the Iycorane system 
(170), while the exo pathway (with n=2) afforded the erythrinane skeleton (169) (scheme 
83). 
0 
/ (169) C(\ I ~ N X ~ n 
(168) 0 
X 
0 
(170) 
Scheme 83. Cyclisation pathways in the intramolecular Heck reaction of (168) 
It was reported that the use of standard Heck conditions (Pd(OAch (10 mol%), (o-tolhP 
(20 mol%), Et.lN (2 eq.), McCN/IIzO, 80°C) afforded mainly the exo derived product 
(169), while use of the Jeffery palladium catalyst system (Pd(OAch (to mol%), n-
Bu4 NCI (2 eq.), KOAc (5.5 eq.), DMF 100°C) provided the product of the endo pathway 
(170) exclusively. 
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5.1.3 The Erythrinane Family 
The Erythrina alkaloids are a large family of biologically active natural products.56 Many 
erythrinane compounds possess curare-like activity and their extracts have been used in 
indigenous medicine.57 A variety of phannacological effects including sedative, 
hypotensive, neuro-muscular blocking and eNS depressant properties are also associated 
with the erythrinane skeleton.58 The vast majority of naturally occurring erythrina 
alkaloids possess a tetracyclic framework and, like the Iycorane family, numerous 
synthetic approaches into the erythrina ring system have been developed. Padwa has 
reported a triple cascade reaction sequenceS9 involving an intramolecular Diels-Alder 
reaction to form cycloadduct (173). This then undergoes ring-opening to generate the 
acyliminium ion (172) followed by cyclisation to give (171). Thus, using this approach 
the ring system (171) is assembled in a single operation (l74~171) (scheme 84). 
(171) 
LG A~03~ < 
(174) 
;. 
Ao--+.-1# 
(172) 
(173) 
Scheme 8-'. Cascade sequence for construction of the erythrinane skeleton. 
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Ikeda has reported a BU3SnH-mediated radical cyclisation approach into the erythrinane 
skeleton.6o Thus. condensation of 2-(cyclohex-l-enyl)ethylamine (175) and 
cyclohexanone (176) formed the imine (177). which was subsequently treated with 
chloroacetyl chloride and triethylamine to afford the cyclisation precursor (178). 
Enamide (178) then underwent cyclisation in the presence of BU3SnH and AIBN to 
furnish the erythrinane skeleton (179) (scheme 85). 
(175) (176) (177) 
• 
Scheme 85. Hu.,Snll-mediated radical cyclisation leading to erythrinane (179) 
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5.2 \Vork previously conducted within the Clark group. 
A range of bicycJic lactam compounds have been synthesised within the group via the 
Jess common 5-endo mode of radical cyclisation.42 Thus, mono bromo-en amide (180) 
underwent cyclisation with 30 mol% CuBr(Me6-tren) in dichloromethane at room 
temperature to furnish two alkene products (181-182) in 82% yield (l: 1 ratio) (scheme 
86). Mechanistically, the reaction has been proposed to occur via an initial 5-endo radical 
cycJisation to give (183) followed by Cu(II) mediated oxidation of the tertiary radical to 
the corresponding N-acyl iminium ion (184). Elimination of a proton then affords the two 
regioisomcrs (181-182). 
f~D 
I 
Bn 
CuBr(Me6-tren) ±:o 
DCM,AT ~ 
• 0 N 
I 
Bn 
:to 
I Bn 
(180) I (181) 1 (182) 
;to 
I Bn 
_0 :(;0 
o 7 
Bn 
(183) (184) 
Scheme 86 Copper mediated 5-elldo cyclisation: radical/polar crossover mechanism. 
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We were interested to see if intramolecular capture of radical (183) (such as in a tandem 
cyclisation process) could compete with the oxidation step. Therefore, by introducing a 
cyclohexenyl-based N-protecting group, it was hoped that an electrophilically triggered 
6-endo cyclisation might follow the initial 5-endo reaction to afford the Band C rings of 
the Iycorane or erythrinane skeleton. However, cyclisation of (185) resulted in a mixture 
of regioisomers of the monocyclised product (186) and (187) only42 (scheme 87). 
(185) 
CuBr(Tren) 
• 
OCM, AT, 
20 min 
(186) 3:2 (187) Not formed 
Scheme 87. Attempted CuBr(Me6-tren) mediated tandem cydisation reaction. 
Clearly, oxidation of the initial radical is faster than capture via 6-endo cyclisation. 
Therefore, we decided to adapt the N-group of the cyclisation precursor to include a 
phenyl ring with a halogen atom in the 2-position. This might then be expected to 
undergo a Ileck type palladium coupling as reported by Rigbl5 to form the B ring of the 
Iycorane or erythrinitol system. If successful, the aromatic protecting group could then be 
replaced hy a pipcronylic alcohol (160) derived amine to form the y-Iycorane skeleton. 
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5.3 Lycorane precursor synthesis. 
The preparation of cyclisation precursors (191-192) was carried out according to standard 
literature procedures. Thus, a solution of 2-bromobenzylamine (189) and cyclohexanone 
(188) in toluene were heated at reflux in a Dean-Stark apparatus with azeotropic removal 
of water for 4 hours. The solvent was then removed under reduced pressure to yield the 
imine (190) (scheme 88). 
0 
6 Br :i~D Et3N 6l) Acid halide .. .. (188) Et3N CC d I # NH2 # Br 
(189) (190) (191) R=Me, X=Br (19%) 
(192) R=X=CI (37%) 
S(."hcme 88. Synthesis of Iycorane skeleton cyclisation precursors. 
The appropriate acid chloridclbromidc was then added dropwise and the mixture was 
stirred for 1 hour at room temperature. After cooling to O°C, triethylamine (3.0 eq.) was 
added and the mixture was stirred for a further 2 hours at room temperature. Following 
work-up, purification by column chromatography afforded halo-enamides (191) and 
(192). The relatively poor yields obtained for precursor (191-192) may be attributed to 
competition between N-acylation and C-acylation of the imine (190). 
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Hence, imine (190) may undergo N-acylation via the N-acyliminium ion (193) to afford 
the desired trichloroacetamide (192). Alternatively, the corresponding enamine (195) can 
undergo C-acylation to give the iminium ion (196). This exists in equilibrium with adduct 
(197) which upon treatment with triethylamine affords the C-acylated by-product (198) 
(scheme 89). 
Br t l3 Br ~~:6 CCI3D ol) 0:6 O~N o N '<:::::: Et3N ~OCI 6 1-" == CI6 1-" 
- cC ~ Br 
(190) (193) (194) (192) 
1~ 
9 ~~ -9 615 
Br ~ B ~ o r
HN CI3CCOCI o H~ Et3N 
-
- HN-ej' - CI3C~ CI3C~ - f , 
(195) (196) (197) (19B) 
Scheme 89. Competing N-aqlation and C-acylation pathways. 
Significant amounts of the C-acylated by-products were isolated during the preparation of 
both (191) and (192), interestingly this problem was not encountered during the 
preparation of enamides described in section 4.2. 
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5.4 Erythrinitol precursor synthesis. 
In order to form the erythrinane alkaloid skeleton the N-group of the cyclisation precursor 
must contain an additional CH2 group. The corresponding amine (201) was not available 
commercially and was therefore synthesised in a two-step procedure61 from 2-
bromobenzaldehyde (199). Thus, an aqueous solution of sodium hydroxide was added to 
a solution of bromobenzaldehyde (199) and nitromethane in methanol. The mixture was 
stirred at room temperature for) hour and then added to an excess of hydrochloric acid to 
deposit the crude product (200). Subsequent recrystallisation from ethanol afforded 2-
bromonitrostyrene (200) as pale yellow pillars in 73% yield. Reduction of the double 
bond and nitro group with lithium aluminium hydride then gave 2-(2-bromo-phenyl)-
ethylamine (201) in 96% yield (scheme 90). 
0 
NaOH ~N02 ~NH2 c(H MeOH LiAIH4 • I~ I~ ~ Br Br Br 
(199) (200) (201 ) 
S<:heme 90. Preparation of 2-(2-bromo-phenyl)-ethylamine. 
2-(2-Bromo-phenyl)-ethylamine (201) and cyclohexanone (188) were then converted to 
the imine (202) by refluxing in toluene with azeotropic removal of water. Acylation with 
2-bromo-2-methyl-propionyl bromide was then conducted as previously described 
(section 5.3) to afford the monobromo-acetamide (203) in 22% yield (scheme 91). 
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~ o B, 
(202) 
Br(Me2)CCOBr 
• 
Br 
(203) 
Scheme 91. Preparation of erythrinane precursor (203). 
5.5 Cyclisation reactions. 
We initially investigated the cyclisation of the monobromoacetamide lycorane skeleton 
precursor (191). Thus, cyclisation of (191) was attempted with 30 mol% CuBr(NPMI) in 
dichloromethane at room temperature. However, after 48 hours only starting material was 
recovered. We therefore repeated the reaction using the more active tripyridyl amine 
(TPA) ligand. 
() 
"Nli 
N~ 
Tripyridyl amine (TPA) N-pentyl-2-pyridylmethanimine (NPMI) 
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We were encouraged to find that reaction of (191) with 30 mol% CuBr(TPA) in 
dichloromethane (0.12M) at room temperature afforded the bicyclic lactam (204) in 90% 
yield after just 20 minutes (scheme 92). 
(191) 
30 mol% CuBr(TPA) 
DCM, RT, 20 mins 
(204) 
Scheme 92. Cyclisation of monobromoacetamide (191). 
Not formed 
Interestingly, the expected mixture of regioisomers was not observed (ef. scheme 86) and 
cyclisation resulted in exclusive formation of the alkene product (204). This is 
advantageous since the double bond in the six-membered ring of (204) is in an ideal 
position for palladium coupling to occur and therefore the difficult separation of 
regioisomers is not required. 
Next we turned our attention to the cyclisation of the trichloroacetamide precursor (192). 
Reaction of (192) with 30 mol% CuCl(TPA) in dichloromethane (0.12M) at room 
temperature failed with only starting material being recovered after 24 hours. 
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More forcing conditions were required thus, precursor (192) and CuCI(TPA) were heated 
under reflux in 1,2-dichloroethane at 80°C for 48 hours. Following purification by 
column chromatography, the diene (205) was isolated in 62% yield (scheme 93). 
(192) 
30 mol% CuBr(TPA) 
DCE, reflux, 48hrs 
CI~ 
aA¢:: 
BrN 
(205) 
Scheme 93. Cyclisation of tricholroacetamide (192). 
Fonnation of dienc (205) is thought to result from Cu(II) mediated oxidiation of cycJised 
radical (206) to give the corresponding N-acyl iminium ion (208) via cation (207). 
Subsequent elimination of a proton followed by elimination of HC] then affords the 
observed product (205) (scheme 94). The double bond in the six membered ring of (205) 
is again ideally positioned for palladium coupling to give the B ring of the Iycorane 
skeleton. 
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C'X'D OW C'W 
°SJ o~ o~ Oxidation 
Br #' Br #' Br #' 
(192) (206) (207) 
f 
)~ CI CI C':to C':t;(J o~ o~ e~ ·Hel ·H+ o~ - -
Br #' Br #' Br #' 
(205) (209) (208) 
Scheme 94. Formation of diene (205). 
Finally, cyclisation of the monobromoacetamide erythrinane skeleton precursor (203) 
was carried out with 30 mol% CuBr(TPA) in dichloromethane (O.l2M) at room 
temperature. After 20 minutes the reaction had gone to completion to give a 1: 1 mixture 
of regioisomers (210) and (211) (scheme 95). The separation of regioisomers was 
problematic and only a very small amount of cyclic product (211) was isolated pure 
(8%). Therefore further investigation of palladium coupling methods to give the 
erythrinane skeleton was not undertaken. 
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ob:) ota 
Br Br 
(210) (211) 
Scheme 95. Cyclisation of monobromoacetamide (203). 
5.6 Palladium coupling reactions. 
Following atom transfer cyclisation, the standard Heck palladium coupling method 
utilised by Rigb/:'i was applied to (204) in an attempt to form the Iycorane skeleton. 
Thus, (204) was heated under reflux. with 10 mol% Pd(OAc)2 and 20 mol% tri-o-
tolylphosphine with triethylamine in acetonitrile and water (10:1) for 48 hours at 85°C. 
However, the reaction failed with only starting material recovered (scheme 96). The 
reaction was repeated using the Jeffery palladium catalyst system (Pd(OAc)2 (10 mol%), 
n-Du4NCI (2 eg.), KOAc (5.5 eq.), DMF (0.2M), 100°C, 48 hours) and was also 
unsuccessful. Reaction of the related precursor (205) to give the Iycorane skeleton also 
failed using both palladium coupling methods with only starting material being 
recovered. 
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Pd(OAch I P(o-tol)a 
Et3N, MeCNIH20, reflux 48 hrs )(. 
(204) 
Scheme 96. Attempted formation of Iycorane skeleton. 
Rigby et al used iodine rather than bromine at the 2-position of the phenyl ring in their 
synthesis of lycorane. It is knownss that palladium acetate facilitates coupling with iodine 
more readily than bromine and this may account for the failure of these reactions. Other 
reported syntheses of the Iycorane and erythrinane skeletons utilise tin-mediated radical 
cyclisations for formation of the B ring. However, the use of this reagent would negate 
many of the advantages associated with the copper(J) methodology and was therefore not 
used to complete the synthesis. For this reason further work to adapt the palladium 
coupling method in order to find more successful conditions would be required to 
complete this work. 
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Chapter 6 
Experimental 
6.1 General Experimental. 
Melting points were recorded on a Stuart Scientific SMPI melting point apparatus and 
are uncorrected. Infra-red spectra were recorded on a Perkin-Elmer 1720X fourier 
transform spectrometer either in a solution cell, as Nujol mulls or neat as stated in the 
text, with only selected absorbances (vmax) being reported. IH NMR spectra were 
obtained using either a Bruker ACF 250, Bruker DPX 300 or Bruker DPX 400 at 
250Mllz, 300Mllz or 400Mllz respectively as stated in the text. DC NMR were recorded 
at either 62.9Mllz, 75.5Mllz or 100.6MHz on a Bruker ACF 250, Bruker DPX 300 or 
Bruker DPX 400 respectively as stated in the text. Chemical shifts (8) are quoted in parts 
per million (ppm) and referenced to the appropriate solvent peak. Coupling constants (1) 
are quoted in Ilertz (lIz). Mass spectra were recorded on either a Kratos MS80 
spectrometer or a Micromass Autospcc spectrometer at the University of Warwick. 
Chemicals were purchased from Sigma-Aldrich, Lancaster or F1uka. Solvents were 
purchased from Fisons Scientific Equipment at SLR grade. Anhydrous solvents were 
obtained as follows: dry toluene, dichloromethane, diethyl ether and methanol were 
purchased from Romi!. Tetrahydrofuran was distilled from sodium-benzophenone under 
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nitrogen. Thin layer chromatography (TLC) was conducted using Kieselgel 60F254, 
0.2mm silica aluminium backed plates and developed using UV flouresence (254nm), 
potassium pennanganate solution or phosphomolybdic acid. Hash column 
chromatography was carried out on Merck Kieselgel 60F254, 230-400 mesh silica gel. 
6.2 Experimental for chapter 2. 
6.2.1 General procedure for the preparation of 2-pyridylmethanimine based 
ligands. 
To a stirred solution of pyridinecarboxaldchyde in diethyl ether containing copious 
anhydrous magnesium sulfate was added amine (1 eq.). The resulting mixture was stirred 
overnight at room temperature. The magnesium sulfate was removed by filtration and the 
solvent removed under reduced pressure. 
6.2.1.1 Pyridin-2-ylmcthylcne-p-tolyl-amine (64b)1 
4 
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2-pyridinecarboxaldehyde (0.88 ml, 9.33 mmol) and p-toluidine (1.03 ml, 9.33 mmol) 
were reacted as described above (6.2.1) to yield pyridin-2-ylmethylene-p-tolyl-amine 
(64b) (1.60 g, 88%) as yellow crystals. Spectral details match those previously reported.! 
VrnaJl (nujol) /em-I 2922, 1626, 1581, 1565, 1504, 1462, 1433, 1376,821,737; SH(300 
MHz, CDCh) 1.76 (3H, s, Cllj ), 6.66 (4H, br s, aromatic H), 6.72 (lH, ddd, J 7.5, J 5.0, 
J 1.0, H-4), 7.14-7.20 (l II, app dt, J 7.5, J 1.5, H-5), 7.58 (lH, d, J 7.5, H-6), 8.01 (lH, s, 
CII=N), 8.07-8.09 (Ill, m, H-3); &(75.5 MHz, CDCb) 20.86 (q), 120.90 (2 x d), 121.57 
(d), 125.11 (d), 129.64 (2 x d), 136.03 (d), 136.41 (s), 148.09 (s), 149.44 (d), 154.47 (s), 
159.45 (d). 
6.2.1.2 Pentylpyridin-2-ylmethyleneamine (54a)2 
4 
6 
I 
N~ 
2-pyridinecarboxaldehyde (1.77 ml, 18.0 mmol) and n-pentylamine (2.16 ml, 18.0 mmol) 
were reacted as described above (6.2.1) to yield pentylpyridin-2-ylmethyleneamine (54a) 
(2.94g, 94%) as a pale yellow oil which was used without further purification. Spectral 
details match those previously rcportcd.2 
Vmalt (film) /ern-I; 3056, 2959, 2932, 2873, 1717, 1650, 1588, 1468, 1436, 1333, 1045, 
992; SII(250 Mllz, CDC!) 0.83 (311, t, J 7.0, Clh), 1.25-1.30 (4H, m, CH2CH2CII2CH3), 
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1.63-1.68 (2H, m, NCHzCH2), 3.59 (2H, t, J 7.0, NCH2CHZ), 7.21 (lH, t, J 5.5, H-4), 
7.64 (lH, t, J 7.5, H-5), 7.92 (lH, d, J 7.5, H-6), 8.30 (lH, s, CH=N), 8.57 (lH, d, J 4.5, 
H-3); Bc(75.5 MHz, CDCh) 12.32 (q), 22.63 (t), 29.92 (t), 30.67 (t), 62.43 (t), 121.57 (d), 
124.98 (d), 136.91 (d), 149.78 (d), 155.00 (s), 162.14 (d); mlz (EI) 177 (MH+, 37%), 146 
(13), 119 (100); (Found: MH+, 177.1397. ClIHI6NZ requires MH+, 177.1392). 
6.2.1.3 (4-l\1ethoxy-phenyl)-pyridin-2-ylmethylene-amine (64c)3 
4 
2-pyridinecarboxaldehyde (0.88 ml, 9.33 mmol) and p-anisidine (l.14g, 9.33 mmol) were 
reacted as described above (6.2.1) to yield (4-methoxy-phenyl)-pyridin-2-ylmethylene-
amine (64c) (1.8 g, 93%) as a colourless oil. Spectral details match those previously 
reported.3 
Vma~ (neat) !em'( 3003, 2932, 2834, 1712, 1624, 1580, 1504, 1466, 1298, 1245, 1033, 
830, 762; 011(300 Mllz, CDCh) 3.84 (311, s, ~C/h), 6.95 (2H, d, J 9.0, aromatic H), 
7.27-7.36 (III, m, 11-4), 7.34 (211, d, J 9.0, aromatic H), 7.77-7.82 (IH, app dt, J 8.0, J 
1.5,11-5),8.19 (III, d, J 8.0,11-6),8.64 (IH. s, CI/=N), 8.69-8.71 (IH, m, H-3); Bc(75.5 
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MHz, CDC)3) 55.89 (q), 114.84 (2 X d), 122.06 (d), 123.07 (2 X d), 125.23 (d), 137.03 
(d), 144.06 (s), 150.04 (d), 155.23 (s), 158.64 (d), 159.33 (s). 
6.2.1.4 Pyridin-2-ylmethylene-(4-trifluoromethyl-phenyl)-amine (64d) 
4 
5~3 
6 I # 
N I 
N~ ~CF' 
2-pyridinecarboxaJdehyde (0.88 ml, 9.33 mmol) and 4-aminobenzotrifloride (1.17 ml, 
9.33 mmol) were reacted as described above (6.2.1) to yield pyridin-2-ylmethylene-(4-
trifluoromethyl-phenyl)-amine (64d) (2.05 g, 89%) as a yellow oil. 
Vnm" (nujol) /em-I 2853, ]609, 1463, 1376, 1322, I ]65, 1]29, 1066, 839, 780; BH(300 
MIIz, CDCb) 7.32 (211, d, J 8.0, aromatic 11), 7.40-7.44 (lH, ddd, J 7.5, J 5.0, J 1.0, H-
4), 7.67 (211, d, J 8.0, aromatic II), 7.82-7.87 (IH, app dt, J 7.5, J 1.0, H-5), 8.20 (tH, d, 
J 7.5,11-6),8.57 (III, s, CIl=N), 8.74 (Ill, d, J 5.0, H-3); &:(75.5 MHz, CDCb) 114.53 
(s), 121.52 (2 x d), 122.62 (d), 126.03 (d), 127.05 (2 X d), 137.21 (d), 137.48 (s), 150.28 
(d), 150.62 (s), 154.55 (s), 162.87 (d); B,.{282 MHz, CDCb) -62.55 (3F, S, CFJ ); mlz (EI) 
151 (Mil+, 22%),145 (36), 70 (13); (Found: MH+, 25l.l084. CI3H9F3N2 requires MH+, 
251.1079). 
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6.2.1.5 Phenyl-pyridin-2-ylmethylene-amine (64a)4 
4 
2-pyridinecarboxaldchydc (0.88 ml, 9.33 mmol) and aniline (0.85 ml, 9.33 mmol) were 
reacted as described above (6.2.1) to yield phenyl-pyridin-2-ylmethylene-amine (64a) 
(1.56 g, 94%) as a yellow solid. Spectral details match those previously reported.4 
811 (300 MIIz, CDCb) 6.64-6.70 (311, m, aromatic H), 6.74-6.84 (3H, m, 2 x aromatic H 
and 11-4), 7.18-7.23 (III, app dt, J 7.5, J 1.5, H-5), 7.60 (1 H, d, J 8.0, H-6), 8.01 (1 H, S, 
CII=N), 8.10-8.12 (111, m, 11-3); &:(75.5 Mllz, CDCb) 121.51 (2 x d), 122.31 (d), 
125.56 (d), 127.14 (d), 129.64 (2 x d), 137.09 (d), 150.12 (d), 151.36 (s), 154.95 (s), 
161.04 (d). 
6.2.1.6 (6-!\1cthyl-pyridin-2-ylmcthylene)-pentylamine (5tb) 
I 
N~ 
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6-Methyl-2-pyridinecarboxaldehyde (prepared according to standard literature 
procedures) (2.0g, 16.5 mmol) and n-pentylamine (1.9 ml, 16.5 mmol) were reacted as 
described above (6.2.1) to yield (6-methyl-pyridin-2-ylmethylene)-pentylamine (Stb) 
(2.5 g, 82%) as a pale yellow oil which was used without further purification. 
Vma)[ (film) /em-I; 3060, 2927, 2855, 1648, 1589, 1572, 1455, 1374, 1325, 1036, 791; 
1.66-1.78 (2H, m, NCH2ClIz), 2.62 (3H, s, ClIJ), 3.68 (2H, dt, J 7.0, J 1.0, NClIzCH2), 
7.19 (lll, d, J 7.0, H-5), 7.63 (I H, t, J 7.0, H-4), 7.78 (lH, d, J 7.0, H-3), 8.35 (lH, s, 
CII=N); &(75.5 MHz, CDCh) 14.37 (q), 22.82 (t), 24.67 (q), 29.85 (t), 30.73 (t), 61.94 
(t), 118.58 (d), 124.54 (d), 137.06 (d), 154.45 (s), 158.39 (s), 162.33 (d); m/z (El) 191 
(MII+, 26%), 149 (100). 133 (85).71 (42); (Found: MH+, 191.1549. CI2H1SN2 requires 
MIl+, 191.1550). 
6.2.1.7 (6-Methoxy-pyridin-2-ylmethylene)-pentylamine (SIc) 
4 
~~3 I~ MeO N I 
N~ 
6-Mcthoxy-2-pyridinccarboxaldchyde (synthesised according to standard literature 
procedures) (0.46g. 3.36 mmol) and n-pentylamine (0.39 ml, 3.36 mmol) were reacted as 
described above (6.2.1) to yield (6-methoxy-pyridin-2-ylmethylene)-pentylamine (SIc) 
(0.67g, 89%) as a pale yellow oil which was used without further purification. 
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Vrnax (film) tcm-); 2928, 2857, 1649, 1595, 1572, 1467, 1433, 1320, 1266, 1032, 804; 
1.70 (2H, qn, J 7.0, NCH2CII2), 3.63 (2H, t, J 7.0, NCII2CH2), 3.96 (3H, s, OCH3), 6.74 
(IH, dd, J 7.5, J 1.5, H-5), 7.56-7.63 (2H, m, H-3 and H-4), 8.24 (lH, s, CH=N); &:(75.5 
MHz, CDCb) 14.43 (q), 22.88 (t), 29.94 (t), 30.85 (t), 53.72 (q), 61.96 (t), 112.27 (d), 
114.32 (d), 139.23 (d), 152.67 (s), 162.18 (d), 164.24 (s); m/z (EI) 207 (MH+, 19%), 149 
(85), 135 (60), 71 (47), 57 (71), 41 (83); (Found: MH\ 207.1487. C)2H)sN20 requires 
MH\ 207.1498). 
6.2.1.8 (5-Methoxy-pyridin-2-ylmethylene)-pentylamine (S4d) 
4 
MeO 
I 
N~ 
5-Mcthoxy-2-pyridinccarboxaldchyde (prepared according to standard literature 
procedures) (46.0 mg, 0.33 mmol) and n-pentylamine (0.04 ml, 0.4 mmol) were reacted 
as described above (6.2.1) to yield (5-methoxy-pyridin-2-ylmethylene)-pentylamine 
(54d) (58 mg, 85%) as a pale yellow oil which was used without further purification. 
Vma" (fiIm)lcm·) 2954,2929, 1649, 1589,1467,1436,1331,1044;8H(300MHz,CDCb) 
0.87 (311, t, J 7.0, CII2CIIJ), 1.28-1.35 (411, m, CH2CH2C1I2CH3), 1.65-1.71 (2H, m, 
NClhClh), 3.59 (211, dt, J 7.0, J 1.0, NClhClh), 3.87 (3H, s, OCIIJ), 7.21 (lH, dd, J 
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8.5, J 3.0, H-4), 7.91 (IH, d, J 8.5, H-3), 8.27 (lH, s, CH=N), 8.29 (lH, s, H-6); &:(75.5 
MHz, CDCb) 13.81 (q), 22.26 (t), 29.28 (t), 30.26 (t), 55.46 (q), 61.27 (t), 120.56 (d), 
121.69 (d), 136.68 (d), 147.35 (s), 156.34 (s), 160.72 (d); mlz (El) 207 (MH+, 6%), 149 
(64), 71 (100); (Found: MH+, 207.1503. C'2H,sN20 requires MH+, 207.1498). 
6.2.1.9 (S-Nitro-pyridin-2-ylmethylene)-pentylamine (S4c) 
I 
N~ 
5-Nitro-2-pyridinecarboxaldchydc (prepared according to standard literature procedures) 
(0.5 g, 3.29 mmol) and n-pentylamine (0.4 ml, 3.29 mmol) were reacted as described 
above (6.2.1) to yield (5-nitro-pyridin-2-ylmethylene)-pentylamine (S4c) (0.61 g, 83%) 
as a pale yellow oil which was used without further purification. 
Vmax (film) /em-I 3046, 2955, 2858, 1644, 1597, 1524, 1456, 1351, 1016, 830; oH(250 
1.76 (211, m, NClhCI/z), 3.72 (211, t, J 7.0, NCI/zCII2), 8.20 (lH, d, J 8.5, H-3), 8.43 
(III, s, CIl=N), 8.51 (III, dd, J 8.5 J 2.5,11-4),9.44 (IH, d, J 2.5, H-6); &:(75.5 MHz, 
CDCb) 14.40 (q), 22.83 (t), 29.88, (t), 30.62 (t), 62.17 (t), 121.60 (d), 132.01 (d), 144.96 
(s), 145.29 (d), 159.61 (s), 160.17 (d); mlz (EI) 222 (MH+, 78%), 208 (96),192 (90),164 
(92),149 (100); (found: Mil+, 222.1247. CIIH'5N)02 requires MH+, 222.1244). 
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6.2.1.10 (S-l\Jethyl-pyridin-2-ylmethylene)-pentylamine (S4b) 
4 
I 
N~ 
5-Methyl-2-pyridi nccarboxaJdchydc (synthesised in accordance to standard literature 
procedures) (0.85g, 7.0 mmol) and n-pentylamine (0.81 ml, 7.0 mmol) were reacted as 
described above (6.2. I) to yield (5-mcthyl-pyridin-2-ylmethylene)-pentylamine (54b) 
(0.92g, 71 %) as a pale yellow oil which was used without further purification. 
VOla" (film) /em'l; 2929, 2853, 1649, 1569, 1372, 1041,792; DH(250 MHz, CDCh) 0.87 
(3H, t, J 7.0, ClhCIlJ ), 1.30-1.35 (411, m, ClhClhClhCH3), 1.69 (2H, qn, J 7.0, 
NCI{zClh), 2.34 (311, s, Cllj ), 3.62 (2H, t, J 7.0, NClIzCH2), 7.51 (lH, dd, J 8.0, J 2.0, 
H-4), 7.85 (lll, d, J 8.0,11-3),8.31 (IH, S, ClI=N), 8.44 (IH, d, J 2.0, H-6); &::(75.5 
Mllz, CDC!) 14.05 (q), 22.50 (t), 24.36 (q), 29.53 (t), 30.49 (t), 61.63 (t), 118.27 (d), 
124.25 (d), 136.76 (d), 154.11 (s), 158.08 (s), 162.03 (d); m/z (EI) 191 (MH+, 63%),149 
(97),133 (83); (Found: MII+, 191.1547. C I2HIsN2 requires MH+, 191.1549). 
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6.2.2 N-Allyl-N-toluenesulfonamide (65)5 
To a stirred solution of tosyl chloride (30.0g, 0.16 mol) in THF (l00 ml) was added 
allylamine (26.4 ml, 0.35 mol) dropwise and the resulting mixture stirred for 2 hours. The 
mixture was then extracted with dichloromethane (2 x 100 ml) and washed with water (2 
x 50 ml), dilute IICI (2 x 50 ml) and a saturated solution of sodium bicarbonate (2 x 50 
ml). The organic extracts were dried over anhydrous magnesium sulfate and the solvent 
removed under reduced pressure to afford N-allyl-N-toluenesulfonamide (65) (26.54g, 
82%) as a white crystalline solid; m.p. 98-100°C (from diethyl ether). Spectral details 
match those previously reported.s 
Villa" (film) /cm'l 3460,2958,2921,2854,16240; 011(250 MHz, CDCh) 2.48 (3H, s, CII3), 
3.62 (211, t, J 5.0, ClhCII=Clh), 4.45 (11-1, br, NIl), 5.10-5.22 (2H, m, CH=CII2 ), 5.68-
5.81 (III, m, CII=CIh), 7.34 (211, d, J 8.0, aromatic II), 7.77 (2H, d, J 8.0, aromatic H); 
&(75.5 Mllz, CDCh) 21.92 (q), 46.12 (t), 117.98 (t), 127.55 (2 x d), 130.12 (2 x d), 
133.38 (d), 137.27 (s), 143.87 (s); mlz (EI) 212 (MH+, 19%),155 (63),91 (100). 
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6.2.3 General procedure for the preparation of N-allyl-N-toluenesulfonyl-N-
haloacetamides. 
To a solution of N-allyl-N-toluenesulfonamide (65) in THF at -78°C under a nitrogen 
atmosphere was added n-BuLi (1.6 M in hexanes, 1.1 eq.) and the resulting solution 
stirred for 30 mins. The appropriate haloacetyl halide (1.1 eq.) was added and the mixture 
allowed to stir for 3 hours at -78°C. The reaction was quenched with saturated 
ammonium chloride solution and allowed to warm to RT. The mixture was extracted with 
dichloromethane (3 x SOml) and washed with a saturated solution of sodium bicarbonate 
(2 x SOml). The organic extracts were dried over anhydrous magnesium sulfate and the 
solvent removed under reduced pressure. 
6.2.3.1 N-Allyl-N-4-toluenesulfonyl-2-bromo-2-methylpropionamide (67) 
J:Bf 
o N 
I 
Ts 
n-BuLi (12.5 ml, 1.6M in hexanes) was added to a stirred solution of N-allyl-N-
toluenesulfonamide (65) (4g, 19.0 mmol) in THF (40 ml) then 2-bromo-2-
methylpropionyl bromide (2.5 ml, 21.0 mmol) was added. Purification by flash column 
chromatography using 4: I petroleum ether:ethyl acetate as eluent afforded N-allyl-N-4-
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toluenesulfonyl-2-bromo-2-methylpropionamide (67) (5.38g, 80%) as a white crystalline 
solid; m.p. 83-84°C (from hexanes). 
Vrnalt (nujol) !cm-1 2921, 1672, 1645, 1592, 1351, 1162, 847; DH(250 MHz, CDCh) 1.90 
(6H, s, CIIJCBrCIIJ), 2.45 (3H, s, CIIJ), 4.98 (2H, dt, J 5.5, J 1.5, CH2CH=CH2), 5.34-
5.46 (2H, m, CH=CII}), 5.94-6.07 (IH, m, CII=CH2), 7.32 (2H, d, J 8.0, aromatic H), 
7.89 (211, d, J 8.0, aromatic H); 8c(75.5 MHz, CDC h) 22.09 (q), 32.42 (2 x q), 51.01 (t), 
57.41 (s), 118.59 (t), 129.26 (2 x d), 129.61 (2 x d), 133.93 (d), 136.48 (s), 145.05 (s), 
170.76 (s); mlz (EI) 362 [(MII-8I Br)+, 23%], 360 [(MH_79Br)+, 25%], 295 (100), 280 (68), 
155 (54),91 (100); (Found: Mil+, 360.0263. CI4111s79BrN03S requires Mil+, 360.0269). 
6.2.3.2 N-Allyl-N-toluenesulphonyl-2,2,2-trichloroacetamide (66)6 
noDuLi (12.5 ml, 1.6M in hexanes) was added to a stirred solution of N-allyl-N-
toluenesulfonamide (65) (4g, 19.0 mmol) in TIIF (40 ml) then trichloroacetyl chloride 
(2.23 011,21.0 mmol) was added. Purification by flash column chromatography using 4: I 
petroleum cther:ethyl acetate as eluent afforded N-allyl-N-4-toluenesulfonyl-2,2,2-
trichloroacrtamidc (66) (4.2g, 60%) as a white crystalline solid; m.p. 74-76°C (from 
hexancs). Spectral details match those previously reported.6 
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Vrnax (nujol) /em-) 2923, 1712, 1595, 1358, 1167, 840, 813; SH(250 MHz, CDCh) 2.44 
(3H, s, CIIJ) , 4.91 (2H, dt, J 5.5, J 1.5, CH2CH=CH2), 5.34-5.48 (2H, m, CH=CH2), 
5.89-6.01 (I H, m, CII=CH2), 7.33 (2H, d, J 8.0, aromatic H), 7.91 (2H, d, J 8.0, aromatic 
H); &(75.5 MHz, CDCh) 22.16 (q). 51.50 (t), 98.23 (s), 119.33 (t), 129.84 (2 x d), 
129.92 (2 x d), 132.66 (d), 135.10 (s), 146.04 (s), 158.96 (s); mlz (EI) 356 (MH+, 32%), 
291 (100),211 (52),155 (80), 91 (51); (Found: MH+, 355.9669. C)2H)2ChN03S requires 
MH+, 355.9681). 
6.2.4 General procedure for the cyclisation of N-allyl-N-toluenesulfonyl-N-
haloacetarnides. 
To a mixture of N-allyl-N-toluenesulfonyl-N-haloacetamide and copper halide (30 
mol%) under a nitrogen atmosphere was added a solution of ligand (30 mol%) in dry 
dichloromethane (0.12M solution). The resulting mixture was stirred at room temperature 
and upon completion was eluted through a silica plug with dichloromethane. Subsequent 
removal of solvent under reduced pressure furnished the ,,(-Iactam as a white solid. 
6.2.4.1 4-n romornct hyl-3,3-d i rnethyl-l-( toluene-4-sulfonyl)-pyrrolidin-2-one (68) 
Br 
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N-AlIyl-N-4-toluenesulfonyl-2-bromo-2-methylpropionamide (67) (100 mg, 0.27mmol) 
was reacted as described above (6.2.5) to furnish 4-bromomethyl-3,3-dimethyl-l-
(toluene-4-sulfonyl)-pyrrolidin-2-one (68) (94 mg, 94%) as a white crystalline solid; m.p. 
Vrnax (film) fcm-' 2923, 1724, 1458, 1375, 1354, 1170, 1090, 815; OH(300 MHz, CDC!) 
0.91 (311, s, CIIJCClh), 1.18 (3H, s, CH3CCIIJ), 2.45 (3H, s, CH3), 2.45 (tH, m, 
CIIClhBr), 3.22 (t II, t, J 10.5, CIIHN), 3.47 (2H, m, CHlBr), 4.16 (1 H, dd, J 10.5, J 
7.5, CHIIN), 7.35 (211, d, J 8.0, aromatic 1-1), 7.94 (21-1, d, J 8.0, aromatic H); &(75.5 
MHz, CDCb) 16.81 (q), 20.70 (q), 22.42 (q), 28.81 (t), 43.99 (d), 44.39 (s), 47.77 (t), 
126.94 (2 x d), 128.72 (2 x d), 133.78 (5), 144.33 (5), 175.87 (5); mlz (EI) 360 (MH+, 
14%), 295 (67). 155 (100). 91 (82); (Found: Mil+, 360.0264. C'4H'8BrN03S requires 
MII+,360.0270). 
6.2.4.2 3,3-Dichloro-4-chloromcthyl-l-(toluene-4-sulfonyl)-pyrrolidin-2-one (69) 
CI 
N 
I 
Ts 
N-AlIyl-N-toJuenesuJphonyl-2,2,2-trichloroacetamide (66) (100 mg, 0.28 mmol) was 
reacted as descrihed ahove (6.2.5) to furnish 3,3-dichloro-4-chloromethyl-l-(toluene-4-
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su!fony!)-pyrro!idin-2-one (69) (97 mg, 97%) as a white crystalline solid; m.p. 156-158 
Vmalt (film) /em-I 2922,2852, 1752, 1462, 1375, 1173, lOSS, S13; 8H(250 MHz, CDCh) 
2.36 (3H, S, Cll), 2.94-3.10 (tH, m, CIICH2CI), 3.52 (III, dd, J 10.0, J 8.0, CHHN), 
3.63 (tH, dd, J 11.5, J 10.0, ClmC!), 3.S9 (tH, dd, J 11.5, J 4.0, CHIICI), 4.1S (tH, dd, 
J 10.0, J 7.0, ClIllN), 7.31 (2H, d, J 8.0, aromatic H), 7.S6 (2H, d, J 8.0, aromatic H); 
8c(75.5 MHz, CDCh) 20.79 (q), 39.15 (t), 46.S2 (t), 49.62 (d), 81.63 (s), 127.25 (2 x d), 
129.04 (2 x d), ]32.28 (s), 145.41 (s), 162.02 (s); mlz (EI) 356 (MH+, 23%),155 (100), 
91 (68); (Found: MH+, 355.9672. CI2HI2ChNO)S requires MH+, 355.9681). 
6.3 Experimental for chapter 3. 
6.3.1 4-Methyl-N-prop-2-ynyl-benzenesulfonamide (75)7 
HN J 
I 
Ts 
To a stirred solution of tosy! chloride (3.12 g, 16.0 mmol) in dichloromethane (10 ml) 
was added propargylamine hydrochloride (1.5 g, 16.0 mmol) and triethylamine (4.56 ml, 
33.0 mmol), the resulting mixture was then stirred for 2 hours. The mixture was then 
washed with water (2 x 10 mt), dilute IIC) (2 x 10 m) and a saturated solution of sodium 
bicarbonate (2 x 20 ml). The organic extracts were then dried over anhydrous magnesium 
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sulfate and the solvent removed under reduced pressure to afford 4-methyl-N-prop-2-
ynyl-benzenesulfonamide (75) (2.53g, 75%) as a colourless viscous oil. Spectral details 
match those previously reported.7 
OH(250 MHz, CDCh) 2.09 (IH, t, J 2.5, CCIl), 2.42 (3H, s, CH3), 3.81 (2H, dd, J 6.0, J 
2.5, NHCllz), 4.57 (tH, br, NIl), 7.30 (2H, d, J 8.0, aromatic H), 7.75 (2H, d, J 8.0, 
aromatic H); &(75.5 MHz, CDCh) 21.97 (q), 33.27 (t), 73.41 (d), 78.32 (s), 127.79 (2 x 
d), 130.11 (2 x d), 136.85 (s), 144.28 (s); mlz (El) 227 (MNH/, 66%),118 (51),91 
(l00); (Found: MNH/, 227.0849. CIOHIIN02S requires MNH/, 227.0854). 
6.3.2 Henzyl-prop-2-ynyl-amine (83) 
To a stirred solution of propargylamine hydrochloride (3.0 g, 33.0 mmol) in 
dichloromethane (20 ml) was added benzyl bromide (0.77 ml, 6.6 mmol) and 
triethylamine (4.6 ml, 33.0 mmol), the resulting mixture was then stirred at room 
temperature overnight. The mixture was then washed with water (3 x 20 ml) and a 
saturated solution of sodium bicarbonate (3 x 20 mI). The organic extracts were then 
dried over anhydrous magnesium sulfate and the solvent removed under reduced 
pressure. Purification by flash column chromatography using 5:2 petroleum ether:ethyl 
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acetate as eluent afforded benzyl-prop-2-ynyl-amine (83) (0.78 g, 82%) as a colourless 
viscous oil. 
VrnaJl (nujol) /cm-J 3226,2133, 1064, 732, 686; 8H(300 MHz, CDCh) 1.17 (IH, br, Nl!), 
2.18 (Ill, t, J 2_0, CCI!), 3.45 (2H, d, J 2.0, NCBz) , 3.91 (2H, s, NCHzPh), 7.26-7.37 
(5H, m, aromatic H); &(75.5 MHz, CDCh) 37.71 (t), 52.65 (t), 71.98 (d), 82.42 (s), 
127.58 (d), 128.83 (2 x d), 128.85 (2 x d), 139.74 (s); mlz (El) 146 (MH+, 35%), 91 (12); 
(Found: Mil+, 146.0969. CIOHJJN requires MH+, 146.0969). 
6.3.3 Prop-2-ynyl-carbamic acid tert-butyl ester (80) 
\ 0 H~-+ 
To a solution of propargylamine hydrochloride (1.5 g, 16.0 mmol) and triethyl amine 
(2.23 ml, 16.0 mmol) in dichloromcthane (20 ml.) was added a solution of di tert-butyl 
dicarbonate (3.57 g, 16.0 mmol) in dichloromethane (5.0 mI). The resulting mixture was 
stirred at room temperature for 2 hours. The solvent was then removed under reduced 
pressure to yield prop-2-ynyl-carbamic acid tert-butyl ester (80) (2.38 g, 96%) as a white 
solid which was used without further purification. 
Vlnax (nujol) /cm- I 3307,2928,2136,1733,1458,1373,1078,814; 8H(300 MHz, CDCh) 
1.38 (911, s, 3 x CI h), 2. ) 5 (Ill, t, J 2.5, CCIl), 3.85 (2H, br d, J 2.5, NBC/h), 4.70 (l H, 
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br, NIl); 8c(75.5 MHz, CDCh) 28.71 (3 X q), 31.59 (t), 46.19 (s), 71.62 (d), 80.47 (s), 
155.64 (s); mlz (EI) 156 (MH+, 82%), 101 (75),57 (60), 39 (87). 
6.3.4 N-But-2-ynyl-4-methyl-benzenesulfonamide (212) 
" HN 
I 
Ts 
To a solution of but-2-ynylamine hydrochloride (1.0 g, 9.47 mmol) and triethyl amine 
(2.65 ml, 18.9 mol) in dichloromethanc (20 ml) was added a solution of tosyl chloride 
(1.80 g, 9.47 mmol) in dichloromethanc (10 mI). The mixture was stirred overnight at 
room temperature. The solvent was then removed under reduced pressure and the 
resultant solid dissolved in diethyl ether. The mixture was washed with water (2 x 20 ml), 
a 10% aqueous solution of hydrochloric acid (2 x 10 ml) and a saturated aqueous solution 
of sodi urn hydrogencarbonate (2 x 10 ml). The organic phase was then dried over 
anhydrous magnesium sulfate and the solvent removed under reduced pressure to afford 
N-but-2-ynyl-4-methyl-benzenesulfonamide (212) (1.78 g, 84%). 
VllIax (nujol) !em'l 2256,2129,1337, 1145,1063,806; DII(300 MHz, CDCh) 1.54 (3H, s, 
CCIi), 2.40 (311, s, Cli), 3.77 (211, d, J 6.0, NIIClh), 4.42 (I H, br, Nil), 7.27 (2H, d, J 
8.0, aromatic 11). 7.75 (211, d, J 8.0, aromatic II); &(75.5 MHz, CDCb) 1.37 (q), 21.49 
(q), 32.64 (t). 77.93 (s), 78.14 (s), 127.77 (2 x d), 130.12 (2 x d), 136.27 (s), 144.49 (s); 
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mlz (CI) 224 (MH+, 49%), 155 (62), 91 (lOO); (Found: MNHt, 241.1006. CIIHI3NOzS 
requires MNH/, 241.1010). 
6.3.5 General procedure for the preparation of I-halo-N-propargylacetamides. 
To a solution of the protected propargyl amine in THF at -78°C under an atmosphere of 
nitrogen was added n-BuLi (1.6 Min hexanes, 1.1 eq.) and the resulting solution stirred 
for 30 minutes. The appropriate haloacetyl halide (1.1 eq.) was then introduced and the 
mixture stirred for a further 3 hours at -78°C. The reaction was quenched with water and 
allowed to warm to room temperature. The mixture was then extracted with 
dichloromcthane (3 x 50 ml.) and washed with a saturated aqueous solution of sodium 
bicarbonate (2 x 50 mI.). The organic phase was then dried over anhydrous magnesium 
sulfate and the solvent removed under reduced pressure. 
6.3.5.1 N-(2-Uromo-2-mcthyl-propionyl)-4-methyl-N-prop-2-ynyl-
bcnzcncsulfonamide (76)8 
1J o N 
I 
Ts 
n-BuLi (2.98 ml, 1.6M in hcxancs) was added to a stirred solution of 4-methyl-N-prop-2-
ynyl-benzencsulfonamide (75) (1.0 g, 4.78 mmol) in THF (20 m!) then 2-bromo-2-
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methylpropionyl bromide (0.6 ml, 4.78 mmol) was added as described previously (6.3.5). 
Purification by flash column chromatography using 4: 1 petroleum ether:ethyl acetate as 
eluent afforded N-(2-bromo-2-methyl-propionyl)-4-methyl-N-prop-2-ynyl 
benzenesulfonamide (76) (0.93 g, 55%) as a white crystalline solid; m.p. 92-93°C (from 
hexanes). Spectral details match those previously reported.s 
Vmax (nujol) !em'\ 3296, 2925, 2126, 1691, 1593, 1462, 1353, 1165, 1082, 811; OH(300 
MHz, CDCb) 1.97 (611, s, C(Br)CIIJCII]) 2.45 (3H, s, CH]), 2.47 (lH, t, J 2.5, CIl), 
5.15 (211, d, J 2.5, NCllzCCH), 7.32 (2H, d, J 8.0, aromatic H), 7.99 (2H, d, J 8.0, 
aromatic II); &(75.5 MHz, CDCh) 22.12 (q), 32.14 (2 x q), 38.18 (t), 57.12 (s), 77.62 
(d), 79.17 (s), 129.48 (2 x d), 129.66 (2 x d), 136.00 (s), 145.35 (s), 170.06 (s); m/z (EI) 
360 [(MII-sIBrt, 66%], 358 [(MII_79Br)+, 67%], 280 (90),204 (24), 186 (64), 124 (70), 
91 (5); (Found: MNII/, 375.0381. CI4HI679BrN03S requires MNH/, 375.0378). 
6.3.5.2 4-Methyl-N-prop-2-ynyl-N-(2,2,2-trichloro-acetyl)-
ben1.cncsulfonamide (79) 
c:J:'J 
o N 
I 
Ts 
n-BuLi (2.98 ml, 1.6M in hexanes) was added to a stirred solution of 4-methyl-N-prop-2-
ynyl-benzenesulfonarnide (75) (1.0 g, 4.78 mmol) in TIIF (20 ml) then trichloroacetyl 
chloride (0.53 ml, 4.78 mmol) was added as described previously (6.3.5). Purification by 
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flash column chromatography using 4: 1 petroleum ether:ethyl acetate as eluent furnished 
4-methyl-N-prop-2-ynyl-N-(2,2,2-trichloro-acetyl)-benzenesulfonamide (79) (1.08 g, 
64%) as a white crystalline solid. 
Vrnax (nujol) !em-I 3279, 2923, 2123, 1717, 1595, 1463, 1358, 1169, 1098, 839; oH(300 
MHz, CDC I) 2.44 (3H, s, CII), 2.45 (l H, t, J 2.5, CIl), 5.06 (2H, d, J 2.5, NCII2CCH), 
7.36 (2H, d, J 8.0, aromatic H), 8.06 (2H, d, J 8.0, aromatic H); 8c(75.5 MHz, CDCI3) 
22.20 (q), 38.92 (t), 74.47 (d), 78.20 (s), 97.47 (s), 129.86 (2 x d), 130.15 (2 x d), 134.52 
(s), 146.33 (s), 164.42 (s); mlz (EI) 371 (MNH/, 96%), 337 (61),302 (45), 189 (85), 91 
(15); (Found: MNH/, 370.9794. CdlIOCI)NO)S requires MNH/, 370.9791). 
6.3.5.3 N-(2,2-Dichloro-acetyl)-4-mcthyl-N-prop-2-ynyl-benzenesulfonamide (213) 
n-BuLi (2.98 ml, 1.6M in hexanes) was added to a stirred solution of 4-methyl-N-prop-2-
ynyl-benzenesulfonamide (75) (1.0 g, 4.78 mmol) in THF (20 ml) then dichloroacetyl 
chloride (0.46 ml, 4.78 mmol) was added as described previously (6.3.5). Purification by 
flash column chromatography using 4: I petroleum ether:ethyl acetate as eluent furnished 
N-(2,2-dichloro-acetyl)-4-mcthyl-N-prop-2-ynyl-benzenesulfonamide (213) (0.88 g, 
58%) as a white crystalline solid. 
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Vrnax (nujol) /cm-I 3298, 2923, 2853, 1727, 1591, 1462, 1374, 1170, 1102, 851, 656; 
8H(300 MHz, CDCb) 2.30 (l H, t, J 2.5, CIl), 2.49 (3H, s, CR3), 4.67 (2H, d, J 2.5, 
NCR}), 6.92 (lH, s, CICRCI), 7.42 (2H, d, J 8.0, aromatic H), 7.94 (2H, d, J 8.0, 
aromatic H); 8cC75.5 MHz, CDCI3) 22.19 (q), 36.69 (t), 63.73 (s), 64.81 (d), 78.03 (s), 
128.80 (2 x d), 130.48 (2 x d), 134.81 (s), 146.67 (s), 163.57 (s); m/z (El) 337 (MNH/, 
10%),255 (6),227 (15), 155 (63),91 (100); (Found: MNH/, 337.0178. CI2H)IChN03S 
requires MNH/, 337.0180). 
6.3.5.4 N-(2-Bromo-propionyl)-4-methyl-N-prop-2-ynyl-benzenesuIfonamide (77) 
Br J XN 
I 
Ts 
n-BuLi (2.98 ml, 1.6M in hexanes) was added to a stirred solution of 4-methyl-N-prop-2-
ynyl-benzenesulfonamide (75) (1.0 g, 4.78 mmol) in THF (20 ml) then 2-bromopropionyl 
bromide (0.5 ml, 4.78 mmol) was added as described previously (6.3.5). Purification by 
flash column chromatography using 4: 1 petroleum ether:ethyl acetate as eluent furnished 
N-(2-bromo-propionyl)-4-mcthyl-N-prop-2-ynyl-benzenesulfonamide (77) (1.06 g, 65%) 
as a colourless oil. 
Vflla~ (nujol) Icm·) 3262,2924,2129,1696,1596,1456,1159,1091,814,668; 8H(300 
MHz, CDCh) 1.63 (311, d, J 6.5, CIl;CHBr), 2.20 (I H, t, J 2.5, CCI!), 2.32 (311, s, CII;), 
4.49 (Ill, dd, J 18.5, J 2.5, NCIlH), 4.73 (I H, dd, J 18.5, J 2.5, NCHl!) , 4.86 (I H, q, J 
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6.5, CH3CHBr), 7.22 (2H, d, J 8.0, aromatic H), 7.79 (2H, d, J 8.0, aromatic H); 8c(75.5 
MHz, CDCb) 21.48 (q), 22.14 (q), 36.05 (t), 39.63 (d), 68.36 (s), 73.78 (d), 128.74 (2 x 
d), 130.17 (2 x d), 135.67 (s), 145.89 (s), 169.31 (s); mlz (El) 346 [(MH-SIBrt, 36%], 
344 [(MH-79Brt, 35%], 281 (45), 174 (85), 155 (80), 91 (100); (Found: MNH/, 
361.0216. C13H1/ 9BrN03S requires MNH/, 361.0221). 
6.3.5.5 N-But-2-ynyl-4-methyl-N-(2,2,2-trichloro-acetyl)-benzenesulfonamide (214) 
~CI 
C',A 
o N 
II 
I 
Ts 
n-BuLi (0.43 ml, 1.6M in hcxancs) was added to a stirred solution of N-but-2-ynyl-4-
mcthyl-bcnzencsulfonamidc (212) (0.] 5 g, 0.67 mmol) in THF (10 m!) then 
trichloroacetyl chloride (0.075 ml, 0.67 mmol) was added as described previously (6.3.5). 
Purification by flash column chromatography using 4:] petroleum ether:ethyl acetate as 
eluent furnished N-but-2-ynyl-4-methyl-N-(2,2,2-trichloro-acetyl)-benzenesulfonamide 
(214) (0.]7 g, 72%) as a colourless oil. 
vllla~ (nujol) /cm-I 2923,2121, 1722, 1598, 1463, 1170, 1081,837,648; OH(300 MHz, 
CDCh) 1.86 (311, t, J 2.5, CCCli), 2.48 (3H, s, Clh), 5.02 (211, d, J 2.5, NCllz), 7.37 
(211, d, J 8.5, aromatic II), 8.08 (211, d, J 8.5, aromatic H); Od75.5 MHz, CDCh) 3.99 
(q), 22.18 (q), 25.86 (t), 73.74 (s), 82.58 (s), 106.91 (s), 129.7] (2 x d), 130.17 (2 x d), 
187 
Chapters 6 : Experimental. 
134.86 (s), 146.13 (s), 163.71 (s); mlz (Cl) 385 (MNH/, 62%), 351 (25),317 (24), 227 
(73), 110 (40), 91 (100); (Found: MNH/, 384.9991. CI3H'2CI3N03S requires MNH/, 
384.9986). 
6.3.5.6 N-(2-Bromo-2-methyl-propionyl)-N-but-2-ynyl-4-methyl-
benzenesulfonamide (95) 
J:' 
a N 
II 
I 
Ts 
n-BuLi (0.42 ml, 1.6M in hexanes) was added to a stirred solution of N-but-2-ynyl-4-
methyl-benzenesulfonamide (212) (0.15 g, 0.67 mmol) in THF (10 ml) then 2-bromo-2-
methylpropionyl bromide (0.083 ml, 0.67 mmol) was added as described previously 
(6.3.5). Purification by flash column chromatography using 4: 1 petroleum ether:ethyl 
acetate as eluent afforded N-(2-bromo-2-methyl-propionyl)-N-but-2-ynyl-4-methyl-
benzenesulfonamide (95) (0.16 g, 65%) as a colourless oil. 
Vmax (nujol) /em-' 2852, 2258, 2126, 1696, 1593, 1463, 1173, 1080, 817,660; DH(300 
MHz, CDCI3) 1.86 (3I1, t, J 2.5, CCClh), 1.98 (6H, s, ClhC(Br)CH3), 2.45 (3H, s, CH3), 
5.09 (2H, d, J 2.5, NCII}), 7.33 (2H, d, J 8.5, aromatic H), 8.00 (2H, d, J 8.5, aromatic 
H); &(75.5 MHz, CDCb) 3.96 (q), 22.09 (q), 30.38 (q), 32.21 (q), 38.87 (t), 57.37 (s), 
74.64 (s), 82.28 (s), 129.47 (2 x d), 129.53 (2 x d), 136.30 (s), 145.14 (s), 164.08 (s); mlz 
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(CI) 391 [(MNH/-8I Br), 100%],389 [(MNH/_79Br), 98%], 374 [(MH-8I Br)+, 40%],372 
[(MH)9Brt, 39%], 294 (26), 217 (40), 140 (45), 91 (100); (Found: MNH/, 389.0544. 
6.3.5.7 N-(2,2-Dichloro-propionyl)-4-methyl-N-prop-2-ynyl-
benzenesulfonamide (78) 
Oxalyl chloride (1.8 ml, 19.0 mmol) was added in a dropwise fashion to 2,2-
dichloropropionic acid (1.0 ml, 9.8 mmol) with stirring and the mixture heated under 
reflux for 2 hours. The excess oxalyl chloride was then removed under reduced pressure 
to yield 2,2-dichloro-propionyl chloride. This was immediately added to a mixture of n-
BuLi (3.0 ml, 1.6M in hexanes) and 4-methyl-N-prop-2-ynyl-benzenesulfonamide (75) 
(1.0 g, 4.78 mmol) as described previously (6.3.5). Purification by flash column 
chromatography using 9: I petroleum ether:ethyl acetate as eluent afforded N-(2,2-
dichloro-propionyl)-4-methyl-N-prop-2-ynyl-benzenesulfonamide (78) (0.96 g, 66%) as a 
colourless oil. 
Villa;.. (neat) /em-I 3291, 3273, 2922, 2126, 1694, 1593, 1367, 1324, 1173, 1080, 823; 
011(300 Mllz, CDCh) 2.19 (311, s, CICCIIJCI), 2.44 (lIf, t, J 2.5, CCI!) , 2.46 (3H, s, 
CIIJ) , 5.17 (211, d, J 2.5, NCII1), 7.33 (211, d, J 8.0, aromatic JI), 8.48 (2H, d, J 8.0, 
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aromatic H); Oc<75.5 MHz, CDCh) 25.93 (q), 35.82 (t), 38.48 (q), 68.35 (d), 78.88 (s), 
79.85 (s), 129.73 (2 x d), 129.81 (2 x d), 135.28 (s), 145.81 (s), 163.82 (s); mlz (CI) 351 
(MNH/, 65%), 334 (MH+, 4%),269 (46), 162 (70), 155 (83), 91 (100); (Found: MNH/, 
351.0339. CI3HI3ChNO)S requires MNH/, 351.0337). 
6.3.5.8 (2-Bromo-2-methyl-propionyl)-prop-2-ynyl-carbamic acid tert-butyl 
ester (81) 
n-BuLi (2.66 ml, 1.6M in hexanes) was added to a stirred solution of prop-2-ynyl-
carbamic acid tat-butyl ester (80) (0.6 g, 3.87 mmol) in THF (20 ml) then 2-bromo-2-
methylpropionyl bromide (0.53 ml, 4.20 mmol) was added as described previously 
(6.3.5). Purification by flash column chromatography using 4: 1 petroleum ether:ethyl 
acetate as eluent afforded (2-bromo-2-methyl-propionyl)-prop-2-ynyl-carbamic acid tert-
butyl ester (81) (0.89 g, 76%) as a colourless oil. 
Villa" (nujol) /em-I 3295, 2936, 1724, 169 I, 1592, 1485, 1] 48, 1072, 8]], 78]; bH(300 
Mllz, CDCIJ) 1.49 (911, S, 3 x Clh), 2.02 (611, s, CIIJC(Br)CIIJ), 2.1 6 (J H, t, J 2.5, 
CCII), 4.30 (211, d, J 2.5, NClh), &(75.5 MHz, CDCh) 28.28 (3 x q), 33.37 (2 x q), 
37.62 (t), 61.57 (s), 66.27 (s), 71.78 (d), 79.] 6 (s), 152.41 (s), 176.75 (s); mlz (CI) 306 
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[(MH+_81 Br), 15%], 304 [(MH+_79Br), 15%], 248 (56), 206 (42), 124 (60), 57 (100); 
(Found: MH+, 304.0551. CI2HI879BrN03 requires MH+, 304.0549). 
6.3.5.9 (2,2-Dichloro-propionyl)-prop-2-ynyl-carbamic acid tert-butyl ester (82) 
Oxalyl chloride (1.8 ml, 19.0 mmol) was added in a dropwise fashion to 2,2-
dichloropropionic acid (1.0 ml, 9.8 mmol) with stirring and the mixture heated under 
reflux for 2 hours. The excess oxalyl chloride was then removed under reduced pressure 
to yield 2,2-dichloro-propionyl chloride. This was immediately added to a mixture of n-
BuLi (1.12 ml, 1.6M in hexanes) and prop-2-ynyl-carbamic acid tert-butyl ester (80) (0.5 
g, 1.79 mmol) as described previously (6.3.5). Purification by flash column 
chromatography lIsing 4: 1 petroleum ether:ethyl acetate as eluent furnished (2,2-dichloro-
propionyl)-prop-2-ynyl-carbamic acid terr-butyl ester (82) (0.12 g, 24%) as a pale yellow 
oil. 
VIm" (nujol) /cm- I 3291,2924, 1695, 1604, 1467, 1369, 1233, 1079,988,781; DH(300 
Mllz, CDCh) 1.52 (911, s, 3 x Clh), 2.20 (HI, t, J 2.5, Cel!), 2.33 (3H, s, CICClhCI), 
4.41 (211, d, J 2.5, NCII]); Dd75.5 MHz, CDCh) 28.16 (3 X q), 37.24 (q), 37.95 (t), 72.31 
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(d), 78.41 (s), 82.24 (s), 85.79 (s), 151.63 (s), 169.15 (s); mlz (Cl) 297 (MNH/, 7%), 263 
(7), 226 (6), 220 (40), 197 (20), 112 (100); (Found: MH+, 280.0512. CllHl5Cl2N03 
requires MH+, 280.0509). 
6.3.6 N-Benzyl-2,2,dichloro-N-prop-2-ynyl-acetamide (74) 
To a mixture of benzyl-prop-2-ynyl-amine (83) (150 mg, 1.03 mmol) and triethyl amine 
(0.16 ml, 1.] 4 mmol) in dichloromethane (5 ml.) was added dichloroacetyl chloride (0.] ] 
ml, 1.14 mmol) dropwise. The mixture was stirred for 4 hours at room temperature and 
then added, with stirring, to a saturated aqueous solution of potassium carbonate (10 mI.). 
The mixture was extracted with ether (3 x ] 0 mI.). The combined extracts were then dried 
over anhydrous magnesium sulfate and the solvent removed under reduced pressure. 
Purification by flash column chromatography using 4:] petroleum ether:ethyl acetate as 
eluent furnished N-benzyl-2,2,dichloro-N-prop-2-ynyl-acctamide (74) (160 mg, 62%) as 
an inseparable mixture of rotomcrs (ratio]:]) in the form of a colourless oil. 
Vma~ (nujol) /em-l mixture 3263, 2924, ]697, ]456, 1329, ] ]59, ]068, 87], 703, 668; 
()11(300 Mllz, CDCh) 2.] 9 (I/211, t, J 2.5, CCIf), 2.33 (J/2H, t, J 2.5, CCIf), 4.08 (JII, d, 
192 
Chapters 6 : Experimental. 
J 2.5, NCHz), 4.11 (lH, d, J 2.5, NCHz), 4.68 (IH, s, NCHzPh), 4.77 (lH, s, NCHzPh), 
6.19 (l/2H, s, CICHCI), 6.30 (1I2H, s, CICHCI), 7.15-7.34 (5H, m, aromatic H); &:(75.5 
MHz, CDCb) mixture 35.92 (t), 36.98 (t), 49.73 (t), 50.91 (t), 65.36 (d), 65.61 (d), 73.55 
(s), 74.52 (s), 77.62 (d), 77.89 (d), 127.41 (2 x d), 128.45 (d), 128.67 (2 x d), 128.77 (d), 
129.29 (2 x d), 129.55 (2 x d), 134.97 (s), 135.67 (s), 163.91 (s), 164.13 (s); mlz (EI) 256 
(MH\ 26%),216 (64), 106 (36), 9 I (100). 
6.3.7 General procedure for the cyclisation of I-halo-N-propargylacetamides. 
To a mixture of I-halo-N-propargylacetamide and copper halide (30 mol%) under a 
nitrogen atmosphere was added a solution of pentylpyridin-2-ylmethyleneamine (54a) 
(30 mol%) in dry dichloromcthane (0.12M solution). The resulting mixture was stirred at 
room temperature overnight and upon completion was eluted through a silica plug with 
dichloromethane. Subsequent removal of solvent under reduced pressure furnished the 
corresponding y-Iactam. 
6.3.7.1 Cyclisation of N-Uenzyl-2,2-dichloro-N-prop-2-ynyl-acetamide (74) 
o ~ 
CI I 
CI ~ ~ N, ~ 
I ~ ~CI 
# 0 
85 
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N-Benzyl-2,2-dichloro-N-prop-2-ynyl-acetamide (74) (40 mg, 0.15 mmol) was reacted as 
described above (6.3.7) and resulted in the formation of N-benzyl-N-{ 6-[benzyl-(2,2-
dichloro-acetyl)-amino ]-hexa-2,4-diynyl }-2,2-dichloro-acetamide (85) (39 mg, 98%) in 
the form of a colourless oil. 
Vrnax (nujol) /cm-I 2922, 2855, 1698, 1456, 1304, 1159, 1091, 871, 703; OH(300 MHz, 
CDCh) 4.20 (411, m, 2 x NClhPh), 4.66 (2H, s, NClh), 4.78 (2H, s, NClIl), 6.18 (lH, s, 
CICIICI), 6.23 (llf, s, CICIICI), 7.19-7.34 (lOH, m, aromatic H); Oc(75.5 MHz, CDCb) 
35.05 (t), 36.21 (1),48.42 (t), 49.83 (t), 63.87 (d), 64.31 (d), 65.35 (2 x s), 73.33 (s), 73.87 
(s), 126.05 (2 x d), 126.86 (d), 127.27 (2 x d), 127.50 (d), 127.95 (2 x d), 128.21 (2 x d), 
137.32 (s), 137.97 (s), 156.65 (s), 162.67 (s); mlz (CI) 528 (MNH/, 92%),441 (25),403 
(23), 371 (54), 235 (76), 106 (100), 91 (30); (Found: MH+, 511.0327. C24H20CI4N202 
requires Mil+, 511.0332). 
6.3.7.2 Cyclisation of N-(2-Bromo-2-methyl-propionyl)-4-methyl-N-prop-2-
ynyl-benzenesulfonamide (76) 
Sr 
Sr :Jj 
I 
Ts 
N 
I 
Ts 
o N 
I 
Ts 
(E)-(92a) (Z)-(92a) 93a 
N-(2-Bromo-2-methyl-propionyl)-4-methyl-N-prop-2-ynyl-benzenesulfonamidc (76) 
(100 mg, 0.28 mmol) was reacted as described above (6.3.7) to yield a mixture of 
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products (yield of combined products: 96 mgs, 96%). Following purification by flash 
column chromatography eluting with 4: 1 petroleum ether:ethyl acetate (£)-4-
bromomethyl-3 ,3-dimethy 1-1-( to 1 uene-4-sulfonyl )-pyrro lidin -2-one (92a), (2)-4-
bromomethyl-3,3-dimethyl-l-(toluene-4-sulfonyl)-pyrrolidin-2-one (92a) and 3,3-
dimethyl-4-methylene-l-(toluene-4-sulfonyl)-pyrrolidin-2-one (93a) were isolated. 
6.3.7.2.1 (E)-4-Bromomethylene-3,3-dimethyl-l-(toluene-4-sulfony1)-
pyrrolidin-2-one (92a)8 
Vmax (nujol) /cm- I 2933, 1740, 1672, 1365, 1169, 1046; OH(300 MHz, CDCh) 1.36 (6H, s, 
CClhClh), 2.39 (31I, s, CIIJ), 4.34 (2H, d, J 2.5, NClh), 6.12 (tH, t, J 2.5, C=CII(Br», 
7.28 (211, d, J 8.0, aromatic H), 7.88 (2H, d, J 8.0, aromatic H); &:(75.5 MHz, CDCh) 
22.13 (q), 22.29 (2 x q), 47.86 (s), 50.50 (t), 101.73 (d), 128.49 (2 x d), 130.19 (2 x d), 
135.01 (s), 139.46 (s), 145.99 (s), 176.87 (s); mlz (EI) 360 [(MH-8I Br)+, 44%], 358 
[(MII-79Brt, 44%], 280 (12), 204 (35), 126 (48), 91 (100); (Found: MH+, 358.0118. 
CI41J1679BrN0,1S requires MIt, 358.0113). 
6.3.7.2.2 (Z)-4-Hromomethylene-3,3-di methyl-l-( toluene-4-sulfonyl)-
pyrrolidin-2-one (92a)8 
Vmax (nujol) /cm-I 2933,1740,1672,1365,1169,1046; oH(300 MHz, CDCh) 1.17 (6H, s, 
CCI/JCIIJ), 2.39 (311, s, CIIJ), 4.38 (2B, d, J 2.5, NClh), 6.08 (11-1, t, J 2.5, C=CII(Br», 
7.28 (211, d, J 8.0, aromatic II), 7.88 (211, d, J 8.0, aromatic H); &:(75.5 MHz, CDCh) 
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22.13 (q), 25.52 (2 X q), 48.04 (s), 50.32 (t), 102.78 (d), 128.46 (2 X d), 130.21 (2 X d), 
135.12 (s), 143.04 (s), 145.96 (s), 176.30 (s); mlz (El) 360 [(MH-8I Br)+, 56%], 358 
[(MH_79Br)+, 57%], 280 (24), 204 (44), 126 (75), 91 (5); (Found: MH+, 358.0125. 
6.3. 7.2.3 3,3-Dimethyl-4-methylene-l-(toluene-4-sulfonyl)-pyrrolidin-2-one (93a)8 
Vmax (nujoJ) tcm-I 1731,1667,1595,1463,1362,1169,1122,901,814; BH(300 MHz, 
CDCh) 1.16 (6H, s, eCIIJCIIJ), 2.36 (3H, s, CIIJ), 4.37 (2H, t, J 2.0, NCR1 ), 5.01 (2H, 
dt, J 11.5, J 2.0, C=Clh), 7.26 (21l, d, J 8.0, aromatic H), 7.84 (2H, d, J 8.0, aromatic H); 
&(75.5 MHz, CDCh) 22.12 (q), 24.79 (2 x q), 46.50 (s), 50.32 (t), 108.86 (t), 128.38 (2 x 
d), 130.11 (2 x d), 135.35 (s), 145.61 (s), 145.68 (s), 177.26 (s); mlz (EI) 280 (MH+, 
43%), 155 (18), 91 (100); (Found: MH+, 280.1005. C I4H 17N03S requires MH+, 
280.0996). 
Table 14 Results of cyclisation of N-(2-Bromo-2-mcthyl-propionyl)-4-methyl-N-
prop-2-ynyl-bcnzenesulfonamide (76) 
Suhstratc 
(76) 
(76) 
(76) 
(8 J) 
Ligand 
NPMI (2) 
NPMI (2) 
MC6-trcn 
NPMI (2) 
a Percentage yield of combined products. 
Solvent 
CH2Ch 
C6H6 
THF 
CH2CJ2 
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AT:Reductiona 
25: 1 (96) 
74: 1 (94) 
1 :20 (95) 
10: J (96) 
Atom trans. E:Z 
5:2 
4:1 
4:1 
2: 1 
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6.3.7.3 Cyclisation of 4-l\Iethyl-N-prop-2-ynyl-N-(2,2,2-trichloro-acetyl)-
benzenesulfonamide (79) 
CI CI 
CI J N N HN I I I Ts Ts Ts 
88 89 7S 
4-Methyl-N-prop-2-ynyl-N-(2,2,2-trichloro-acetyl)-benzenesulfonamide (79) (100 mg, 
0.28 mmol) was rcactcd as describcd above (6.3.7) to yield a mixture of products (yield 
of combined products: 96%). Following purification by flash column chromatography 
eluti ng with 4: 1 pctroleum cther:ethyl acetate, 3-chloro-4-dichloromethyl-I-(toluene-4-
sui fonyl)- I ,5-dihydro-pyrrol-2-one (88), 3-chloro-4-chloromethyl-I-(toluene-4-sulfonyl)-
1,5-dihydro-pyrrol-2-onc (89) and 4-methyl-N-prop-2-ynyl-benzenesulfonamide (75) 
wcre isolated. 
6.3.7.3.1 3-Chloro-4-dichloromethyl-l-(toluene-4-sulfonyl)-1 ,S-dihydro-pyrrol-
2-one (88) 
Villa" (neat) tcm'l 2923, 2855, 1748, 169 I, 1652, 135 I, 1163, 833; oH(300 MHz, CDCh) 
2.37 (311, S, CIIJ), 4.65 (211, S, NCII1), 6.64 (1 H, s, CICIICI), 7.31 (21-1, d, J 8.0, aromatic 
II), 7.93 (211, d, J 8.0, aromatic II); &(75.5 MHz, CDCb) 22.17 (q), 48.12 (t), 62.50 (d), 
124.81 (s), 128.72 (2 x d), 130.32 (2 x d), 134.61 (s), 146.54 (s), 147.94 (s), 164.14 (s); 
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mlz (EI) 371 (MNH/, 52%),354 (MH+, 15%),337 (30), 303 (36), 189 (52), 155 (12), 91 
(12); (Found: MH+, 353.9530. C12HlOCbN03S requires MH+, 353.9526). 
6.3.7.3.2 3-Chloro-4-chloromethyl-l-( tol uene-4-sulfonyl)-1 ,5-dihydro-pyrrol-2-
one (89) 
Vmax (neat) /cm-1 2922,2851, 1696, 1462, 1343, 1173, 1080,817; OH(300 MHz, CDCb) 
2.48 (3I1, s, Cllj), 4.39 (21-1, s, NClh), 4.57 (2H, s, ClhCI), 7.32 (2H, d, J 8.0, aromatic 
H), 7.98 (2B, d, J 8.0, aromatic H); &(75.5 MHz, CDCb) 22.14 (q), 36.77 (t), 50.76 (t), 
127.79 (s), 128.76 (2 x d), 130.12 (2 x d), 136.47 (s), 146.29 (s), 147.98 (s), 164.17 (s); 
mlz (CI) 337 (MNH/, 23%), 283 (38), 226 (21),155 (34), 91 (64). 
6.3.7.3.3 4-Methyl-N-prop-2-ynyl-benzenesulfonamide (75)' 
Isolated as a white crystalline solid, spectral details match those previously cited (section 
6.3.1). 
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6.3.7.4 4-Bromomethylene-3,3-dimethyl-2-oxo-pyrrolidine-l-carboxylie acid 
tert-butyl ester (92b) 
Br 
(2-Bromo-2-methyl-propionyl)-prop-2-ynyl-carbamic acid tert-butyl ester (81) (l00 mg, 
0.33 mmol) was reacted as described above (6.3.7) to yield 4-bromomethylene-3,3-
dimethyl-2-oxo-pyrrolidine-l-carboxylic acid terr-butyl ester (92b) (96 mg, 96%) as an 
inseparable oily mixture of EIZ isomers (ratio 1 :2). 
VOla" (neat) /em-I mixture 2924, 2851, 1772, ]457, ]328, ]296, 1027,780; DH(300 MHz, 
CDCb) major isomer 1.26 (6H, s, ClljCCllj), 1.49 (9H, S, 3 x Cllj), 4.22 (2H, d, J 4.5, 
NCIIJ), 6.08 (] II, t, J 4.5, C=CIlBr); millor isomer].44 (6H, s, ClljCCllj), ].49 (9H, S, 
3 x Cllj), 4.19 (211, d, J 2.0, NClIl), 6.11 (1 H, t, J 2.0, C=CIIBr); &(75.5 MHz, CDCb) 
mixture 21.97 (2 x q), 25.35 (2 x q), 27.78 (3 x q), 47.50 (s), 49.38 (t), 49.66 (t), 83.39 
(s), 100.10 (d), 101.27 (d), 139.90 (s), 143.36 (s), 149.58 (s), 176.52 (s); mlz (EI) 306 
[(MH-s1Br)+, 53%], 304 [(MH-79Brt, 56%], 223 (78), 148 (17), 112 (9); (Found: MH+, 
304.0550 Cdlls79BrNO] requires Mil+, 304.0548). 
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6.3.7.5 4-(1-Bromo-ethylidene )-3,3-dimethyl-l-( toluene-4-sulfonyl)-pyrolidin-
2-one (96) 
Sr 
a N 
I Ts 
N-(2-Bromo-2-methyl-propionyl)-N-but-2-ynyl-4-methyl-benzenesulfonamide (95) (50 
mg, 0.13 mmol) was reacted as described above (6.3.7) to yield 4-(l-bromo-ethylidene)-
3,3-dimethyl-l-(toluene-4-sulfonyl)-pyrolidin-2-one (96) (47 mg, 94%) as an inseparable 
oily mixture of EIZ isomers (ratio 1: 1). 
Vmu (nujol) /em'l 1739, 1669, 1598, 1367, 1178, 1102,814,756; BH(300 MHz, CDCh) 
1.26 (311, s, CIIJCCII). 1.32 (311. s, CH3CCIIJ). 2.17 (3/2H, 5, C=C(Br)CHJ), 2.34 
(31211, s, C=C(Br)CIIJ), 2.39 (311, s, CIIJ), 4.28 (Ill, s, NClh), 4.33 (IH, s, NCIIl ), 7.27 
(211, d, J 8.0, aromatic II), 7.89 (211, d, J 8.0, aromatic H); &(75.5 MHz, CDC h) mixture 
22.13 (q), 22.66 (q), 24.29 (q), 25.56 (q), 26.62 (q), 47.47 (5),49.76 (t), 52.47 (t), 119.35 
(5),128.49 (2 x d), 130.16 (2 x d). 134.41 (s), 135.18 (s), 145.87 (s), 177.19 (5); mlz (EI) 
391 [(MNII4-SI Brt, 22%]. 389 [(MNII4-79Brt. 20%]. 374 [(MH-s1Br)+, 25%], 372 
[(MH_79Br)+, 23%], 292 (95), 228 (48), 155 (45), 91 (100); (Found: MH+, 372.0263. 
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6.3.7.6 4-Dichloromethyl-3-methyl-l-( toluene-4-sulfonyl)-1 ,5-dihydro-pyrrol-
2-one (86a) 
CI 
CI 
o N 
I 
Ts 
N-(2,2-Dichloro-propionyl)-4-methyl-N-prop-2-ynyl-benzenesulfonamide (78) (100 mg, 
0.31 mmol) in the presence of CuCl (31 mg, 1 eq.) and pentylpyridin-2-
ylmethyleneamine (54a) (55 mg, 1 eq.) was reacted as previously described (6.3.7). 
Purification by flash column chromatography using 4: 1 petroleum ether:ethyl acetate as 
eluent afforded 4-dichloromethyl-3-methyl-I-(toluene-4-sulfonyl)-I,5-dihydro-pyrrol-2-
one (86a) (40 mg, 48%) in the form of a colourless oil. 
Vm3X (neat) /cm-I 2924, 1736, 1667, 1464, 1363, 1179,814,734; DH(300 MHz, CDCh) 
1.85 (311, s, C=CCllj), 2.44 (3B, s, Clh), 4.64 (2B, s, NCIIz) , 6.65 (lH, s, CICIlCI), 
7.37 (2I1, d, J 8.0, aromatic II), 7.98 (2H, d, J 8.0, aromatic H); &(75.5 MHz, CDCh) 
9.34 (q), 22.12 (q), 48.56 (t), 63.88 (d), 128.55 (2 x d), 130.27 (2 x d), 131.06 (s), 135.34 
(s), 145.93 (s), 148.45 (s), 168.04 (s); mlz (CI) 334 (MH+, 17%), 298 (23), 261 (21), 155 
(59),91 (84); (Found: MII+, 334.0065. C13H13CIzN03S requires MH+, 334.0071). 
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6.3.7.7 4-Dichloromethyl-3-methyl-2-oxo-2,5-dihydro-pyrrole-l-carboxylic 
acid tert-butyl ester (86b) 
CI 
CI 
a N 
oAo 
A--
(2,2-Dichloro-propionyl)-prop-2-ynyl-carbamic acid tert-butyl ester (82) (50 mg, 0.18 
mmol) was reactcd as previously described (6.3.7). Purification by flash column 
chromatography using 4: I petroleum ether:ethyl acetate as eluent afforded 4-
dichloromethyl-3-mcthyl-2-oxo-2,5-dihydro-pyrrole-l-carboxylie acid tert-butyl ester 
(86b) (25 mg, 50%) as a colourless oil. 
V,nax (neat) !em') 2924, 2852, 1775, 1456, 1298, 1155, 1028, 732, 669; ~H(300 MHz, 
CDCh) 1.57 (911, s, 3 xCII]), 2.33 (311, s, C=CCIIJ ), 4.41 (2H, s, NCIIl ) , 6.63 (1 H, s, 
CICIICI); &:(75.5 Mllz, CDCI) 9.34 (q), 28.18 (3 x q), 35.01 (t), 64.21 (d), 82.25 (s), 
131.44 (s), 147.13 (s), 149.71 (s), 164.23 (s); mlz (CI) 280 (MH+, 38%), 209 (32), 168 
(63), 74 (46). 
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6.3.8 4-Methyl-S-oxo-l-(toluene-4-sulfonyl)-2,S-dihydro-IIl-pyrrole-3-
carbaldehyde(87a) 
)::)CHO 
o N 
I 
Ts 
To 4-dichloromethyl-3-methyl-l-(toluene-4-sulfonyl)-1 ,5-dihydro-pyrrol-2-one (86a) (13 
mg, 0.039 mmol) in 1:1 TIIFfH20 (0.5 ml) was added silver nitrate (28 mg, 0.15 mmol). 
The mixture was heated under reflux overnight and then extracted with diethyl ether (3 x 
1.0 ml). The combined extracts were then dried over anhydrous magnesium sulfate and 
the solvent removed under reduced pressure. Purification by flash column 
chromatography eluting with 5:2 petroleum ether:ethyl acetate afforded 4-methyl-5-oxo-
1-(to)uenc-4-su)fony)-2,5-dihydro-IIl-pyrro)c-3-carbaldehyde (87a) (10 mg, 77%) as a 
yellow oil. 
Vmax (neat) fcm·' 2922,2835, 1774, 1728, 1462, 1367, 1178, 1027,817; CH(300 MHz, 
CDCh) 2. I I (311, s, C=CCI h), 2.37 (3H, s, Clh), 4.44 (2B, s, NClh), 7.28 (211, d, J 8.0, 
aromatic II), 7.89 (211, d, J 8.0, aromatic H), 10.11 (1 H, s, CliO); Be( 100 MHz, CDCb) 
9.24 (q), 21.75 (q), 48.41 (t), 128.20 (2 x d), 129.93 (2 x d), 134.79 (s), 144.36 (s), 144.67 
(s), 145.71 (s), 168.42 (s), 186.10 (d); mlz (EI) 280 (MH+, 64%), 250 (7),155 (82), 91 
(100); (Found: MII+, 280.0645. CJ3HJ3N04S requires MH+, 280.0644). 
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6.4 Experimental for chapter 4 
6.4.1 General procedure for preparation of methylene-amines 
To a stirred solution of the aldehyde in dry dichloromethane containing anhydrous 
magnesium sulfate under a nitrogen atmosphere was added primary amine (1 eg.). The 
resulting mixture was stirred for four hours at room temperature. The magnesium sulfate 
was removed by filtration and the solvent removed under reduced pressure to afford the 
imine. 
6.4.1.1 HenzJI-cyclohexylmethylene-amine (215)9 
NrC) 
Cyclohcxanecarboxaldehydc (2.25 ml, 18.6 mmol) and benzylamine (2.04 ml, 18.6 
mmol) were reacted as described above (6.4.1) to afford benzyl-cyclohexylmethylene-
amine (215) (3.1g, 87%) as a colourless oil which was used without further purification. 
Spectral details match those previously reported.9 
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OH(300 MHz, CDCI3) 1.1-1.32 (5H, m, CH2), 1.57-1.79 (5H, m, CH2), 2.12-2.22 (tH, m, 
NCHCII), 4.47 (2H, s, NCH2Ph), 7.13-7.27 (5H, m, aromatic H), 7.56 (tH, d, J 5.0, 
N=CII); &(75.5 MHz, CDCh) 25.87 (2 x t), 26.41 (t), 30.11 (2 x t), 43.98 (d), 65.38 (t), 
127.20 (d), 128.17 (2 x d), 128.80 (2 x d), 139.91 (s), 170.64 (d); mlz (El) 202 (MH+, 
18%),146 (58),133 (94),91 (100); 
6.4.1.2 Cyclohexylmethylene-( 4-methoxy -benzyl)-amine (216) 
-0 
Cyclohcxanccarboxaldchydc (2.25 ml, 18.6 mmol) and p-methoxy-benzylamine (2.4 ml, 
18.6 mmol) were reacted as described above (6.4.1) to yield cyclohexylmethylene-(4-
methoxy-benzyl)-amine (216) (3.98g, 92%) as a colourless oil which was used without 
further puri fication. 
Vmax (film) Icm- I 3313,2924,1666,1610,1512,1446,1247,1174,1034,820; oH(300 
MHz, CDC!]) 1.13-1.29 (5I1, m, Clh), 1.57-1.77 (5II, m, Clh), 2.1-2.23 (I H, m, 
NCHCII), 3.76 (311, s, OClh), 4.41 (211, s, NClhAr), 6.79 (2B, d, J 9.5, aromatic H), 
7.08 (211, d, J 9.5, aromatic H), 7.54 (lll, d, J 5.0, N=CII); &(75.5 MHz, CDCb) 25.85 
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(2 X t), 26.4 (t), 30.11 (2 X t), 43.94 (d), 55.63 (q), 64.81 (t), 114.2 (2 X d), 130.19 (2 X d), 
132.03 (s), 158.92 (s), 170.21 (d); m/z (El) 232 (MH+, 7%), 163 (37), 121 (100),91 (44); 
6.4.1.3 Cyclohexylmethylene-(l-phenyl-ethyl)-amine (217)10 
Cyclohexanecarboxaldehyde (2.0 ml, 15.5 mmol) and (R)-( + )-methylbenzylamine (1.87 
ml, 15.5 mmol) were reacted as described above (6.4.1) to yield cyclohexylmethylene-(l-
phenyl-ethyl)-amine (217) (3.23g, 96%) which was obtained as a colourless oil and was 
used without further purification. Spectral details match those previously reported. to 
OH(300 MHz, CDCh) 1.08-1.33 (5H, m, CII2), 1.4 (3H, d, J 7.0, CII3), 1.55-1.78 (5H, m, 
Clh), 2.09-2.19 (Ill, m, N=CHCll), 4.17 (lH, q, J 7.0, NCII(CH3)Ph), 7.11-7.28 (5H, 
m, aromatic 1-1), 7.51 (lH, d, J 5.5, N=Cll); Oc(75.5 MHz, CDCh) 25.13 (q), 25.78 (2 x 
t), 26.36 (t), 30.17 (2 X t), 43.90 (d), 69.88 (d), 126.87 (2 X d), 127.05 (d), 128.73 (2 x d), 
145.64 (s), 168.12 (d); m/z (El) 232 (MNH/, 96%), 216 (MH+, 85),150 (100),105 (55), 
91 (23). 
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6.4.1.4 tert-Butyl-cyclohexylmethylene-amine (218)11 
Cyclohexanccarboxaldchyde (3.2 ml, 26.0 mmol) and tert-butylamine (2.8 ml, 26.0 
mmol) were reacted as described above (6.4.1) to furnish tert-butyl-
cyclohexylmcthylenc-amine (218) (4.17g, 95%) as a colourless oil which was used 
without further purification. Spectral details match those previously reported. ll 
S.1(300 MHz, CDCb) 1.08 (9H, s, 3 x Clh), 1.09-1.29 (5H, m, Clh), 1.59-1.68 (5H, m, 
Clh), 2.04-2.14 (III, m, N=CHCII), 7.32 (lH, d, J 6.0, N=Cll); &(75.5 MHz, CDC!) 
25.76 (2 x t), 26.33 (t), 30.07 (3 x q), 30.34 (2 x t), 44.51 (d), 56.54 (s), 163.48 (d). 
6.4.1.5 (2-Uromo-benzyl)-cyclohexylmethylene-amine (219) 
3 
4 
5 
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Cyclohexanecarboxaldehyde (1.1 ml, 9.13 mmol) and 2-bromo-benzylamine (1.7 g, 9.12 
mmol) were reacted as described above (6.4.1) to yield (2-Bromo-benzyl)-
cyclohexylmethylene-amine (219) (2.2g, 88%) as a yellow oil which was used without 
further purification. 
Vrnax (film) Icm- l 3027, 2957, 1651, 1522, 1449, 1364, 1172, 1024, 824, 698; llH(300 
MHz, CDC!) 1.11-1.32 (5H, m, CHz), 1.59-1.83 (5H, m, CHz), 2.15-2.21 (tH, m, 
N=CHCII), 4.54 (2H, s, NCHz), 7.04 (tH, dt, J 7.5, J 1.5, H-5), 7.17-7.28 (2H, m, H-4 
and H-6), 7.46 (tH, dd, J 8.0, J 1.0, H-3), 7.60 (IH, d, J 5.0, N=CH); &:(75.5 MHz, 
CDC!) 25.85 (2 x t), 26.40 (t), 30.08 (2 x t), 44.09 (d), 64.67 (t), 123.98 (s), 127.86 (d), 
128.73 (d), 130.01 (d), 132.88 (d), 139.15 (s), 171.85 (d); mlz (EI) 282 [(MH-SIBrt, 
51 %],280 [(MHJ9Brt. 100%].250 (54), 214 (36),169 (100). 132 (72). 
6.4.1.6 Benzyl-isobutylidene-amine (220)12 
2-Methyl-propionaldehyde (1.7 mI. 18.6 mmol) and benzylamine (2.03 mI, 18.6 mmol) 
were reacted as described above (6.4.1) to furnish benzyl-isobutylidene-amine (220) 
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(2.82g, 93%) as a colourless oil which was used without further purification. Spectral 
details match those previously reported. 12 
DH(300 MHz, CDCh) 1.13 (3H, s, CIIJ), 1.15 (3H, s, CII3), 2.48-2.59 (1 H, m, 
N=CHCII), 4.58 (2H, s, NClIl), 7.24-7.38 (5H, m, aromatic), 7.69 (lH, app dt, J 5.0, J 
1.5, N=CII), ); &:(75.5 MHz, CDCb) 19.76 (2 x q), 34.56 (d), 65.22 (t), 127.23 (d), 
128.17 (2 x d), 128.81 (2 x d), 139.85 (s), 171.42 (d). 
6.4.2 Cyclopentanecarhoxaldehyde (221) 
CycIopentanemethanol (2.15 ml, 19.9 mmo!) in dichloromethane (20 ml) was added in 
one portion to a stirred solution of PCC (9.46g, 43.9 mmol) in dichloromethane (60 ml). 
The resulting mixture was stirred at room temperature for one hour. Diethyl ether (100 
ml) was added to the mixture and the whole filtered through a small pad of f1orisil. 
Subsequent removal of the solvents under reduced pressure furnished 
cyclopentanecarboxaldehyde (221) (1.2g, 65%) as a pale purple oil. 
DH(300 MHz, CDCb) 1.58-1.68 (4H, m, Clh), 1.79-1.84 (4H, m, Clh), 2.75 (1H, app 
dqn, J 7.0, J 2.5, CIICHO), 9.62 (lH, d, 2.5, ClIO); Dc(75.5 MHz, CDC!) 26.22 (2 x t), 
26.89 (2 x t), 51.99 (d), 203.72 (d); mlz (CI) 115 (MNH/, 58%), 97 (33), 86 (42), 73 
(100),69 (51), 41 (50). 
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6.4.1.7 Benzyl-cyclopentylmethylene-amine (222) 
eyclopentanecarboxaldehyde (1.12 g, 11.0 mmol) and benzylamine (1.24 ml, 11.0 mmol) 
were reacted as described above (6.4.1) to furnish benzyl-cyclopentylmethylene-amine 
(222) (l.89g, 91 %) as a pale brown oil which was used without further purification. 
Vrnax (neat) /em-) 3023, 2944, 1652, 1602, 1453, 1347, 1157, 1024, 729; ()H(300 MHz, 
eDeb) 1.56-1.73 (6H, m, Clh), 1.89-1.95 (2H, m, Clh), 2.70-2.81 (tH, m, N=eHCH), 
4.56 (2H, s, NClh), 7.26-7.39 (5H, m, aromatic), 7.71 (tH, d, J 5.0, N=C//); <>C(75.5 
MHz, eDeb) 26.12 (2 x t), 30.56 (2 x t), 45.79 (d), 65.18 (t), 127.57 (d), 127.78 (2 x d), 
128.82 (2 x d), 139.81 (s), 170.37 (d); m/z (el) 204 (MNH/, 29%), 136 (71), 108 (66), 
91 (100). 
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6.4.1.8 Cyclohexylmethylene-isobutyl-amine (223) 
Cyclohexanecarboxaldchyde (3.2 ml, 26.0 mmol) and isobutylamine (2.58 ml, 26.0 
mmol) were reacted as described above (6.4.1) to yield cyclohexylmethylene-isobutyl-
amine (223) (4.08g, 93%) as a colourless oil which was used without further purification. 
Vmax (neat) /em-I 3373, 2964, 1652, 1667, 1492, 1374, 829, 696; (5H(300 MHz, CDCh) 
0.79 (611, d, J 6.5, CIICIIJCIIJ), 1.10-1.29 (5H, m, CI/z), 1.61-1.74 (5H, m, CIIl), 1.79 
(III, ddt, J 7.0, CII2CIIC1hClh), 2.07-2.11 (lB, m, N=CHCII), 3.09 (2H, d, J 6.5, 
NCI/z), 7.36 (III, d, J 5.5, N=CII); &(75.5 MHz, CDCh) 20.84 (2 x q), 25.36 (2 x t), 
25.81 (t), 29.46 (d), 30.19 (2 x t), 43.81 (d), 69.91 (t), 169.35 (d); mlz (CI) 185 (MNH/, 
63%), ]53 (7), ] 10 (3]), 48 (37). 
6.4.1.9 Bcnzyl-(2-mcthyl-butylidcne)-amine (224)13 
211 
Chapters 6 : Experimental. 
2-Methylbutylaldehyde (3.0 ml, 27.0 mmol) and benzyl amine (3.05 ml, 27.0 mmol) were 
reacted as described above (6.4.1) to yield benzyl-(2-methyl-butylidene )-amine (224) 
(4.63g, 97%) as a colourless oil which was used without further purification. Spectral 
details match those previously reported.13 
Vrnax (neat) /cm-l 3027, 2962, 2873, 1667, 1494, 1452, 1379, 1027, 696; oH(300 MHz, 
CDCh) 0.95 (3H, t, J 7.5, CH2Clh), 1.11 (3H, d, J 7.0, CHClh), 1.38-1.52 (JH, m, 
CHCIIHCH3), 1.53-1.67 (JH, m, CHCHIICH3), 2.34 (lH, app sp, J 7.0, N=CHCH), 4.59 
(2H, s, NCIIJ), 7.23-7.39 (51l, m, aromatic H), 7.64 (lH, dt, J 6.0, J 1.5, N=CIl); 8c(75.5 
MHz, CDCh) 12.03 (q), 17.34 (q), 27.41 (t), 41.44 (d), 65.35 (t), 127.21 (d), 128.19 (2 x 
d), 128.95 (2 x d), 139.87 (s), 171.09 (d). 
6.4.1.10 Henzyl-(3-methyl-butylidene)-amine (225)14 
3-McthylbutyJaldchydc (3.0 ml, 27.0 mmo!) and benzylamine (3.05 ml, 27.0 mmol) were 
reacted as described above (6.4.1) to yield benzyl-(3-methyl-butylidene)-amine (225) 
(4.49g, 94%) as a pale yellow oil which was used without further purification. 
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Vrnax (neat) /cm- I 3027, 2866, 1650, 1494, 1453, 1365, 1157, 1027, 731, 697; DH(300 
MHz, CDCh) 0.99 (6H, d, J 6.5, CHCIIJCIIJ), 1.97 (lH, ddt, J 7.0, CH2CIlCH3CH3), 
2.23 (2H, dd, J 7.0, J 5.S, N=CHClll ), 4.60 (2H, s, Neill), 7.23-7.37 (SH, m, aromatic 
H), 7.79 (lH, t, J 7.0, N=CII); &:(7S.S MHz, CDCh) 22.96 (2 x q), 26.74 (d), 4S.19 (t), 
6S.63 (t), 126.82 (d), 128.59 (2 x d), 128.94 (2 x d), 139.76 (s), 166.28 (d). 
6.4.3 Cycloheptyl-methanol (226)]5 
OH 
A solution of cyclohcptanecarboxylic acid (5.0g, 3.S mmol) in diethyl ether (25 ml) was 
added over a period of 30 minutes to a suspension of LiAIH4 (4.0g, 10.5 mmol) in diethyl 
ether (100 ml) under an atmosphere of nitrogen. The mixture was stirred for 90 minutes 
at room temperature. Excess LiAIH4 was destroyed by careful addition of water (IS ml) 
followed by the addition of 15% sodium hydroxide solution (20 ml). The resulting 
precipitate was removed by filtration and the filtrate extracted with diethyl ether (3 x 30 
ml). The combined extracts were dried over anhydrous magnesium sulfate and the 
solvent removed under reduced pressure to yield cycloheptyl-methanol (226) (4.48g, 
99%) as a colourless oil. Spectral details match those previously reported. IS 
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BH(300 MHz, CDCb) 1.12-1.24 (2H, m, ClIz) , 1.37-1.79 (11H, m, ClIz and CII and 
CH2011), 3.42 (2H, d, J 7.5, ClIzOH); &:(75.5 MHz, CDCb) 26.89 (2 x t), 28.97 (2 x t), 
31.13 (2 x t), 42.46 (d), 69.03 (t). 
6.4.4 Cycloheptanecarboxaldehyde (227)15 
Cycloheptylmethanol (58) (3.0g, 23.0 mmol) in dichloromethane (30 ml) was added in 
one portion to a stirred solution of PCC (II.I Ig, 51.5 mmol) in dichloromethane (100 
mI). The resulting mixture was stirred at room temperature for one hour. Diethyl ether 
(150 ml) was added to the mixture and the whole filtered through a small pad of florisil. 
Subsequent removal of the solvents under reduced pressure furnished 
cyclohcptanccarboxaldchyde (227) (2.76g, 95%) as a yellow oil. 
villa" (film) /em-) 2925, 1705, 1461, 1416, 1273, 1225, 942, 876, 833; BH(300 MHz, 
CDCh) 1.46-1.76 (1011, m, ClIz), 1.90-2.00 (2I1, m, ClIz), 2.34-2.42 (IH, m, CllCHO), 
9.64 (I II, s, CliO), &:(75.5 Mllz, CDCb) 26.66 (2 x t), 27.59 (2 x t), 28.94 (2 x t), 52.25 
(d), 203.94 (d). 
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6.4.1.11 Benzyl-cycloheptylmethylene-amine (228) 
CycloheptanccarboxaJdehydc (227) (2.0g, 15.8 mmoJ) and benzylamine (1.73 ml, 15.8 
mmoJ) were reactcd as describcd above (6.4.1) to yield benzyl-cycloheptylmethylene-
amine (228) (2.7g, 83%) as a yellow oil which was used without further purification. 
Vllla~ (neat) fcm· l 2926,2862,1662,1611,1517,1446,1247,1177,1035,731; OH(300 
Mllz, CDCh) 1.42-1.75 (lOll, m, Clh), 1.81-1.96 (2H, m, ClIl) , 2.36-2.41 (lH, m, 
N=CIICII), 4.56 (211, S, NClIl), 7.20-7.37 (5H, m, aromatic H), 7.69 (IH, d, J 5.0, 
N=CII); &(75.5 Mllz, CDCb) 26.97 (2 x t), 28.75 (2 x t), 30.83 (2 x t), 45.62 (d), 65.21 
(t), 127.75 (d), 128.19 (2 x d), 128.37 (2 x d), 139.88 (s), 171.15 (d); mlz (EI) 216 (MH+, 
12%), 158 (82), 91 (100). 
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6.4.5 General procedure for the preparation of bromo-enamides 
To a stirred solution of methylene-amine in dry dichloromethane under an atmosphere of 
nitrogen was added 2-bromo-2-methylpropionyl bromide (1.1 eq.) dropwise. 
Diethylaniline (1.1 eq.) was then added dropwise and the mixture stirred for two hours at 
room temperature. The resulting mixture was washed with a 10% solution of Hel (2 x 20 
ml) followed by a saturated solution sodium chloride (2 x 50 ml). The organic phase was 
then dried over anhydrous magnesium sulfate and the solvent removed under reduced 
pressure to yield the crude product. 
6.4.5.1 N-Uenzyl-2-bromo-N-cyclohexylidenemethyl-2-methypropionamide (119) 
To a solution of benzyl-cyclohexylmethylene-amine (215) (1.0g, 4.97 mmol) was added 
2-bromo-2-methylpropionyl bromide (0.61 ml, 5.46 mmol). Purification by flash column 
chromatography eluting with 5:2 petroleum ether:ethyl acetate afforded N-benzyl-2-
bromo-N-cyc1ohexylidcnemethyl-2-methypropionamidc (119) (0.93g, 58%) as a pale 
yellow oi\. 
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Vrnax (neat) /cm-1 3028, 2929, 1737, 1639, 1495, 1390, 1365, 1178, 749, 698; oH(300 
MHz, CDCh) 1.48-1.56 (6H, m, CII2), 2.06 (6H, S, 2 x ClIJ), 2.11-2.15 (4H, m, CII2), 
4.69 (2H, S, NCII2Ph), 6.32 (lH, s, NCII), 7.23-7.34 (5H, m, aromatic H); &(75.5 MHz, 
CDCb) 26.45 (t), 26.62 (t), 27.84 (t), 28.96 (t), 32.71 (2 x q), 33.21 (t), 55.45 (t), 58.9 (s), 
123.16 (d), 127.53 (d), 128.26 (2 x d), 128.79 (2 x d), 137.74 (s), 141.54 (s), 171.04 (s); 
m/z (EI) 352 [(MH-SIBrt, 34%], 350 [(MH_79Br)+, 34%], 270 (86), 200 (27), 178 (52), 
III (73),91 (l00); (Found: MH+, 350.1082. ClsH2/ 9BrNO requires MH+, 350.1079). 
6.4.5.2 2-Bromo-N-cyclohexylidenemethyl-N-(4-methoxy-benzyl)-2-methyl-
propionamide (126) 
o 
I 
To a solution of cyc!ohcxylmcthylcne-(4-methoxy-benzyl)-amine (216) (2.0g, 9.3 mmol) 
was added 2-bromo-2-mcthylpropionyl bromide (1.14 ml, 10.2 mmol). Purification by 
flash column chromatography eluting with 6: 1 petroleum ether:ethyl acetate furnished 
bromo-N-cyclohcxylidcncmcthyl-N-(4-methoxy-bcnzyl)-2-methyl-propionamide (126) 
(1.43g, 55%) as a pale yellow oi I. 
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Vrnax (film) fcm-) 2930,2853,2834, 1737, 1639, 1612, 1512, 1390, 1247, 1174,835,737; 
~(300 MHz, CDCh) 1.48-1.62 (6H, m, CH2), 1.99 (6H, s, 2 x CH3), 2.06-2.13 (4H, m, 
Clh), 3.81 (3H, s, OCH3), 4.62 (2H, s, NCH2Ar), 6.27 (IH, s, NCH), 6.86 (2H, d, J 9.0, 
aromatic H), 7.19 (2H, d, J 9.0, aromatic H); &(75.5 MHz, CDCb) 26.45 (t), 26.63 (t), 
27.86 (t) 28.95 (t), 32.71 (2 x q), 33.22 (t), 54.82 (t), 55.62 (q), 58.99 (s), 114. 14 (2 x d), 
123.09 (d), 129.75 (2 x d), 129.92 (s), 141.49 (s), 159.15 (s), 170.91 (s); mlz (El) 381 
[(M-8I Br)+, 34%], 379 [(M_79Br)+, 34%], 300 (100), 230 (12), 182 (33),121 (83). 
6.4.5.3 2-Bromo-N-cydohexylidenemethyl-2-methyl-N-(I-phenyl-ethyl)-
propionamide (130) 
To a solution of cyclohexylmcthylcne-(l-phenyl-ethyl)-amine (217) (2.9g, 13.0 mmol) 
was added 2-bromo-2-mcthylpropionyl bromide (1.66 ml, 14.3 mmol). Purification by 
flash column chromatography eluting with 9: I petroleum ether:ethyl acetate afforded 2-
bromo-N-cyc lohcx yl idcnemcthyl-2-mcthyl-N-( l-phcnyl-ethyl)-propionamide (130) 
(2.50g, 58%) as a colourless oil. 
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Vrnax (neat) /cm-I 2927, 1739, 1691, 1637, 1486, 1364, 1177,750; DH(250 MHz, CDCh) 
1.11-1.69 (6H, m, CliJ), 1.47 (3H, d, J 7.0, NCH(CH3)Ph), 1.92 (6H, s, 2 x CH3), 1.98-
2.10 (4H, m, Clll), 5.75 (IH, s, NCII=C), 5.91 (lH, q, J 7.0, NCH(CH3)Ph), 7.19-7.32 
(5H, m, aromatic II); &(75.5 MHz, CDC!) 16.92 (q), 26.35 (t), 26.51 (t), 27.63 (t), 29.34 
(t), 33.24 (q), 33.35 (q), 33.61 (t), 56.40 (d), 60.06 (s), 118.81 (d), 127.71 (2 x d), 128.47 
(d), 128.71 (2 x d), 140.83 (s), 144.83 (s), 171.32 (s); mlz (El) 366 [(MH-8IBr)+, 87%), 
364 [(MHJ9Br)+, 100%], 300 (54), 284 (100), 180 (85), 105 (96); (Found: MH+, 
364.1280. CI9112679BrNO requires MH+, 364.1277). 
6.4.5.4 N-Uenzyl-2-bromo-N-cycloheptylidenemethyl-2-methyl-propionamide (123) 
To a solution of henzyl-cycloheptylmethylene-amine (228) (2.57g, 12.0 mmol) was 
added 2-bromo-2-methylpropionyl bromide (1.4 ml, 13.0 mmol). Purification by flash 
column chromatography eluting with 9: I petroleum ether:ethyl acetate afforded N-
bcnzyl-2-hromo-N-cycloheptylidcncmethyl-2-methyl-propionamide (123) (2.75g, 63%) 
as a colourless oil. 
219 
Chapters 6 : Experimental. 
Vrnax (nujol) /em-1 3027,2929, 1725, 1640, 1448, 1367, 1176,987,837; 8H(300 MHz, 
CDCh) 1.54-1.62 (8H, m, 4 X CII2), 1.98 (6H, s, 2 X CII3), 2.28-2.33 (4H, m, 2 X CII2), 
4.69 (2H, s, NCII}Ph), 6.39 (IH, s, NCII), 7.23-7.33 (5H, m, aromatic H); &:(75.5 MHz, 
CDCI3) 26.07 (t), 28.75 (t), 29.85 (t), 30.74 (2 X t), 32.48 (2 X q), 34.24 (t), 54.56 (t), 
58.88 (s), 126.04 (d), 127.49 (d), 128.09 (2 x d), 128.79 (2 x d), 137.85 (s), 143.91 (s), 
170.83 (s); mlz (EI) 366 [(MH_81 Br)+, 100%], 364 [(MH_79Br)+, 100%], 300 (29), 284 
(86), 178 (65), 108 (76), 91 (30); (Found: MH+, 364.1263. Cl9H2679BrNO requires MH+, 
364.1277). 
6.4.5.5 N-Bcnzyl-2-bromo-2-methyl-N-(2-methyl-propenyl)-propionamide (121) 
To a solution of bcnzyl-isobutylidcne-amine (220) (2.0g, 12.0 rnmo!) was added 2-
bromo-2-rncthylpropionyl bromide (1.53 rnl, 13.1 rnrnol). Purification by flash column 
chromatography eluting with 6: 1 petroleurn ether:ethyl acetate furnished N-benzyl-2-
bromo-2-rnethyl-N-(2-mcthyl-propcnyl)-propionarnide (121) (2.75g, 74%) as a colourless 
oil. 
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Vmax (neat) !em"t 3028,2974, 1737, 1640, 1495, 1463, 1353, 1179, 1108,831,699,620; 
OH(300 MHz, CDCh) 1.62 (3H, S, C=CCIlJCH3), 1.73 (3H, S, C=CCH3CIIJ), 1.98 (6H, S, 
2 x CIlJ), 4.70 (2H, S, Clh), 6.35 (tH, s, NCII), 7.24-7.35 (5H, m, aromatic H); &(75.5 
MHz, CDCh) 18.56 (q), 21.48 (q), 32.46 (2 x q), 54.82 (t), 58.69 (s), 126.13 (d), 127.53 
(d), 128.22 (2 x d), 128.81 (2 x d), 135.33 (s), 137.67 (s), 171.01 (s); mlz (El) 312 [(MH-
8I Br)+, 76%], 310 [(MH)9Brt, 77%], 247 (65), 230 (100), 140 (27), 91 (51); (Found: 
Mil+, 310.0785. Ct51ho79BrNO requires MH+, 310.0779). 
6.4.5.6 2-Rromo-N-tert-butyl-N-cyclohexylidenemethyl-2-methyl-
propionamide (127) 
To a solution of tert-butyl-cyclohexylmethylene-amine (218) (3.71g, 22.0 mmol) was 
added 2-bromo-2-methylpropionyl bromide (2.74 ml, 24.2 mmoJ). Purification by flash 
column chromatography eluting with 9: 1 petroleum ether:ethyl acetate afforded 2-bromo-
N-tert-butyl-N-cyclohexylidenemethyl-2-methyl-propionamide (127) (1.95g, 28%) as a 
pale yellow oil. 
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Vrnal{ (neat) !em-I 2929, 2855, 1738, 1640, 1448, 1366, 1179, 1078, 837; oH(300 MHz, 
CDC]3) 1.39 (9H, s, tert-Bu 3 x CHJ), 1.43-2.12 (8H, m, CH2), 1.86 (3H, s, 
C(Br)ClhCIIJ), 1.96 (3H, s, C(Br)CIIJCH3), 2-24-2.36 (2H, m, CH2), 6.05 (lH, s, 
NCIl); &(75.5 MHz, CDCb) 26.59 (t), 26.75 (t), 27.66 (t), 28.66 (3 x q), 29.31 (t), 32.94 
(q), 33.44 (t), 34.68 (q), 60.52 (s), 62.31 (s), 121.56 (d), 143.09 (s), 171.77 (s); mlz (El) 
318 [(MII-8IBrt, 58%], 316 [(MII_79Br)+, 59%], 236 (42),194 (20). 
6.4.5.7 N-nenzyl-2-bromo-N-cyclopenlylidenemethyl-2-methyl-propionamide (122) 
To a solution of benzyl-cyclopcntylmethylenc-aminc (212) (1.75g, 9.0 mmol) was added 
2-bromo-2-methylpropionyl bromide (I.I 5 ml, 9.0 mmol). Purification by flash column 
chromatography eluting with 5: I petroleum ether:ethyl acetate afforded N-benzyl-2-
bromo-N-cyclopcntylidcncmcthyl-2-mcthyl-propionamide (122) (1.61g, 53%) as a pale 
yellow oil. 
V/Jla~ (neat) !em·1 3033,2927, 1717, 1497, 1374, 1178,751,663; oH(300 MHz, CDCb) 
1.65-1.73 (411, m, CII2), 1.99 (611, S, 2 x Cli), 2.19-2.23 (2I1, m, Cllz), 2.30-2.34 (2H, 
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m, CII}), 4.75 (2H, s, Neill), 6.57 (IH, s, NCII), 7.24-7.35 (5H, m, aromatic H); Oc(75.5 
MHz, CDCh) 26.25 (t), 26.30 (t), 30.12 (t), 31.57 (t), 32.42 (2 x q), 53.59 (t), 58.77 (s), 
122.65 (d), 127.44 (d), 127.91 (2 x d), 128.79 (2 x d), 138.04 (s), 145.27 (s), 170.58 (s); 
mlz (EI) 338 [(MH-SIBrt, 96%], 336 [(MH)9Br)\ 100%],256 (80), 186 (9), 166 (21), 
91 (17); (Found: MH+, 336.0976. CI7H2/9BrNO requires MH+, 336.0979). 
6.4.5.8 N -Henzyl-2-bromo-2-methyl-N-(2-methyl-but-1-enyl)-propionamide (124) 
To a solution of benzyl-(2-methyl-butylidene)-amine (224) (3.0g, 17.0 mmol) was added 
2-bromo-2-methylpropionyl bromide (2.1 ml, 18.7 mmol). Purification by flash column 
chromatography eluting with 9: I petroleum ether:ethyl acetate furnished N-benzyl-2-
bromo-2-methyl-N-(2-methyl-but-l-cnyl)-propionamide (124) (2.52g, 52%) as a 
colourless oil. 
Vma~ (film) !em'\ 3029,2966,1737,1638,1495,1462,1365,1262,1178,1108, 845, 698; 
bll(300 MHz, CDCb) 1.04 (311, t, J 7.5, CH2CII), 1.61 (3H, s, C=CCIIJ), 1.98 (6H, s, 2 
x CIIJ), 2.10 (211, q, J 7.5, CI hCII]), 4.69 (211, s, NClIl), 6.36 (Ill, s, NCII), 7.23-7.33 
(511, m, aromatic II); &(75.5 Mllz, CDCh) 11.21 (q), 14.60 (q), 29.36 (t), 32.45 (2 x q), 
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54.72 (t), 58.87 (s), 125.56 (d), 127.54 (d), 128.38 (2 X d), 128.78 (2 X d), 137.68 (s), 
140.17 (s), 170.97 (s); mlz (CI) 326 [(MH-BIBrt, 76%], 324 [(MHJ9Br)+, 80%], 294 
(22),244 (85), 91 (38); (Found: MIl+, 324.0966 CI6H2/ 9BrNO requires MH+, 324.0964). 
6.4.5.9 N-Benzyl-2-bromo-2-methyl-N-(3-methyl-but-l-enyl)-propionamide (125) 
To a solution of benzyl-(3-methyl-butylidene)-amine (225) (3.0g, 17.0 mmoI) was added 
2-bromo-2-methyIpropionyl bromide (2.1 ml, ] 8.7 mmol). Purification by flash column 
chromatography eluting with 6:] petroleum ether:ethyl acetate afforded N-benzyl-2-
brorno-2-methyl-N-(3-methyl-but-I-enyl)-propionarnide (125) (2.9g, 60%) as a pale 
yellow oil. 
Vmax (neat) /em-I 2974, 1737, 1641, 1496, 1390, 1262, 1179, 1079,830,699; SH(300 
MHz, CDCI) 1.00 (6J1, d, J 7.0, CIICIIJCII), 2.02 (6H, s, CBrCIIJClh), 2.35 (lH, m, 
CHCIICII.lCII.l), 4.94 (2J1, s, NClh), 5.10 (III, dd, J 7.5, J 6.5, NC=CII), 7.16-7.39 (5H, 
m, aromatic II), 7.32 (III, d, J 6.5, NCII); &(75.5 MHz, CDCb) 23.08 (2 X q), 29.79 (d), 
32.99 (2 x q), 50.41 (t), 57.51 (s), 122.74 (2 x d), 126.84 (2 x d), 127.24 (d), 128.91 (2 x 
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d), 137.67 (s), 169.40 (s); mlz (CI) 326 [(MH-SIBrt, 65%], 324 [(MH-79Brt, 66%], 244 
(24), 176 (52), 91 (77). 
6.4.5.10 2-Bromo-N-cyclohexylidenemethyl-N-isobutyl-2-methyl-
propionamide (128) 
o I 
To a solution of cyclohexylmethylene-isobutyl-amine (223) (4.38g, 26.0 mmo) was 
added 2-bromo-2-methylpropionyl bromide (3.2 ml, 28.6 mmol). Purification by flash 
column chromatography eluting with 5: 1 petroleum ether:ethyl acetate afforded 2-bromo-
N-cyclohexylidcnemethyl-N-isobutyl-2-methyl-propionamide (128) (3.8g, 47%) as a 
colourless oil. 
Villa" (neat) /em-I 2929, ] 736, ] 645, ] 463, ] 389, 1173, 833; OH(300 MHz, CDCb) 0.88 
(611, d, J 7.0, CIICIIJCIi), 1.56-1.65 (611, m, CIIJ), 1.95 (6H, s, CBrCIIJCIIJ), 2.04-
2.1] (311, m, Clh and CII2CIICIIJCJh), 2.] 3-2.] 7 (2H, m, CIIJ), 3.31 (2H, d, J 7.5, 
NClIl ) , 6.49 (] II, s, NCII); &(75.5 MHz, CDC!) 20.72 (2 x q), 26.45 (t), 26.56 (t), 
27.]2 (d), 27.84 (t), 27.92 (t), 32.77 (2 x q), 33.23 (t), 59.36 (s), 59.79 (t), ]23.82 (d), 
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140.23 (s), 170.72 (s); mlz (EI) 318 [(MH_8I Br)+, 43%], 316 [(MHJ9Brt, 45%], 236 
(18),180 (38); (Found: MH+, 316.1278 CI5H2679BrNO requires MH+, 316.1277). 
6.4.5.11 2-Bromo-N-(2-bromo-benzyl)-N-cyclobexylidenemetbyl-2-metbyl-
propionamide (129) 
, 0 
B, N~ 
eX Br 3 ~ 4' ~ 6 
5 
To a solution of (2-bromo-benzyl)-cycJohexylmethylene-amine (219) (2.0g, 7.14 mmol) 
was added 2-bromo-2-methylpropionyl bromide (0.88 ml, 8.14 mmol). Purification by 
flash column chromatography eluting with 9: 1 petroleum ether:ethyl acetate furnished 2-
bromo-N-(2-bromo-benzyl)-N-cyclohexylidenemethyl-2-methyl-propionamide (129) 
(2.02g, 66%) as a colourless oil. 
Vma~ (film) !em') 2930, 2853, 1726, 1641, 1568, 1463, 1444, 1390, 1288, 1108, 1030, 
834, 746; 811(300 Mllz, CDCh) 1.54-1.62 (6H, m, CII]) , 2.02 (6H, s, CBrCIIJCIIJ), 
2.06-2.1 I (211, m, Cllz) , 2.18-2.23 (211, m, ellz), 4.79 (2H, s, NCII]) , 6.39 (Ill, s, 
Nell), 7.12 (III, dt, J 7.5, J 1.5, 11-5), 7.26-7.32 (21l, m, H-4 and H-6), 7.52 (tH, d, J 
8.0, 11-3), &(75.5 Mllz, CDCh) 26.33 (t), 26.57 (t), 27.63 (t), 28.98 (t), 32.64 (2 x q), 
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33.17 (t), 55.41 (t), 58.88 (s), 122.98 (d), 123.64 (s), 127.98 (d), 128.91 (2 X d), 133.71 
(d), 136.71 (s), 141.99 (s), 171.12 (s); m/z (EI) 432 [(MH-8IBr 8IBr)+, 76%J, 430 [(MH-
81Br 79Br)+, 100%J, 428 [(MH_79Br 79Br)+, 75%J, 350 (96), 270 (37), 169 (68). 
6.4.5.12 N-Benzyl-2-bromo-N -cyclohexylidenemethyl-propionamide (120) 
To a solution of bcnzyl-cyclohcxylmcthylcne-amine (215) (2.0g, 9.95 mmol) was added 
2-bromopropionyl bromide (1.04 ml, 10.9 mmol). Purification by flash column 
chromatography eluting with 9: 1 petroleum ether:ethy1 acetate afforded N-benzyl-2-
bromo-N-cyclohcxylidcncmethyl-propionamide (120) (1.35g, 40%) as a pale yellow oil. 
Vllla~ (ncat) /cm- I 2927,2836, ]7]9, ]644, ]6]2, 1468, 1244, 1114,743; BH(300 MHz, 
CDCb) 1.43-1.54 (611, m, Cllz), 1.77 (311, d, J 6.5, CHCIIJ), 1.82-1.88 (2H, m, ellz), 
1.99-2.06 (211, m, Cllz) , 4.58 (lll, d, J 6.5, NCIlH), 4.64 (1 H, d, J 6.5, NCIIII), 4.65 
(lIJ, q, J 6.5, CIlCIIJ), 5.76 (lIl, s, NCll), 7.21-7.26 (51I, m, aromatic H); &:(75.5 MHz, 
CDCh) 21.40 (q), 24.10 (t), 24.53 (t), 26.84 (t), 27.12 (t), 31.53 (t), 38.48 (d), 53.17 (t), 
1 ]9.54 (d), ]27.98 (d), ]28.31 (2 x d), ]28.75 (2 x d), ]37.89 (s), 146.73 (s), 170.15 (s); 
",/z (EI) 338 [(MII-8I Ort, 85%], 336 [(MII-790rt, 100%J, 256 (100), 200 (7), 91 (100). 
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6.4.6 Tris-(2-pyridyl-methyl)-amine (132) 
To a solution of 2-picolyl chloride hydrochloride (9.75g, 59.5 mmol) in deionized water 
(25 ml) at O°C was added with stirring a 5.3 N aqueous solution of sodium hydroxide (12 
ml). The resulting free amine appeared as a red emulsion following the neutralisation. To 
this mixture was added a solution of 2-(aminomethyl)pyridine (3.2g, 29.5 mmol) in 
dichloromethanc (50 ml). The resulting mixture was allowed to warm to room 
temperature and, over a 48 hour period, an additional aliquot of 5.3 N aqueous sodium 
hydroxide solution (12 ml) was added. During this addition the pH of the aqueous portion 
of the reaction mixture was not permitted to exceed 9.5. The mixture was then washed 
with a 15% sodium hydroxide solution (2 x 50 ml) and the organic phase dried over 
anhydrous magnesium sulfate. Removal of solvent under reduced pressure yielded a solid 
mass which was extracted with boiling diethyl ether (3 x 30 ml). Removal of the solvent 
followed by recrystallisation from diethyl ether afforded tris-(2-pyridyl-methyl)-amine 
(132) (6.4g, 80%) as a white crystalline solid; m.p. 82-83°C. 
228 
Chapters 6 : Experimental. 
VrnaJ( (film) /cm-I 2818, 1589, 1569, 1475, 1437, 1368, 1124, 766; DH(250 MHz, CDCh) 
3.72 (6H, s, 3 x NClh), 6.98 (3H, t, J 6.0, 3 x H-5), 7.41 (3H, d, J 7.5, 3 x H-3), 7.49 
(3H, t, J 7.5,3 x H-4), 8.36 (3H, d, J 5.0, 3 x H-6); &:(75.5 MHz, CDCh) 59.92 (3 x t), 
121.76 (3 x d), 122.69 (3 x d), 136.39 (3 x d), 148.86 (3 x d), 159.12 (3 x s); m/z (EI) 291 
(MH+, 80%),171 (13), 198 (l00). 93 (l00). 
6.4.7 General procedure for the cyclisation of bromo-enamides. 
To a mixture of bromo-enamide and copper (I) bromide (30 mol%) under a nitrogen 
atmosphere was added a solution of tris-(2-pyridyl-methyl)-amine (132) (30 mol%) in dry 
dichloromethanc (0. 12M solution). The resulting mixture was stirred at room temperature 
and upon completion was eluted through a silica plug with dichloromethane. Subsequent 
removal of solvent under reduced pressure furnished the p-lactam as a colourless oil. 
6.4.7.1 4-( I-Bromo-cyclohexyl)-I-( 4-methoxy-benzyl)-3,3-dimethyl-azetidin-
2-one (134) 
0", 
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2-Bromo-N-cyclohexylidenemethyl-N-(4-methoxy-benzyl)-2-methyl-propionamide (126) 
(100 mg, 0.26 mmol) was reacted as described above (6.4.7) to furnish 4-(I-bromo-
cyclohexyl)-I-(4-methoxy-benzyl)-3,3-dimethyl-azetidin-2-one (134) (98 mg, 98%) as a 
colourless oil. 
Vrnax (film) /em-! 2934, 1751, 1614, 1514, 1246, 1176, 1034,831; OH(300 MHz, CDCb) 
1.24 (3H, s, C1I3), 1.44 (3H, s, CH3), 1.41-2.15 (lOH, m, CH2), 3.44 (lH, s, NCH), 3.76 
(3H, s, OC1I3), 4.04 (lH, d, J 18.0, NCHH), 4.85 (IH, d, J 18.0, NCHH), 6.83 (2H, d, J 
8.0, aromatic H), 7.16 (2H, d, J 8.0, aromatic H); &(75.5 MHz, CDCb) 18.73 (q), 22.32 
(t), 22.97 (t), 24.85 (q), 25.39 (t), 37.65 (t), 37.96 (t), 45.22 (t), 55.62 (q), 55.77 (s), 72.77 
(d), 74.94 (s), 114.41 (2 x d), 128.5 (s), 130.03 (2 x d), 159.39 (s), 175.33 (s); m/z (El) 
382 [(MH-SIBrt, 89%], 380 [(MH-79Brt, 100%], 316 (62), 299 (45), 136 (36), 121 
(100); (Found: MH+, 380.1183. CI9H2679BrN02 requires MH+, 380.1179). 
6.4.7.2 1-Benzyl-4-(I-bromo-cyclohexyl)-3,3-dimethyl-azetidin-2-one (133) 
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N-Benzyl-2-bromo-N-cyclohexylidenemethyl-2-methypropionamide (119) (100 mg, 0.28 
mmol) was reacted as described above (6.4.7) to furnish I-benzyl-4-(1-bromo-
cyclohexyl)-3,3-dimethyl-azetidin-2-one (133) (96 mg, 96%) as a colourless oil. 
Vma,,- (film) /cm-I 2962, 1646, 1521, 1466, 1438, 1265, 740, 705; OH(300 MHz, CDCh) 
1.24 (3H, s, CIIJ), 1.42 (3H, s, Cllj), 1.31-2.07 (lOH, m, ell]), 3.35 (lH, s, NCII), 4.04 
(IH, d, J 18.0, NCIIH), 4.85 (lH, d, J 18.0, NCHII), 7.18-7.3 (5H, m, aromatic H); 
&(75.5 MIIz, CDC h) 18.76 (q), 22.31 (t), 22.97 (t), 24.9 (q), 25.38 (t), 37.67 (t), 37.92 
(t), 45.83 (t), 55.87 (s), 72.03 (d), 74.76 (s), 128.04 (d), 128.75 (2 x d), 129.1 (2 x d), 
136.49 (s), 175.36 (s); mlz (El) 353 [(MH-8I Br)+, 78%], 351 [(MH)9Br)+, 80%], 270 
(46), 137 (100), 91 (83); (Found: MH+, 350.1116. CISH2/9BrNO requires MH+, 
350.) ) 19). 
6.4.7.3 4-( l-Hromo-cyclohcxyl)-3,3-dimethyl-l-(1-phenyl-ethyl)-azetidin-2-one 
(146) 
N 
o 
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2-B romo-N-cyclohex ylidenemethyl-2-methyl-N-( I-phen yl-ethyl)-propionamide (130) 
(100 mg, 0.27 mmol) was reacted as described above (6.4.7) to afford 4-(1-bromo-
cyclohexyl)-3,3-dimethyl-l-(I-phenyl-ethyl)-azetidin-2-0ne (146) (97 mg, 97%) as a 
colourless oily mixture of two isomers (ratio 1: 1). 
Vmax (film) /cm-1 2929, 1714, 1628, 1463, 1387, 1288, 1029, 932, 836; oH(250 MHz, 
CDCh) 0.75-2.06 (IOH, m, Clll) 1.15 (3/2H, s, CIlJ), 1.29 (3/2H, s, CIIJ), 1.36 (3/2H, s, 
CIIJ), 1.38 (3/2H, s, Clh), 1.66 (3/2H, d, J 7.5, NCH(CHJ)Ph), 1.81 (3/2, d, J 7.5, 
NCH(CIlJ)Ph), 3.41 (lI2H, s, NCII), 3.62 (lI2H, s, NCll), 4.67 (lI2H, q, J 7.5, 
NCIl(CH3)Ph), 4.78 (lI2H, q, J 7.5, NCH(CH3)Ph), 7.19-7.29 (5H, m, aromatic H); 
&:;(75.5 MHz, CDCb) mixture 17.49 (q), 17.61 (q), 19.35 (q), 19.82 (q), 20.87 (2 x t), 
21.65 (2 x t), 23.23 (q), 23.84 (q), 23.90 (t), 36.27 (s), 36.78 (s), 53.39 (s), 53.66 (s), 
54.06 (d), 54.82 (d), 71.31 (d), 74.19 (d), 125.91 (2 x d), 126.29 (2 x d), 126.34 (d), 
126.51 (d), 127.49 (2 x d), 127.69 (2 x d), 140.42 (s), 141.08 (s), 174.13 (s), 174.25 (s); 
m/z (EI) 366 [(MH-8I Br)+, 100%], 364 [(MH_79Br)+, 98%], 284 (l00), 136 (100), 105 
(36), 83 (100). 
6.4.7.4 1-Benzyl-4-(1-bromo-cyclopentyl)-3,3-dimethyl-azetidiD-2-oDe (143) 
N 
o 
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N-Benzyl-2-bromo-N-cycIopentylidenemethyl-2-methyl-propionamide (122) (100 mg, 
0.30 mmol) was reacted as described above (6.4.7) to furnish I-benzyl-4-(t-bromo-
cycIopentyl)-3,3-dimethyl-azetidin-2-one (143) (94 mg, 94%) as a colourless oil. 
Vmax (film) /cm-I 2934, 1697, 1574, 1455, 1263, 1137, 926, 701; oH(250 MHz, CDCb) 
1.26 (31-1, s, CI!J) , 1.38 (3H, s, CIIJ), 1.50-1.92 (61-1, m, ell]). 2.10-2.25 (2H, m, CII]), 
3.35 (11-1, s, NCIl), 3.95 (til, d, J 15.5, NCIIH), 4.86 (tH, d, J 15.5 Hz, NCHH), 7.15-
7.28 (5H, m, aromatic II); 0cC75.5 MHz, CDCb) 16.42 (q), 21.84 (t). 22.86 (t), 23.04 (q), 
28.69 (t). 40.45 (t), 44.09 (t), 54.32 (s), 69.16 (d), 74.69 (s), 126.71 (d), 127.12 (2 x d), 
127.80 (2 x d), 134.89 (s), 173.70 (s); m/z (EI) 368 [(MH-8I Br)+, 100%], 366 [(MH-
79Br)+, 83%], 256 (92),186 (30),122 (100), 91 (56). 
6.4.7.5 I -Ucnzyl-4-( I-bromo-l-methyl-ethyl)-3,3-dimethyl-azetidin-2-one (14 1) 
N-BcnzyI-2-bromo-2-mcthyl-N-(2-mcthyl-propenyl)-propionamide (121) (200 mg, 0.62 
mmol) was reacted as described above (6.4.7) to furnish I-benzyl-4-( I -bromo- I -methyl-
ethy\)-3,3-dimcthyl-azctidin-2-one (141) (194 mg, 97%) as a colourless oil. 
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Vrnax (film) fcm-) 2928, 1695, 1600, 1582, 1457, 1377, 1288, 933, 710; DH(300 MHz, 
CDCb) 1.20 (3H, s, CIIJ ), 1.32 (3H, s, CIIJ), 1.73 (3H, s, C(Br)CIIJCH3), 1.74 (3H, s, 
C(Br)C1I3CIIJ), 3.53 (111, s, NCIl), 4.15 (tH, d, J 15.0, NCHH), 4.85 (tH, d, J 15.0, 
NCHIl), 7.18-7.27 (5H, m, aromatic H); &::(75.5 MHz, CDCb) 18.28 (q), 19.18 (q), 
31.61 (q), 31.69 (q), 45.37 (t), 55.72 (s), 65.58 (s), 73.16 (d), 128.03 (d), 128.88 (2 x d), 
129.06 (2 x d), 136.53 (s), 175.09 (s); mlz (El) 312 [(MH-8)Br)+, 97%], 310 [(MH-79Brt, 
100%], 230 (86), 178 (32), 142 (36), 91 (100); (Found: MH+, 310.0772. C)5H2079BrNO 
requires MH+, 310.0779). 
6.4.7.6 1-(2-n romo-benzy 1)-4-( I-bromo-cyclohexyl)-3,3-dimethyl-azetidin-2-
one (136) 
N 
o 
Sr 
5\,. 
3 
4 
2-Bromo-N-(2-bromo-bcnzyl)-N-cyclohexylidenemethyl-2-methyl-propionamide (129) 
(100 mg, 0.23 mmol) was reacted as described above (6.4.7) to furnish 1-(2-bromo-
benzyl)-4-(I-bromo-cyclohexyl)-3,3-dimethyl-azetidin-2-one (136) (98 mg, 98%) as a 
colourless oil. 
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Vrnax (film) /cm-1 2854, 1728, 1640, 1568, 1441, 1390, 1288, 1181,1109, 1030,835,751; 
bH(300 MHz, CDCb) 1.35 (3H, s, CHJ), 1.51 (3H, s, CHJ), 1.49-1.72 (6H, m, CH1), 
1.80-1.88 (2H, m, CIIJ), 2.04-2.10 (2H, m, CH1), 3.57 (tH, s, NCH), 4.45 (tH, d, J 16.5, 
NClnl), 4.77 (lH, d, J 16.5, NCHII), ), 7.05-7.11 (lH, m, H-5), 7.23-7.28 (2H, m, H-4 
and H-6), 7.48 (Ill, d, J 7.5, H-3); &(75.5 MHz, CDCh) 17.46 (q), 20.86 (2 x t), 21.50 
(2 x t), 23.91 (q), 23.93 (t), 44.19 (t), 54.57 (s), 72.29 (s), 72.67 (d), 121.95 (s), 126.64 
(d), 128.06 (d), 128.35 (d), 132.09 (d), 134.09 (s), 174.15 (s); mlz (El) 432 [(MH-sIBr 
slBrt, 76%],430 [(MII-slnr 79Br)+, 100%],428 [(MH_79Br 79Br)\ 56%], 385 (53), 350 
(52),169 (36), 83 (100). 
6.4.7.7 l-Uenzyl-4-(1-bromo-l-methyl-propyl)-3,3-dimethyl-azetidin-2-one (142) 
N 
o 
N-Benzyl-2-bromo-2-methyl-N-(2-methyl-but-l-enyl)-propionamide (124) (100 mg, 0.28 
mmol) was rcactcd as described above (6.4.7) to afford I-benzyl-4-(t-bromo-l-methyl-
propyl)-3,3-dimethyl-azctidin-2-one (142) (95 mg, 95%) as a colourless oily mixture of 2 
isomers ratio (2: I). 
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Vrnax (film) /em-) mixture 2934, 1695, 1602, 1579, 1457, 1438, 1377, 1287, 743, 710; 
DH(300 MHz, CDCh) major isomer 0.98 (3H, t, J 7.0, CH2CHj), 1.18 (3H, s, CHj), 1.27 
(3H, s, Clh) , 1.68 (3H, s, CBrCIIj), 1.83 (2H, m, CH1CH3), 3.68 (lH, s, NCH), 4.24 
(IH, d, J 15.0, NCHH), 4.87 (IH, d, J 15.0, NCHH), 7.23-7.30 (5H, m, aromatic H); 
minor isomer 0.80 (311, t, J 7.0, CH2CIIJ), 1.19 (3H, s, CHj), 1.36 (3H, s, CHj ), 1.62 
(3H, s, CBrCIIj), 1.71 (2I1, m, CII1CH3), 3.55 (tH. s, NCII) , 4.05 (lH, d, J 15.0, 
NCIIII), 4.86 (lll, d, J 15.0, NCB/I), 7.17-7.25 (5H, m, aromatic H); &(75.5 MHz, 
CDCh) mixture 8.92 (q), 9.1 (q), 17.13 (q), 17.17 (q), 23.11 (q), 23.35 (q), 26.13 (q), 
26.39 (q), 34.42 (t), 34.75 (t), 43.82 (t), 44.11 (t), 54.11 (s), 54.45 (t), 70.45 (5), 70.93 (d), 
71.11 (d), 72.26 (5),126.51 (d), 126.65 (d), 127.32 (2 x d), 127.57 (2 x d), 127.58 (2 x d), 
127.69 (2 x d), 135.01 (s), 135.34 (s), 173.48 (s), 173.78 (5); m/z (El) mixture 326 [(MH-
8I Br)+, 94%],324 [(MII-79Brt, 100%],2]4 (86), 91 (lOO). 
6.4.7.8 4-( 1· Uromo-cyclohexyl)-1-isobutyl-3,3-dimethyl-azetidin-2-one (135) 
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2-Bromo-N-cyclohexylidenemethyl-N-isobutyl-2-methyl-propionamide (128) (100 mg, 
0.31 mmol) was reacted as described above (6.4.7) to furnish 4-(l-bromo-cyclohexyl)-I-
isobutyl-3,3-dimethyl-azetidin-2-one (135) (97 mg, 97%) as a colourless oil. 
Vmax (neat) /cm-I 2932, 1642, 1464, 1380, 1288, 1079, 837, 746; DH(300 MHz, CDCh) 
0.86 (3H, d, J 7.0, CHCIlJCH3), 0.87 (3H, d, J 7.0, CHCH3CIlJ), 1.29 (3H, s, Clh), 1.38 
(3H, s, CIlJ), 1.43-1.89 (8H, m, CIl2), 1.92-2.15 (3H, m, CH2 and NCH2CH), 2.92 (lH, 
dd, J 14.0, J 5.5, NCIlHCH), 3.26 (IH, dd, J 14.0, J 5.5, NCHlICH), 3.66 (IH, s, NCIl); 
&:(75.5 MIIz, CDCh) 17.54 (q), 18.95 (q), 19.34 (q), 20.97 (2 x t), 21.65 (2 x t), 24.13 
(t), 24.30 (q), 28.68 (d), 36.17 (s), 47.92 (t), 54.08 (s), 72.73 (d), 173.54 (s); mlz (Cl) 318 
[(MII-8t art. 73%], 316 [(MII)9Br)+, 76%], 287 (32), 235 (94), 194 (38). 
6.4.7.9 t.nenzyl-4-(1-bromo-cycloheptyl)3,3-dimethyl-azetidin-2-one (144) 
o 
N-Benzyl-2-bromo-N-cycloheptylidenemethyl-2-methyl-propionamide (123) (100 mg, 
0.27 mmol) was reacted as described above (6.4.7) to furnish I-benzyl-4-(l-bromo-
cyclohcptyl)3,3-dimcthyl-azctidin-2-one (144) (96 mg, 96%) as a colourless oil. 
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Vrnal{ (film) /cm-1 2934, 1732, 1643, 1519, 1416, 1265,926,701; oH(300 MHz, CDCh) 
l.23 (3H, s, CIIJ), l.39 (3H, s, CIl), 1.41-2.14 (WH, m, CIl]), 2.20-2.36 (2H, m, CIIJ), 
3.42 (lH, s, NCII), 4.09 (lH, d, J 15.0, NCIIH), 4.93 (lH, d, J 15.0, NCHH), 7.19-7.29 
(5H, m, aromatic H); &:(75.5 MHz, CDCh) 16.20 (q), 2l.48 (q), 23.59 (t), 25.25 (t), 
26.04 (t), 26.95 (t), 28.67 (t), 30.04 (t), 39.04 (s), 43.67 (t), 53.77 (s), 67.43 (d), 127.69 (2 
x d), 127.74 (2 x d), 128.46 (d), 137.86 (s), 173.85 (s); m/z (EI) 366 [(MH-8I Br)+, 87%], 
364 [(MH_79Br)+, 91 %],284 (52),271 (23), 184 (14), 91 (100). 
6.4.8 General procedure for the elimination of tertiary-bromo-~-Iactams. 
To a stirred solution of the tertiary-bromo-p-lactam in dichloromethane under a nitrogen 
atmosphere was added DBU (l eq.). The resulting mixture was stirred for 12 hours at 
room temperature. The mixture was then washed with a 5% aqueous solution of HCI 
followed by a saturated solution of sodium chloride. The organic phase was then dried 
over anhydrous magnesium sulfate and the solvent removed under reduced pressure to 
yield the corresponding alkene. 
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6.4.8.1 4-Cyclohex-l-enyl-l-( 4-methoxy-benzyl)-3,3-dimethyl-azetidin-2-one (138) 
N 
o 
4-( 1-Bromo-cyclohexyl)-I-( 4-methoxy-benzyl)-3,3-dimethyl-azetidin-2-one (134) (30 
mg, 0.08 mmol) was reacted as described above (6.4.8) to furnish 4-cyclohex-l-enyl-l-
(4-methoxy-benzyl)-3,3-dimethyl-azetidin-2-one (138) (23 mg, 98%) as a pale yellow oil. 
VlIlax (neat) Icm- I 2932, 2842, 1719, 1672, 1438, 1024, 836, 753; OH(300 MHz, CDCI3) 
0.98 (311, s, CIIJ) , 1.17 (3H, S, Cllj), 1.41-1.74 (6H, m, CH2), 1.98-2.05 (2H, m, C1I2), 
3.25 (111, S, NCII), 3.72 (JlI, d, J 15.0, NCIIH), 3.73 (3H, S, OCllj), 4.69 (tH, d, J 15.0, 
NCIIII), 5.50 (1 II, br s, C=CIl) , 6.78 (2H, d, J 8.0, aromatic H), 7.09 (2H, d, J 8.0, 
aromatic II); &(75.5 MIlz, CDCh) 17.13 (q), 22.75 (t), 22.80 (q), 25.21 (0,25.41 (t), 
27.70 (t), 44.16 (t), 55.09 (s), 55.64 (q), 66.44 (d), 114.40 (2 x d), 123.63 (d), 128.63 (s), 
130.07 (2 x d), 133.26 (s), 159.35 (5), 174.67 (s); mlz (El) 300 (MH\ 60%), 136 (71), 
121 (89),81 (12); (Found: MIt, 300.1959. CI9H24N02 requires MH+, 300.1967). 
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6.4.8.2 1-Benzyl-4-cyclohex-l-enyl-3,3-dimethyl-azetidin-2-one (137) 
N 
I-Benzyl-4-(1-bromo-cyclohexyl)-3,3-dimethyl-azetidin-2-one (133) (t 00 mg, 0.28 
mmol) was reacted as described above (6.4.8) to afford I-benzyl-4-cyclohex-l-enyl-3,3-
dimethyl-azetidin-2-one (137) (71 mg, 94%) as a colourless oil. 
VOla" (neat) !em'l 2929, 1727, 1642, 1464, 1440, 1268, 1027,845,751; OH(300 MHz, 
CDCI3) 0.98 (311, S, CII), 1.19 (311, S, CII), 1.46-1.75 (6H, m, Cllz), 1.97-2.04 (2H, m, 
Cllz), 3.28 (111, s, NCII), 3.79 (III, d, J 15.0, NCIlH), 4.74 (tH, d, J 15.0, NCHIl), 5.48 
(lII, br s, C=CII), 7.] ]-7.27 (511, m, aromatic H); &:(75.5 MHz, CDCh) 17.13 (q), 22.73 
(t), 22.79 (t), 22.85 (q), 25.21 (t), 27.70 (t), 44.77 (t), 44.25 (s), 66.69 (d), 123.74 (d), 
]27.94 (d), ]28.75 (2 x d), ]29.09 (2 x d), ]33.16 (s), 164.21 (s), 174.8] (s); mlz (EI) 270 
(Mil+, 100%),200 (34), ]36 (100), 9] (90); (Found: MH+, 270.1862. C1SH23NO requires 
MIl+, 270.1859). 
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6.4.8.3 1-(2-Bromo-benzyl)-4-cyclohex-l-enyl-3,3-dimethyl-azetidin-2-one (139) 
N 
6 
Sr 
5~ 
3 
4 
1-(2-Bromo-benzyl)-4-( l-bromo-cyclohexyl)-3,3-dimethyl-azetidin-2-one (136) (30 mg, 
0.08 mmol) was reacted as described above (6.4.8) to furnish 1-(2-bromo-benzyl)-4-
cyclohex- I -cnyl-3,3-dimethyl-azetidin-2-one (139) (23 mg, 97%) as a colourless oil. 
Vrnax (neat) /em-I 3062,2929, 1728, 1640, 1441, 1366, 1281, 1109,752; DH(300 MHz, 
CDCb) 0.99 (311, s, CIIJ), 1.22 (311, s, Clh), 1.41-1.62 (6H, m, Clh), 1.95-2.04 (2H, m, 
Cllz), 3.30 (III, s, NCII), 4.10 (III, d, J 15.0, NCIIB), 4_73 (tH, d, J 15.0, NCB/I), 5.49 
(III, br s, C=CII), 7.05-7.1 I (III, m, JI-5), 7.18-7.24 (211, m, H-4 and H-6), 7.47 (tH, d, 
J 8.5, 11-3); Bc(75.5 Mllz, CDCIJ ) 17.31 (q), 22.78 (2 x t), 23.10 (q), 25.25 (t), 27.80 (t), 
45.03 (t), 55.33 (s), 67.47 (d), 123.88 (d), 124.22 (s), 128.10 (d), 129.67 (d), 131.11 (d), 
133.31 (d), 133.51 (s), 135.58 (s), 174.59 (s); mlz (EI) 350 [(MH-8IBrt, 95%], 348 
[(MII_79Br)+, 100%], 268 (33), 169 (21), 136 (lOO), 91 (16); (Found: MB+, 348.0952. 
C1!!1I2279BrNO requires Mil+, 348.0961). 
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6.4.8.4 I-Benzyl-4-cyclohept-l-enyl-3,3-dimethyl-azetidin-2-one (229) 
N 
o 
I-Benzyl-4-(l-bromo-cycloheptyl)3,3-di methyl-azetidin-2-one (144) (50 mg, 0.14 mmol) 
was reactcd as dcscribed above (6.4.8) to furnish I-benzyl-4-cyclohept-l-enyl-3,3-
dimethyl-azetidin-2-one (229) (0. I 6 mg, 94%) as a colourless oil. 
vmax (neat) !em-I 2934, 1731, 1697, 1574, 1439, 1264,786,701; ()H(300 MHz, CDCh) 
0.98 (311, s, CIIJ), 1.22 (311, s, CIIJ), 1.34-1.46 (4B, m, Cllz), \.63-1.70 (2B, m, Cllz), 
1.85-\.90 (211, m, Cllz), 2.08-2.14 (2B, m, CJlz), 3.34 (lB. s, NCII), 3.77 (lH. d, J 15.0, 
NCIIII), 4.74 (III, d, J 15.0, NCII/I), 5.64 (JlI, t, J 6.5, C=CII) , 7.14-7.26 (5H, m, 
aromatic II); &-(75.5 Mllz, CDCb) 13.12 (q), 21.45 (q), 25.27 (t), 26.09 (t), 27.26 (t), 
30.91 (t), 31.31 (t), 43.36 (t), 53.93 (s), 67.10 (d), 126.55 (d), 127.66 (2 x d), 128.07 (2 x 
d), 128.40 (d), 134.97 (s), 138.24 (s), 173.28 (s); mlz (EI) 284 (MB+, 85%),187 (23), 91 
(100); (Found: Mil+, 284.2003. CI91bNO requires MH+, 284.2005). 
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6.4.9 But-3-enylamine (230)17 
H2N~ 
To a suspension of potassium phthalimde (4.5 g, 24.0 mmol) in DMF (50.0 ml) was 
added 4-bromo-l-butene (2.25 ml, 22.0 mmol) and the mixture was stirred at room 
temperature overnight. The resulting mixture was diluted with water (50 ml) and then 
extracted with dichloromethane (3 x 20 mI). The combined organic extracts were washed 
with a 10% aqueous solution of sodium hydroxide (2 x 30 m\.) and dried over anhydrous 
magnesium sulfate. The solvent was then removed under reduced pressure to furnish 2-
but-3-enyl-isoindole-I,3-dione (2.74 g, 62%). DH(300 MHz, CDCh) 2.44 (2H, q, J 7.0, 
NClhCllzCII), 3.75 (211, t, J 7.0, NClhClh), 4.97-5.28 (2H, m, CH=Cllz), 5.69-5.85 
(III, m, CIhCII=CIb), 7.65-7.72 (211, m, aromatic II), 7.78-7.85 (2H, m, aromatic H); 
&·(75.5 Mllz, CDCh) 33.23 (t), 37.69 (t), 117.95 (t), 123.59 (2 x d), 132.45 (2 x s), 
134.28 (2 x d), 134.85 (d), 168.74 (2 x s). To a solution of 2-but-3-enyl-isoindole-l ,3-
dione (2.0 g. 9.95 mlllol) in diethyl ether (30 m!.) was added hydrazine hydrate (0.92 mI. 
29.85 mrnol) and the mixture stirred at room temperature overnight. The mixture was 
diluted with water (20 Ill!.) and then added to an excess of concentrated hydrochloric 
acid. The resulting precipitate was filtered off and the filtrate extracted with diethyl ether 
(3 x 15 mI.). The aqueous phase was then concentrated under reduced pressure to yield 
but-3-enylamine 41S the hydrochloride salt. Spectral details match those previously 
reported. J7 
2·D 
Chapters 6 : Experimental. 
~(300 MHz, CDCh) 2.21 (2H, app dq, J 6.5, J 1.5, NH2CH2CllzCH), 2.74 (2H, t, J 6.5, 
NI-IzClhCH2), 4.85 (2H, br, Nllz) , 5.04-5.12 (2H, m, CH=Cllz), 5.68-5.84 (IH, m, 
CH2CII=CH2); &(75.5 MHz, CDCh) 38.23 (t), 41.42 (t), 117.15 (t), 136.43 (d). 
6.4.1 0 But-3-enyl-isobutylidene-amine (231) 
Isobutylaldchydc (1.02 ml, 1 1.0 mmol) and but-3-enylamine (0.8 g, 11.0 mmol) were 
reacted as described previously (6.4.1) to afford but-3-enyl-isobutylidene-amine (231) as 
a colourless oil which was used without further purification (1.32 g, 96%). 
VlTla~ (neat) tcm· 1 3027, 2948, 1650, 1452, 1372, 1029, 728; 611(300 MHz, CDCI3) 0.94 
(311, d, J 7.0, CIICIIJCII.l), 1.04 (311, app dd, J 7.0, J 1.0, CHCI-hCllj ), 2.23 (2H, q, J 
7.0, NClbCllzClI), 2.26-2.30 (III, m, CIIClhClh), 3.34 (211, t. J7.0, NClhCH2), 4.91-
5.05 (211. m. CII=CII1 ). 5.62-5.76 (lll. m, CJI=Clh), 7.42 (JH, dd, J 5.5, J 1.0, 
N=CIICII); &·(75.5 Mllz, CDCh) 19.82 (q), 19.92 (q), 34.38 (d), 35.51 (t), 60.90 (t), 
1 16.44 (t), 1 36.60 (d). 170.69 (d); m/z (EI) 126 (Mf t, 64%), 84 (19), 63 (9). 
6.4.11 Allyl-cydohcxylmethlcnc-amine (232) 
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Cyclohexanecarboxaldehyde (2.7 ml, 22.0 mmol) and allylamine (1.67 ml, 22.0 mmol) 
were reacted as described previously (6.4.1) to furnish allyl-cyclohexylmethlene-amine 
(232) as a colourless oil which was used without further purification (3.1 g. 91 %). 
Vrnax (film) /cm-I 2954, 2866, 1650, 1365, 1158, 731; 8H(300 MHz, CDCh) 1.08-1.32 
(5H, m, Clh), 1.56-1.77 (511, m, ellz), 2.04-2.18 (tH, m, N=CHCH), 3.90 (2H, d, J 6.5, 
NCllzCII), 4.98-5.22 (211, m, CH=Cllz), 5.82-5.97 (lH, m, CH2CH=CH2), 7.45 (IH, d, J 
6.0, N=CIICH); &(75.5 MHz, CDCI3) 25.34 (2 x t), 25.83 (t), 29.78 (2 x t), 43.88 (d), 
63.71 (t), 115.82 (t), 136.56 (d), 170.43 (d). 
6.4.12 Allyl-isohutylidcne-amine (233)18 
IsobutylalJchyJc (2.51 011,27.7 mmol) and allylamine (2.07 ml, 27.7 mmol) were reacted 
as descrihed previously (6.4.1) to furnish allyl-isobutylidene-amine (233) as a colourless 
oil which was used without further purification (2.7 g, 89%). Spectral details match those 
previously reported. I !l 
811(300 Mill, CDCh) 1.12 (611, d, J 7.0, CIICIfJCIfJ ), 2.4 1 -2.52 (l H, m, CIICH3CH3), 
3.99 (211, dt, J 5.0, J 1.0, NClfzCII), 5.07-5.19 (211, m, CH=CI/z), 5.92-6.04 (t H, m, 
CII=CI 12), 7.56 (III, upp dt, J 5.0, J 1.0, N=CIfCH); &(75.5 MHz, CDCh) 19.67 (2 x q). 
34.48 (d), 63.59 (t), 115.92 (t). 136.54 (d), 171.31 (d). 
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6.4.13 N-Allyl-2-bromo-2-methyl-N-(2-methyl-propenyl)-propionamide (150) 
To a solution of allyl-isobutylidcne-amine (233) (1.95 g, 17.0 mmol) was added 2-
bromo-2-mcthylpropionyl bromide (2.17 ml, 17.0 mmol). Purification by flash column 
chromatography eluting with 5:2 petroleum ether:ethyl acetate afforded N-alIyl-2-bromo-
2-mcthyl-N-(2-mcthyl-propcnyl)-propionamide (150) (2.5 g, 57%) as a pale yellow oil. 
Vma~ (film) Iem·1 2929, 2852, 1737, 1641, 1462, 1179, 1002, 728; bH(300 MHz, CDC))) 
1.64 (311, d, J 1.0, ell=eClljell.l), 1.76 (311, d, J 1.0, CH=CCH)CIIJ), 1.93 (6H, s, 
C(Br)ClljCllj ), 4.06 (211, br d, J 5.5, NClhell), 5.11-5.20 (2H, m, eH=CIIJ), 5.76-5.89 
(III, m, CII=eJl2), 6.41 (III, br s, NClI=C); &(75.5 MHz, eDCb) 14.59 (q), 18.61 (q), 
32.35 (2 x q), 54.50 (t), 58.60 (s), 116.90 (t), 126.22 (d), 132.98 (d), 134.91 (s), 170.70 
(s); 111/:' (el) 262 [(MII-R1Ur)+' 64lfr'], 260 [(MII_79Br)+, 64%],178 (72),138 (32); (Found: 
MII+, 260.0651. el l ll l K79BrNO requires MIt, 260.0652). 
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6.4.14 2-Bromo-N-but-3-enJI-2-methyl-N-(2-methyl-propenyl)-propionamide 
(151) 
B\ JL /\ 'y 
To a solution of but-3-cnyl-isobutylidcne-amine (231) (0.45 g. 3.6 mmol) was added 2-
bromo-2-methylpropionyl bromide (0.57 mi. 3.6 mmol). Purification by flash column 
chromatography eluting with 5:2 petroleum cthcr:ethyl acetate furnished 2-bromo-N-but-
3-enyl-2-mcthyl-N-(2-mcthyl-propenyl)-propionamide (151) (0.52 g. 53%) as a 
colourless oi I. 
V"\a~ (film) !em'l 2976. 1737, 1641, 1447, 1393, 1294. 1185. 1108. 914. 833; bH(300 
Mllz, CDCh) 1.64 (311. d. J 1.0, CII=CCIIJClh). 1.85 (311. d. J 1.0. CH=CCH3Clh). 
1.97 (611, S, C(Br)CIIJClh). 2.35 (211. q. J 7.5, ClhClhCH). 3.53 (2H, t, J 7.5, 
NCII1CII2). 4.99-5.11 (211. m, CII=Cllz). 5.69-5.84 (Ill, m, CII=CI-h). 6.41 (lH. br s, 
NCII=C); &-(75.5 Mill, CDCI,,) 15.62 (q). ]9.69 (q), 29.32 (2 x q), 34.74 (t), 51.04 (t), 
58.45 (s). 116.23 (t), 124.39 (d). 134.12 (d). 129.87 (s). 170.42 (s); mlz (EI) 276 [(MH-
8I Br)\ 44'4J. 274 [(MII_7'JUr)+, 42fkJ. 193 (65).138 (26). 55 (19). 
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6.4.15 N-Allyl-2-bromo-N-cyclohexylidenemethyl-2-methyl-propionamide (149) 
To a solution of allyl-cyclohcxylmcthlcne-amine (232) (3.0 g, 19.0 mmol) was added 2-
bromo-2-mcthylpropionyl bromide (2.45 ml, 19.0 mmol). Purification by flash column 
chromatogr'lphy eluting with 9: 1 petroleum ether:ethyl acetate furnished N-allyl-2-
bromo-N-cyclohexylidcnemethyl-2-methyl-propionamide (149) (2.96 g, 52%) as a 
colourless oi I. 
Vma~ (film) !em·1 2930,1738,1639,1448,1365,1180,1109,836,751; OH(300 MHz, 
CDC!.!) 1.52-1.65 (611, m, Cllz), 2.03 (611, s, C(Br)ClhCIIJ), 2.1 ]-2.]8 (4H, m, ellz), 
4.05 (211, d, J 5.5, NCllzCII), 5.11-5.20 (211, m, CH=CI/z), 5.77-5.90 (IH, m, CII=CH2), 
7.28 (III, hr s, NCII=C); &:(75.5 Mllz, CDCb) 26.49 (t), 26.62 (t), 27.87 (t), 28.88 (t), 
32.61 (2 x q), 33.20 (I), 55.18 (t), 58.83 (s), 116.94 (t), 123.22 (d), 133.03 (d), 141.19 (s), 
170.69 (s); ",/:. (EI) 302 [(MII-8I Br)+, 64%J, 300 [(MII)9Brt, 67%J, 219 (78), 163 (31), 
136 (17); (round: MII+, 300.0969. CI411n79BrNO requires MH+, 300.0964). 
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6.4.16 4-(I-Bromo-l-methyl-ethyl)-I-but-3-enyl-3,3-dimethyl-azetidin-2-one (156) 
Sr 
N 
o 
2-Bromo-N-but-3-cnyl-2-mcthyl-N-(2-mcthyl-propenyl)-propionamide (151) (100 mg, 
0.36 mmol) was rcacted as described previously (6.4.7) to afford 4-(1-bromo-l-methyl-
cthyl)-I-but-3-cnyl-3,3-dimcthyl-azctidin-2-onc (156) (89 mg, 89%) as a colourless oil. 
Vrn,u (film) !em"' 3368,2975, 1731, 1651, 1530, 1461, 1412, 1284, 1170,920,739; 
811(300 Mllz, CDCh) 1.24 (311, s, C(Br)CIIJClh), 1.25 (311, s, C(Br)ClhCH]), 1.82 (6H, 
s, CCIIJCIIJ), 2.39 (211, app dq, J 7.5, J 1.0, CH2ClhCII), 3.15-3.23 (IH, m, 
NCIIIIClh), 3.59-3.69 (III, m, NCIIIIClh), 3.78 (III, S, NCII), 4.97-5.11 (2H, m, 
CII=Clll), 5.66-5.75 (III, m, CI bCII=CI h); &(75.5 MHz, CDCb) 16.95 (q), 25.27 (q), 
30.59 (q), 31.80 (q). 32.35 (I). 39.56 (1),55.5 I (5),66.48 (s), 73.07 (d), 117.78 (t), 135.44 
(d), 174.77 (s); ",/= (EI) 276 [(MII-slnr)+, 86%]. 274 [(MH)9Brt, 90%],193 (44), 152 
(68),58 (23): (Found: Mil+, 274.0811. Cdho79BrNO requires MII+, 274.0807). 
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6.4.17 Cyclisation of N-Allyl-2-bromo-2-methyl-N-(2-methyl-propenyl)-
propionamide (150) 
Br 
Br 
o 
155 154 
N-Allyl-2-bromo-2-mcthyl-N-(2-mcthyl-propcnyl)-propionamide (150) (100 mg, 0.38 
mmol) was reactcd as dcscribcd prcviously (6.4.7) to furnish an inseperable (3:2) mixture 
of J -allyl-4-(bromo- J -mcthyl-ethyl)-3,3-dimethyl-azetidin-2-one (155) and 4-
bromomcthyl-3,3-dimcthyl-l-(2-mcthyl-propenyl)-pyrrolidin-2-one (154) (92 mg) in the 
form of a colourless oil. 
Vma~ (film) !em-\ mixture 3273, 2924, 1745, 1658, 1462, 1369, 1173, 1079, 817; 
Discernible data for l-allyl-4-(bromo-l-mcthyl-ethyl)-3,3-dimethyl-azetidin-2-one (155), 
011(300 Mill, CDCh) 1.26 (311, s, CCIIJClh), 1.30 (3H, s, CCH3Cl/3), 1.80 (6H, s, 
C(Br)CIIJCIIJ), 3.69 (III, s, NCII), 3.70 (III, m, NClnI), 4.19 (1 H, ddt, J 15.5, J 5.5, J 
1.1, NCIIII) 5.16-5.27 (211, m, CII=CI/z), 5.69-5.75 (Ill, ru, CH2Cl/=CH2); discernible 
data for and 4-bromomcthyl-3,3-di mcthyl-l-(2-mcthyl-propenyl)-pyrrolidin-2-one (154), 
011(300 Mill, CDCh) 1.26 (311, s, CCl/JCH), 1.30 (3H, s, CCH3Cl/3), 1.61 (3H, d, J 
1.5, CII=CCIIJCI b), 1.68 (311, d, J 1.5, CII=CH.~CII3), 2.39-2.48 (lI-I, m, NCH2CII), 
3.18-3.30 (III, m, NCIIII), 3.45 (III, dd, J 10.0, J 4.5, NCH/I), 3.67-3.74 (2H, m, 
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CHClIzBr), 5.77-5.82 (lH, m, NClI=C); <5c(75.5 MHz, CDCh) mixture 16.84 (2 x q), 
22.09 (2 x q), 28.68 (t), 29.83 (t), 30.17 (2 x q), 30.26 (q), 30.39 (q), 39.24 (s), 39.89 (d), 
41.34 (s), 42.64 (t), 49.36 (s), 72.22 (d), 104.63 (s), 116.23 (d), 117.78 (t), 130.89 (d), 
179.03 (s), 182.79 (s). 
6.4.18 Cyclisation of N-allyl-2-bromo-N-cyclohexylidenemethyl-2-methyl-
propionamide (149) 
152 153 
N-Allyl-2-hromo-N-cyc!o!Jexylidenemethyl-2-methyl-propionamide (149) (l00 mg, 0.33 
mmol) was reacted as descrihed previously (6.4.7) to furnish an inseperable (l: 1.75) 
mixture of l-allyl-4-(I-hromo-cyclo!Jexyl)-3,3-dimethyl-azetidin-2-one (152) and 4-
Dromol11cthyl-l-cyc1ohexylidenemcthyl-3,3-dimethyl-pyrrolidin-2-one (153) (96 mg) in 
the form of a colourless oi I. 
Vl1la~ (film) Icrn· 1 mixture 3394, 2929, 1734, 1651, 1461, 1414, 1371, 1170, 1038,920, 
739; Discernible data for and 4-hromomethyl-l-cyclohexylidenemethyl-3,3-dimethyl-
pyrroJidin-2-onc (153), 811(300 Mill, CDCh) 1.17 (311, s, CCIIJClh), 1.18 (3H, s, 
CCJlJCII./), 2.37-2.47 (III. m. CIICII~Br), 3.19-3.29 (2B, m, CHCI/zBr), 3.46 (HI, dd, J 
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10.0, J 4.5, NCIIH), 3.62 (lH, m, NCHH), 5.80 (tH, s, NCIl=C); discernible data for 1-
allyl-4-(l-bromo-cyclohexyl)-3,3-dirnethyl-azetidin-2-one (152), OH(300 MHz, CDCb) 
1.27 (31f, s, CClhCH), 1.49 (3H, s, CCH)CIlJ ), 3.61 (tH, s, NCH), 3.64 (lH, m, 
NCIIH), 4.20 (III, ddt, J 15.5, J 5.0, J 1.5, NCIIH), 5.15-5.20 (2H, m, CH=CH2), 5.67-
5.75 (lll, m, CII2CII=CH2); 8c(75.5 MHz, CDCb) mixture 18.75 (q), 18.86 (q), 22.37 (2 
x t), 23.02 (t), 24.62 (q), 25.36 (q), 25.46 (t), 26.74 (t), 27.59 (t), 28.46 (t), 29.38 (2 x t), 
31.80 (2 x t), 34.31 (t), 37.94 (5), 44.06 (5), 46.93 (d), 52.24 (t), 55.84 (s), 73.61 (d), 
116.40 (d), 119.07 (t), 132.54 (d), 136.28 (s), 178.45 (s), 182.47 (s). 
6.5 Experimental ror chapter 5 
6.5.1 General proC('dlJre for the preparation of imines. 
A solution of primary amine (1 eq.) and cyc!ohexanone (t eq.) in toluene were heated at 
renux in a Dean-Stark apparatus with azeotropic removal of water for 4 hours. The 
solvent was then removed under reduced pressure to yield the imine. 
6.5.1.1 (2-nromo-ht.·nl.)'I)-cydohexylidene-amine (190) 
I N 
#' Br 
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Condensation of o-bromobenzylamine (4.0g, 21.0 mmol) and cyclohexanone (2.06 g, 
21.0 mmol) as described above (6.5.1) afforded (2-bromo-benzyl)-cyclohexylidene-
amine (190) (5.05 g, 91 %) as a pale yellow oil which was used without further 
purifcation. 
Vma" (neat) /cm- I 2934, 2859, 1716, 1663, 1568, 1464, 1441, 1347, 1026; 8H(300 MHz, 
CDCI) 1.42-2.08 (811, m, Cllz), 2.23-2.40 (2H, m, ClIz), 4.50 (2H, s, NCllz), 6.98-7.09 
(III, m, aromatic 11),7.12-7.24 (211, m, aromatic H), 7.46 (IH, d, J 7.0, C(Br)C1/); m/z 
(CI) 268 [(MII-SIBrt, 30%], 266 [(M_79Brt, 29%],186 (30). 
6.5.2 I-Bromo-2-(2-nitro-vin),l)-benzene (200)16 
To a solution of 2-hromobcn7.aldehyde (5.0 ml, 43.2 mmol) and nitromethane (2.34 mI, 
43.2 mrnol) in methanol (10 ml) was addcd an aqueous solution of sodium hydroxide (1.8 
ml, 25 M). A white prccipitate formcd immediately and the resulting mixture was stirred 
for one hour at room tcmperature. The prccipitate was dissolved by the addition of water 
(100 ml) and the aqueous solution added to an excess of hydrochloric acid to deposit the 
crude product. Recrystallisation from ethanol afforded I-bromo-2-(2-nitro-vinyI)-
benzene (200) (3.4Rg. 73fh,) as pale ycllow pillars; m.p. 89-92°C. Spectral details match 
those previow,ly rcportcd. '6 
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Vmax (neat) tcm'l 1634, 1584, 1502, 1466, 1340, 1286, 1025,953, 760,599; oH(300 MHz, 
CDCb) 7.24-7.36 (2H, m, aromatic H), 7.47 (1H, d, J 12.0, CH=CHN02), 7.47-7.53 (IH, 
m, aromatic H), 7.62 (lH, dd, J 7.5, J 1.5, C(Br)CHCH), 8.34 (lH, d, J 12.0, 
CH=CHN02); 0cC75.5 MHz, CDCh) 126.74 (s), 128.50 (d), 128.88 (d), 130.73 (s), 
132.98 (d), 133.56 (d), 137.98 (d), 139.23 (d); mlz (El) 229 [(M_8lBr)+, 29%J, 227 [(M-
79Br)+, 31%],148 (48),118 (100), 75 (52). 
6.5.3 2-(2-Bromo-phcnyl)-ethylamine (201)16 
To a suspension of LiAIII4 (0.52 g, 14.1 mmol) in ether (20 ml) under an atmosphere of 
nitrogen was slowly added a solution of o-bromo-~-nitrostyrene (200) (0.8 g, 3.52 mmol) 
in ether (10 ml) with ice cooling. The mixture was stirred at room temperature for 30 
minutes then the excess LiAIII4 was carefully destroyed by addition of wet ether and 
water. The mixture was then filtered through a cclite pad, the organic phase was dried 
over anhydrous magnesium sulfate and the solvent removed under reduced pressure to 
furnish 2-(2-hromo-phenyl)-ethylamine (20 I) (0.67 g, 96%) as a pale yellow oil which 
was used without further purification. Spectral details match those previously reported. l6 
Villa" (neat) !em·1 3383,3062,2919, 1568, ]47], ]440, 1025,656; OH(300 MHz, CDCb) 
1.10-1.54 (211, br s, NI/z), 2.73-2.94 (411, m, CI/zCI/zNH2), 6.92-6.98 (JH, m, aromatic 
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H), 7.03-7.22 (2H, m, aromatic H), 7.47 (tH, d, J 7.5, C(Br)CIl); Oc(75.5 MHz, CDCb) 
39.94 (t), 41.76 (t), 124.45 (s), 127.21 (d), 127.74 (d), 130.69 (d), 132.71 (d), 148.09 (s); 
mlz (EI) 202 [(MH-SIBrt, 94%], 200 [(MH)9Br)\ 100%], 170 (3),118 (8). 
6.5.1.2 [2-(2-Bromo-phenyl)-ethyl]-cyclohexylidene-amine (202) 
Condensation of 2-(2-bromo-phenyl)-ethylamine (0.46 g, 2.3 mmol) and cyc1ohexanone 
(0.24 ml, 2.3 mmol) as described above (6.5. I) afforded [2-(2-bromo-phenyl)-ethyl]-
cyclohcxylidcnc-arninc (202) (0.37 g, 58%) as a yellow oil which was used without 
further purifcalion. 
Vllla~ (neat) !em'· 2928,1724, J657, 1442, 1029; 011(300 MHz, CDCI3) 1.45-2.11 (8H, m, 
Clh), 2.23-2.39 (211, m, C1l1 ), 3.03-3,08 (211, m, NClhCFh), 3.42-3.49 (2H, m, 
NClhCllz), 7.02-7.10 (J II, m, aromatic II), 7.22-7.28 (2H, m, aromatic H), 7.54 (tH, d, J 
7.0, C(Dr)CII); 111/:' (EI) 282 [(MII-sl l3r)+, 46%],280 [(MH_79I3r)+, 51%], 200 (13). 
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6.5.4 General procedure for the preparation of enamides. 
To a solution of 2-bromo-2-methylpropionyl bromide (1.1 eq.) or trichloroacetyl chloride 
(1.1 eq.) in dry toluene under an atmosphere of nitrogen was added dropwise a solution 
of the imine (1.0 eq.) in dry toluene. After stirring for 1 hour at room temperature, the 
mixture was cooled to ODC and triethylamine (3.0 eq.) added. Stirring was continued for 2 
hours at room temperature, the mixture was then added to a saturated aqueous solution of 
Na2C03 and extracted with diethyl ether (3 x 20 mI.). The combined organic extracts 
were dried over anhydrous magensium sulfate and the solvent removed under reduced 
pressure. 
6.5.4.1 N-(2-Bromo-hcnz),I)-2,2,2-trichloro-N-cyclohex-l-enyl-acetamide (192) 
(2-Bromo-henzyl)-cyclohcxylidcne-amine (190) (2.0g, 7.5 mmol) and trichloroacetyl 
chloride (1.0 ml, 9.02 11111101) were reacted as described above (6.5.4). Purification by 
fla!-.h column chromatogr<lphy eluting with 20: I hexane:ethyl acetate furnished N-(2-
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bromo-benzyl)-2,2,2-trichloro-N-cyclohex-l-enyl-acetamide (192) (1.17 g, 37%) as a 
pale yellow oil. 
V rnall (neat) /em-I 2938, 2862, ]667, ]44], 135], 1391, 1218, 1027, 823; BH(300 MHz, 
CDCb) 1.37-1.76 (611, m, CIIJ), 1.87-2.09 (2H, m, CliJ) , 4.64 (lH, br, NCHH), 5.07 
(lll, br, NCIIII), 5.68 (III, t, J 4.0, NC=CII), 7.11 (IH, dt, J 7.5, J 1.5, H-4), 7.29 (IH, 
dt, J 7.5, J 1.5, 11-5), 7.42 (III, dd, J 7.5, J 1.5, H-6), 7.50 (]H, dd, J 7.5, J 1.5, H-3); 
&,(75.5 Mill, CDCb) 21.24 (1), 22.7] (t), 25.13 (t), 28.01 (t), 52.69 (t), 98.07 (s), 124.44 
(s), 125.22 (d), 127.60 (d), 129.57 (d), 130.]6 (d), ]33.15 (d), 134.27 (s), 136.06 (s), 
]63.67 (s); m/:. (EI) 412 [(MII-8Inrt, 68%], 410 [(MH_79Br)+, 32%], 342 (76), 306 (74), 
260 (6),226 (8), 186 (5). 
6.5.4.2 2-Bromo-N-(2-hromo-hcnZll)-N-cydohex-l-enyl-2-methyl-
propion:ami<ic (191) 
(2-Bromo-hl'lllyl)-<"yclohcxylidcne-amine (190) (2.0g, 7.5 mmol) and 2-bromo-2-
mcthylpropiollyl hromide (1.1 ml, 9.02 mmol) were reacted as described above (6.5.4). 
Purification hy OJ,h column chromatography eluting with ] 6:] hexane:ethyl acetate 
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furnished 2-bromo-N-(2-bromo-benzyl)-N-cyclohex-l-enyl-2-methyl-propionamide (191) 
(0.6 g, 19%) as a yellow oil. 
Vmax (neat) !em·· 2931,2856,1781.1704,1631.1466,1393,1295,1183,1106,1029; 
DIl(300 Mllz, CDCh) 1.42-1.64 (611, m, CII]), 1.99 (6H, s, C(Br)CHJCIIJ), 2.14-2.31 
(2B, m, CII]), 4.11 (III, br d, J 18.0, NCIIII), 5.23 (lH, br d, J 18.0, NCHlI), 5.12 (lH, 
t, J 3.5, NC=CII), 7.02 (III, dt, J 8.0, J 1.5, H-4), 7.19 (lH, app dt, J 8.0, J 1.5, H-5), 
7.43 (lll, apr dd, J 8.0, J 1.5, 11-6), 7.46 (111, app dd, J 8.0, J 1.5, H-3); &(75.5 MHz, 
CDCb) 19.98 (I), 22.52 (I), 23.96 (I), 27.40 (I), 31.44 (2 x q), 51.07 (t), 57.68 (s), 121.21 
(s), 128.83 (d), 126.47 (d), 127.57 (d), 128.20 (d), 131.41 (d), 135.74 (5), 136.82 (s), 
169.46 (s); mIl. (EI) 418 [(MII-8I nr Klnrt. 25%), 416 [(MII-8I Br 79Br)+, 100%),414 
[(MII_79Br 79nr)+, 61 '7c J. 336 (8), 291 (5), 170 (4). 
6.5.4.3 2-B romo-N -[ 2-(2-hromo-phrnJ1)-ethJI J-N -cyclohex-l-enyl-2-methyl-
propionamidc (203) 
4 
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[2-(2-Bromo-phenyl)-ethyIJ-cyclohexylidene-amine (202) (-2.0g, 10.0 mmol) and 2-
bromo-2-mcthylpropionyl bromide (] .36 m], 1].0 mmol) were reacted as described above 
(6.5.4). Puri fication by flash column chromatography eluting with 4: 1 heptane:ethyl 
acetate furnished 2-bromo-N-[2-(2-bromo-phenyl)-ethyl]-N-cyclohex-l-enyl-2-methyl-
propionamidc (203) (0.89 g. 22fk) as a yellow oil. 
Vma~ (neat) !em-I 2938,1743, ]634, ]471, 1393, ]366, 1287, 1161, 1110, 1017; oH(300 
Mllz, CDCIJ ) 1.48- 1.59 (411, m, ClIl), 1.62-1.70 (2H, m, Clh), 1.93 (6H, s, 
C(Br)CIIJCIIJ ), 2.04-2.09 (211, m, Clll ), 2.98 (211, t, J 8.0, NCH2CII2 ), 3.24 (tH, br s, 
NCIIIICII2), 3.70 (I II, br s, NCIIIICI h), 5.69 (] II, br, C=CIICH2), 7.00 (lH, dt, J 7.5, J 
J .5, 11-4), 7. J 6 (III, dt, J 7.5, J 1.5,11-5), 7.23 (III, dd, J 7.5, J ] .5, H-6), 7.34 (IH, dd, J 
7.5, J 1.5, 11-3); ~{75.5 Mill, CDCb) 21.09 (t), 22.43 (2 x t), 24.48 (t), 26.80 (t), 27.53 
(2 x q), 48.52 (t), 58.05 (s), ]24.32 (s), 127.41 (d), ]27.92 (d), 128.20 (d), 130.95 (d), 
132.76 (d), 137.88 (s), I3lU8 (s), J6J.R6 (s); m/z (EI) 432 [(MII-8I Br 8I Br)+, 61%],430 
[(MII-RIBr 7'lBr)+, )()()~], 428 [(MII_79Br 7QUr)+, 66%], 350 (42), 270 (3), 196 (4). 
6.5.5 1-(2·Hrof1lo-ht·l1l) 1)-3·dlloro-l ,4,5,6-tctrahydro-indol-2-one (205) 
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To a mixture of N-(2-bromo-benzyl)-2,2,2-trichloro-N-cyclohex-l-enyl-acetamide (192) 
(0.1 g, 0.24 mmol) and copper (I) chloride (24.0 mg, 0.24 mmoI) under a nitrogen 
atmosphere was added a solution of tris-(2-pyridyl-methyl)-amine (132) (7.0 mg, 0.24 
mmol) in dry dichlorocthane (3.2 ml, 0.12M solution). The resulting mixture was stirred 
under reflux at 80°C for 48 hours. The mixture was then eluted through a silica plug with 
dichloromcthane and subsequent removal of solvent under reduced pressure furnished 1-
(2-bromo-bcnzyl)-3-chloro- l,4,5,6-tetrahydro-indol-2-one (205) (51.0 mg, 62 %) as a 
pale yellow oil. 
Vnla, (neat) !em-I 2932,1717,1657,1558.1433,1340,1318,1144,1027, 958; ~H(300 
Mill, CDCll) 1.77 (211. qn. J 6.0, CIICI hCllzClh), 2.23 (2H, q, J 6.0, CHClIzCH2CH2), 
2.58 (211, t, J 6.5, CIICII~CJl~CII.l), 4.83 (211, s. NCllz), 5.50 (J H, t, J 5.0, C=CIICH2), 
6.92 (J II, d, J 7.5, 11-6), 7.05 (J II, t, J 7.5, 11-4), 7. J 6 (Jll, t, J 7.5, H-5), 7.47 (tH, d, J 
7.5, 11·3); &{75.5 Mill, C[)Ch) 22.05 (t), 22.36 (t), 24.06 (t), 43.13 (t), 111.87 (d), 
124.84 (s), 127.55 (d). 127.81 (d). 128.64 (d), 132.49 (d), 137.54 (s), 138.26 (s), 139.95 
(s), 142.20 (s), 163.59 (s); ml:. (EI) 340 [(MII.Blnr)+, 1000/0],338 [(MH_79Br)+, 74%], 306 
(8).260 (X), 226 (4). 
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6.5.6 1-(2-Bromo-benz)'1)-3,3-dimethyl-l ,3,3a,4,5,6-hexahydro-indol-2-one (204) 
4 
o 
6 
3 
To a mixture of 2-bromo-N-(2-bromo-bcnzyl)-N-cyclohex-l-enyl-2-methyl-
propionamide (191) (0.2 g. 0.48 rnmol) and copper (I) bromide (20.0 rng, 0.14 rnrnol) 
under a nitrogcn atmosphere was added a solution of tris-(2-pyridyl-rnethyl)-arnine (132) 
(42.0 mg, 0.14 mmol) in dry dichloromethane (0.12M solution). The resulting rnixture 
was stirred al room temperature for 15 rninutes. The rnixture was then eluted through a 
silica plug with dichlorol11cthane and subsequent rernoval of solvent under reduced 
pressure afforded J -(2-bromo-hcnzyl)-3,3-dimethyl-1 ,3,3a,4,5,6-hexahydro-indol-2-one 
(204) (0.18 g, 90~) as a pale ycllow oil. 
vrrkl~ (neal) !em·1 2<)3~, 1715, 1677, 1570, 14~1, 1407, 1338, 1171, 1028; ~H(300 MHz, 
CDCh) 1.09 «(lli. rn, eel/JellJ), 1.4 I -2.00 (611. m, CIIJ), 4.42 (J H, d, J 16.0, NClm), 
4.73 (III, I, J 3.5, CIIC=CII). 4.93 (III, d. J 16.0, NCIIII), 5.24 (lH, br s, C=Cll), 7.01 
(III, app t. J 7.5,11-4).7.13-7.20 (211, m. 11-5, 11-6), 7.47 (III, d, J 7.5, H-3); &:(75.5 
Mllz, CDC") 20.06 (q), 23.32 (t). 2~.81 (I), 2~.90 (q), 25.94 (t), 44.32 (t), 49.16 (s), 
JOO.8~ (d). 123.07 (s), 125.17 (d). 127.89 (d), 128.09 (d), 128.54 (d), 133.14 (d), 136.07 
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(s), 143.66 (s), 180.35 (s); mil. (El) 336 [(MH-8I Br)+, 15%],334 [(MH)9Brt, 32%], 291 
(60).279 (27), 254 (3), 108 (8). 
6.5.7 1-[2-(2-Hromo-phenJI)-ethyl]-3,3-dimethJI-1 ,3,4,5,6,7-hexahydro-indol-2-one 
(211) 
o 
4 
To a mi xlure of 2-hromo-N-[2-(2-hromo-phcnyl)-ethyl]-N-cyclohex-l-enyl-2-methyl-
propional11idc (20.1) (0. J g. 0.23 I11mol) and copper (I) bromide (l0.0 mg. 0.07 mmol) 
under a nitrogen atmosphere was added a solution of tris-(2-pyridyl-methyl)-amine (132) 
(20.0 mg, 0.07 mlllol) in dry dichlororncthane (0.12M solution). The resulting mixture 
was stirred at roorn temperature for 5 minutes. The mixture was then eluted through a 
silica plug with dil'hloromethane and the solvent removed under reduced pressure. 
Purification hy fla,h column chromatography eluting with 20:1 heptane:ethyl acetate 
afforded J ·r 2·(2·hrol1lo-phcnyl )-ethyl J-3.3-dimcthyl-l.3.4.5.6.7-hexahydro-indol-2-one 
(211) (30.0 mg. Wlt) as a yellow oil. 
VllI,u (ncal) km· 1 2936. 1707, 1676. 1568. 1472. 1394, 1355, 1116, 1016; DH(300 MHz. 
CDCh) 1.02 «(,II, s, eCIIJCIIJ), 1.51-1.59 (411, m, CII1), 1.82-1.89 (4H. m, CII1). 2.97 
Chapters 6 : Experimental. 
(2H, t, J 7.0, NCH:Cllz), 3.57 (211, t, J 7.0, NCI/zCH2), 7.00 (lH, app dt, J 7.5, J 1.0, H-
4), 7.09-7.18 (211, m, 11-5,11-6),7,49 (III, d, J 7.5, H-3); &<75.5 MHz, CDCb) 21.02 (t), 
21.88 (I), 22.26 (1),22.33 (2 X q), 23.39 (t), 33.06 (t), 40.13 (t), 46.12 (s), 127.89 (2 X d), 
129.29 (2 X d), 133.13 (s), 137.Q.t (s), 138.78 (s), 139.97 (s), 178.15 (s); mlz (EI) 350 
[(MII-8IBrt. 80~), 3~8 [(MII-,9Br)+, 10017£-],268 (4),178 (6). 
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